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ABSTRACT
The New technique for the in vitro roller culture of 9•5-day rat con- 
ceptuses in homologous serum has been used to provide direct quantit­
ative biochemical evidence for the long-suspected nutritional function 
of the visceral yolk sac during early organogenesis.
Conceptuses, cultured in the presence of ^X—labelled FVP, dextran,
‘125l-dBSA, [5h ¡ leucine-labelled serum proteins or [5h| leucine-labelled 
homologous haemoglobin showed no uptake of intact macromolecules into 
the embryo. All five however were taken by pinocytosis into the 
visceral yolk sac. The indigestible macromolecules I-labelled FVP
and [ * 1  dextran accumulated in the yolk sac lysosomes, but the radio—J fl25 1labelled proteins were digested there to yield either | I| iodo—
tyrosine or [%] leucine. Iodotyrosine (non-metabolisable)
was released into the culture medium but ]^hJ leucine was used for 
protein synthesis in both the yolk sac and the embryo. The digestive 
capacity of the yolk sac was further demonstrated by direct assay of 
lysosomal acid hydrolase activity in yolk sac homogenates. SDS 
Polyacrylamide gel electrophoresis showed that leucine, derived
from the digestion^pll] leucine-labelled haemoglobin, became 
incorporated 'into a large number of yolk sac and embryo proteins. 
Although free non—radiolabelled leucine was shown to decrease the 
extent to which £3hJ leucine from radiolabelled protein was incor­
porated into the proteins of the conceptus, it is argued that, 
in vivo, yolk sac degradation of pinocytosed protein is of paramount 
importance in the provision of amino acids for protein synthesis in 
the conceptus.
^be lysosomotropic teratogens trypan blue, suramin, sodium aurothio- 
fflalate, anti-visceral yolk sac antiserum and leupeptin, present in 
culture with radiolabelled macromolecules, inhibit either pinocytosis 
by the yolk sac”(trypan blue, suramin, antiserum), normal fusion of 
Pinosomes and lysosomes (suramin) or proteolysis in the yolk sac 
(aurothiomalate, leupeptin). It is that the mechanism of
teratogenic action of these compounds^involve an inhibition of yolk 
sac-mediated histiotrophic nutrition. ,
1X1
Some of the data in this thesis have been published, or submitted 
for publication as follows:
Freeman, S.J. & Lloyd, J.B., (1980). Differential uptake of a macro­
molecule by yolk sac and embryo of early rat conceptuses cultured 
in vitro. Biochem. Soc. Trans. 8, 434*
Freeman, S.J. & Lloyd, J.B. (1981). Amino acids for developing rat 
embryo supplied by proteolysis in yolk sac lysosomes. Biochem. Soc. 
Trans. £, 262P.
Freeman, S.J., Beck, F. & Lloyd, J.B. (1981). The role of the visceral 
yolk sac in mediating protein utilisation by rat embryos cultured 
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CHAPTER ONE
GENERAL INTRODUCTION
1.1 Embryotrophic Nutrition
1.1.1 Current Status of Knowledge
A placenta is defined by Mossman (quoted by Beck, 1976) as "an 
intimate apposition or fusion of :fetal organs to maternal tissues 
for physiological interchange". Usually, reference to a placenta 
implies a chorioallantoic placenta, a highly vascularised organ 
which has assumed the principal role in; maternal-fetal exchange 
in the Eutheria. The effectiveness of the chorioallantoic 
placenta depends on a well-developed embryonic cardiovascular 
system and, clearly therefore, organogenesis is well advanced at 
"the onset of function of this placenta. In rodents chorioallantoic 
placentation does not occur until mid-gestation, by which time 
many organs are well differentiated. The question therefore 
arises as to how the nutritional demands of the rodent embryo are 
satisfied during the early stage of organogenesis - what mechanisms 
exist to nourish the embryo during this time?
In the absence of a chorioallantoic placenta, the growing embryo 
must be sustained by nutrients present in its immediate environment. 
Such nutrients, termed histiotroph by early embryologists, are 
considered to consist largely of maternal macromolecules, chiefly 
the breakdown products of proliferated endometrial cells, uterine 
secretions and extravasated maternali-blood (Beck, 1970). It is 
uncertain however whether the largely macromolecular nature of 
histiotroph is in itself important. It could simply be that the 
nutritional demands of the embryo are satisfied by micromolecular 
nutrients which diffuse into, and are assimilated by, the cells of 
the embryo, there being no need of a specialised mechanism to l
channel nutrients to the embryo.
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To gain a better understanding of histiotrophic nutrition is not of 
mere academic interest. Teratologists have long recognised that the 
developing embryo is maximally sensitive to* teratogenic insult 
during the period of early organogenesis (Wilson, 1973)* A large 
number of studies (summarised by Wilson, 1973) has conclusively 
proved that before and following organogenesis the embryo is almost 
completely refractory to teratogenesis, whereas during organogenesis 
it is highly susceptible to the action of teratogens. Chemical * 
teratogens act on biochemical mechanisms of the embryo, and it is 
important to understand what these biochemical mechanisms are.
Only in rodents, and in particular the rat, has histiotrophic 
nutrition been studied in any detail. Mounting evidence, albeit 
indirect, implicates the visceral yolk sac in serving a nutritional 
function during early organogenesis. This conspicuous extras 
embryonic membrane lies adjacent to the embryo at the primitive
streak stage * and during early organogenesis comes to surround it
]
completely, persisting like this till term (Beck,1970, 1976).
Brunschwig (1927) inferred a placental function of yolk sac from 
investigations of iron uptake by the early post-implantation embryo.
He observed that the yolk sac provided the only route of access for 
the iron during its passage to the embryo. Several workers (.
(Goldman, 1^09; WiSlocki, 1921; Everett, 1935) noted that the 
visceral yolk sac was capable of "absorbing" the dye trypan blue, 
and suggested a placental role for the yolk sac. Payne and Deuchar 
(1972) found that the removal of the visceral yolk sac from 10-day 
rat embryos grown in culture for 24 hours led to poor growth and 
development. Relative to controls, these embryos showed a much lower 
iotal protein content and a reduced ability to incorporate leucine,
- 4 -
present in the culture medium, into embryonic tissue.
Morphological studies have revealed that the endodermal cells of the
visceral yolk sac (see section 1.2), which are exposed to histio—
troph present in the yolk sac cavity during early organogenesis,
bear numerous microvilli on their apical surfaces, and have a
well-developed vacuolar system (Lanj^on, 1^66; Beck et al., 1967a$
Krzyzo. wska-Gruca and Schiebler, 1967» Jollie and Triche, 1970*
These features are characteristic of cells engaged in pinocytosis
(see section 1 .3) and the use of suitable histochemical markers
such as horseradish peroxidase (HEP) (Beck et al., 1967a$ Seibel,
1974) and electron-dense compounds such as ferritin and iron
clextran (Gupta et al., 1979) have confirmed that pinocytosis of
macromolecules, followed by inclusion within intracellular vacuoles,
is a property of these cells during early organogenesis. Following
their studies with HEP, Beck et al. (1967a) proposed a mechanism
a.
whereby the visceral yolk sac could act asjfplacenta. They observed 
that soon after parenteral administration of HEP, the enzyme became 
enclosed within apical vacuoles of the yolk sac endoderm. With time 
the HEP, still entrapped within vacuoles, was seen deeper in the 
°ell, ultimately localising in regions of the cytoplasm that gave a 
strong reaction for acid phosphatase, an enzyme known to be located 
exclusively in lysosomes, digestive organelles of the cell. Later 
still, the intralysosomal concentration of HEP was observed to fall. 
Interestingly, at no stage were there present significant quantities 
of marker enzyme in the embryonic tissues. They hypothesised that 
although the HEP was unable to penetrate intact to the embryo tissues, 
"the cells of the yolk sac endoderm pinocytosed the HEP and digested
I
It within their lysosomes. This implied that protein, and perhaps
other macromolecular nutrients, was taken up and degraded by the 
visceral yolk sac endodenn, yielding digestion products, amino acids 
which were subsequently available to the embryo for its own anabolic 
purposes. Proteins were hot transmitted intact directly across the 
yolk sac to any significant extent. .Seibel (1974) has since 
confirmed that in the rat horseradish peroxidase does not reach 
the embryo during organogenesis, while Sharma and Peel (1979) have 
made similar observations with fluoroscein-labelled serum proteins. 
In the early post-implantation mouse conceptus, Sherman and 
Atienza-Samols (l979) have reported that a maternally-derived 
esterase is present in the yolk sac layer but not in the embryo 
and, as far back as 1959» Anderson (Anderson, 1959) observed a very 
low rate of transfer of intact gamma-globulin across the yolk sac 
and suggested that this was due to degradation of the protein in 
this layer.
However, the Beck and Lloyd hypothesis is open to alternative
i
i
explanation. For example, HELP was measured enzymatically and the 
low level of its activity in lysosomes may simply reflect denatur- 
ation of the enzyme in the acidic milieu of the lysosome. Further­
more, there is absolutely no evidence for the utilisation by the 
embryo of amino acids derived from any protein digestion in the 
yolk sac. Most importantly of all, there is no clue as to the 
Possible significance of the contributions of this process, if it 
exists, to embryotrophic nutrition as a whole. As already stated, 
is conceivable that amino acids exogenous to the conceptus are 
Able to satisfy the obvious needs of the embryo for protein building 
blocks, or that specific embryonic proteins are synthesised in 
maternal tissues and are transferred directly to the embryo, perhaps
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gaining access to the latter by a specific mechanism of transport 
through the yolk sac. • >.. .
Since for the formulation of this hypothesis, Beck and Lloyd and 
their associates have sought more direct evidence of the yolk sac's 
ability to pinocytose and digest macromolecules. However, owing to 
the minute amount of tissue available at early organogenesis, 
quantitative biochemical studies have been difficult. Accordingly, 
yolk sac from later in gestation — 17 -5 days - has been studied in 
an organ culture system. Of course in vivo, any placental function 
of the yolk sac is likely to have been taken over by the chorio­
allantoic placenta at this stage, and consequently there is some 
risk in extrapolating back to early organogenesis the interpretations"V
of observations made with the 17*5 day tissue. Nevertheless, ultras
structural appearance of the tissue is similar at both organogenesis
i
and 17 .5 days (Williams et al., 1976), and the distribution of HEP 
in the near-term conceptus is essentially identical to that described 
above for the early organogenetic conceptus (Beck et al., 1967a).
Using the 17 .5-day rat yolk sac culture system, a wealth of data has 
been accumulated which clearly demonstrates the tissue's ability to 
Pinocytose and degrade macromolecules.(Williams et al., 1975a»b;
Roberts et al., 1976, 1977; Moore et al., 1977; Duncan and Lloyd,
1978; Pratten et al., 1978, 1980; Duncan et al., 1979, 1981;
Ibbotson and Williams, 1979; Livesey and Williams, 1979)* Of 
specific relevance to the alleged role of the yolk sac in histio— 
inophic nutrition are results showing that proteins are taken 
Pinocytically into the yolk sac cells and are digested intralysosomally
- 7 -
to the amino acid level (Williams et al., 19756» Livesey and Williams, 
1979). These amino acids are quickly released from the tissue back 
into the culture medium. It is clear from such a quantitative 
study that the (17.5-day) yolk sac has the capability to perform 
the nutritional function suggested for it. Whether or not the 
tissue behaves similarly during early organogenesis is still 
questionable. And of course, the 17.5 day yolk sac in culture does 
not, and inevitably cannot, reveal whether amino acids derived from 
yolk sac proteolysis are utilised by the embryo. Certainly, a 
considerable advance towards resolving this issue would be made if 
similar quantitative experiments could be performed with the early 
rat conceptus in vitro. A convenient method now exists for the 
culture of the early post-implantation rat conceptus complete with 
visceral yolk sac (Hew et al., 1973» 1976a). Conceptuses of 9*5 days 
gestational age can be grown continuously for 48 hours, during which 
time development in vitro parallels that seen in vivo. This 48 hour 
period represents the principal organogenetic phase of development 
and includes the period immediately prior to the formation of a 
functional chorioallantoic placenta. The technique thus presents an 
ideal opportunity to establish the extent to which if any, the 
visceral yolk sac is involved in histiotrophic nutrition, an area 
study for which the technique has not before been used.
.1»1.2 A Target for Teratogens
Reference has already been made to the observations of some decades 
sgo (Goldman, 1909«, Everett, 1955) that the bisazo dye, trypan blue, 
vhen administered to the pregnant rat, localises in the visceral yolk 
Sac, specifically theilysosomes (Beck et al., 1967a)» &ud does not
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reach the embryo save for trace quantities in the gut endoderm 
(Dencker, 1977)» It has also been known for many years that trypan 
blue is teratogenic in the rat when administered during organo­
genesis (Gillman et al., 1948)* The dye therefore, is ideally 
placed to affect any nutritional function in which the yolk sac 
lysosomes might be involved. It was regarded as rather significant, 
therefore, when trypan blue was observed to inhibit a number of 
lysosomal enzymes (Beck et al., 1967b;,-Lloyd et al., 1968). 
Interestingly, trypan blue if applied later than day 10 of gestation 
in the rat, abruptly ceases to be teratogenic (Wilson et al., 1959)- 
This is about the time when the chorioallantoic placenta becomes 
operative and presumably takes over the major nutritional mechanism. 
In the light of these observations, a hypothesis to account for the 
teratogenic action of trypan blue was advanced (Beck et al., 1967b; 
Lloyd and Beck, 1967). Briefly, this was as follows:
Trypan blue, bound to plasma albumin, is pinocytosed by thei
visceral yolk sac endoderm and comes to lie within the lysosomes 
of these cells. Free trypan blue is generated here by digestion 
of the associated albumin, and the dye, unable to diffuse out of 
the lysosomes, accumulates, eventually reaching a concentration 
inhibitory to the lysosomal enzymes. The hypothesis goes on to 
Bay that as a consequence of lysosomal enzyme inhibition, histio- 
"troph remains undigested and the supply of nutrients to the embryo 
al this most critical stage of development is interrupted, with 
irreparable consequences for the embryo. Once the chorioallantoic
V *
Placenta becomes functional, the yolk sac's role in providing for the 
embryo becomes greatly diminished and any inhibition of its function 
seems to cause no permanent damage to the embryo.
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The 17.5-day yolk sac culture system has again provided useful quant­
itative information regarding the mechanism of action of trypan blue. 
Formaldehyde-denatured ^5i_iabelled bovine serum albumin is a sub­
strate that is normally rapidly pinocytosed and digested by 17 .5-day 
yolk sac, the radiolabelled digestion products, chiefly N  iodo- 
tyrosine, being released back into' the culture medium (Williams 
et al., 1975b). The addition of trypan blue to the culture medium 
at concentrations above 100 yig/ml inhibits the uptake and degradation 
of the radiolabelled protein. Closer analysis of this inhibitory 
action of the dye showed that pinocytosis rather than intralysosomal 
digestion was being affected (Williams et al., 1976). Pinocytosis 
by the yolk sac and not, as was at first thought, intralysosomal 
digestion was therefore considered to be the primary target of 
trypan blue's action. The original hypothesis was therefore modified 
(Williams et al., 1976) in accordance with these observations.
However, the postulated consequence of trypan blue's teratogenic 
action, a reduced flux of amino acids to the embryo, remained unaltered.
Further evidence for an inhibition by trypan blue of yolk sac 
pinocytosis has come from a morphological study of conceptuses from 
trypan blue-treated mice (Batten and Haar, 1979). The dye was observed 
to cause a marked reduction in the number of microvilli on the apical 
borders of the yolk sac endodermal cells. Compatible with both the 
original and modified hypotheses are observations made by Berry (1970), 
confirming earlier work (jensh and Brent, 1967), who showed that 
embryos from rats treated with trypan blue on day 7 of pregnancy 
contained less protein than controls up to the 35-somite stage.
Following the establishment of a chorioallantoic placenta however, 
the difference between control and treated embryos disappeared.
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Furthermore, within the experimental group, abnormal embryos were 
observed to have a lower protein content than morphologically normal 
embryos. Zawoiski (1975) showed that when the diets of trypan blue- 
treated pregnant mice were supplemented with either protein or 
glutamic acid, a significant reduction in the incidence of certain 
malformations occurred. A similar action has since been described 
for supplement of threonine (Zawoiski, 1980).
It has already been emphasised that the postulated role of the 
visceral yolk sac in mediating the nutritional supply of the early 
rat embryo lacks definitive evidence. Its candidacy as a target for 
teratogenic action is, therefore, likewise in need of further 
investigation.
1.2 Normal Development of the Rat Conceptus between 9.5 and 11.5 
days of Gestation
It is appropriate here to consider some of the more notable develop-i!
mental events occurring during early organogenesis in the rat. 
Description will be confined to the embryo itself, and to the 
visceral yolk sac. The parietal yolk sac and overlying Reichert's 
membrane (Figure 1.1) are not described. Observations made in vivo 
suggest that these two structures do not retard the access of 
Potentially nutritive protein to the visceral yolk sac endoderm 
(Beck et al., 1967a; Seibel, 1974» Sharma and Peel, 1979)«
4t 9.5 days, the head-fold stage rat embryo (Figures 1.1 and 1.2)
18 relatively undifferentiated. It is estimated to contain about
3,000 cells (Kohler et al., 1972) and less than 5 /¿g of protein 
(Cockroft, 1977)* The somites, blocks of mesoderm lying in two 
longitudinal strips either side of the neural tube, have not yet
- 11
appeared. The embryo at this stage is dorsally concave, the gut 
endoderm being contiguous with the visceral yolk sac endoderm and 
lining the inner face of the yolk sac cavity. Also present at 9*5 
days are the allantoic bud, neural plate and cardiogenic primordium 
(Beaudoin, 1980). During the period between 9»5 and 10.5 days, 
considerable growth and differentiation occurs (Figures 1.2 - 1 .4). 
The cell number has now risen to about 100,000 (Kohler et al., 1972) 
and protein content to between 30 and 50/ig (Cockroft, 1977)* At
10.5 days embryonic somites number 7 - 15 » A neural tube has formed, 
and fused along a considerable portion of its length, though both 
anterior and posterior neuropores are still unclosed (Edwards, 1968). 
Three brain vesicles are present, as are optic and otic vesicles 
(Nishimura and Shiota, 1977)« An S-shaped heart has now formed and 
has begun contracting. The allantois has fused with the chorion and 
the development of the chorioallantoic placenta is nearing completion 
(New, 1978).
i
By 11.5 days (Figure 1.5)> cell number has risen to several 
Million (Kohler et al., 1972) and protein content is now between 200 
^ d  500¿ag (Cockroft, 1977)» Perhaps the most conspicuous feature of 
development during this time is the axial rotation of the embryo to 
the dorsally convex position and its detachment from the visceral 
yolk sac. This turning of the embryo to the characteristic fetal 
Position has been described by Deuchar (1971)• Another easily 
observable feature of the conceptus by this stage is the vitelline 
circulation, connecting the yolk sac with the embryo. This is a 
Significant event for the embryo since it increases the efficiency 
of delivery of nutrients derived from degradation of histiotroph in 
the yolk sac, as well as enabling more rapid excretion of waste from
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the embryo. The heart is now a four-chambered, structure and is 
beating strongly. Both posterior and anterior neuropores have now 
closed and the brain has developed five vesicles (Beaudoin, 1980).
The morphogenesis of the neural tube has recently been investigated 
(Morriss and New, 1979)- The fore-limb buds are also detectable by
11.5 days. Table 1.1 summarises the early organogenetic development 
of the rat embryo.
The rodent visceral yolk sac has been the subject of a great deal 
of morphological study over the past two decades (Anderson, 1959; 
Padykula and Vislocki, 1961; Padykula et al., 1966; Beck et al.,
1967a; Krzyzowska-Gruca and Schiebler, 1967; Lloyd et al., 1968; 
Carpenter and Ferm, 1969$ King and Enders, 1970; Haar, 1971;
Jollie and Triche, 1971; Seibel, 1974; Franke et al., 1975, 1976; 
Schluter, 1978; Baeckland and Heinen, 1979; Batten and Haar, 1979; 
Carpenter and Dishaw, 1979; Gulamhusein et al., 1979; Gupta et al., 
1979; Sharma and Peel, 1979)-
Three distinct morphological zones can be identified. The first 
of these, the major component, is the endodermal cell layer, which 
lines the inner face of the yolk sac cavity. The columnar endodermal 
cells, as already pointed out, display all the characteristics of a 
pinocytosing cell. These include a well developed microvillous 
apical border and a subapical canalicular system. A variety of 
electron-dense and electron-lucent vesicles are also detectable in 
the supranuclear region of the cell. Gupta et al. (1979) have 
classified four distinct types of vesicle within the cell, all of 
which are implicated in the pinocytic process. A large nucleus is 
basally located and all the common cell organelles are present.
A schematic diagram of an endodermal cell is presented in Figure 1.6.
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The endodermal layer is delimited by a basement membrane below which 
lies a mesenchymal layer, the second distinct region of the visceral 
yolk sac. Within this layer are observed loosely distributed 
connective tissue macrophages. Further, it is in the mesenchyme that 
the vitelline capillaries develop, complete with lining endothelial 
cells. A serosal basement membrane separates the mesenchymal layer 
from a narrow basophilic layer of mesothelium, the third morpho­
logical zone, which lines the exocoelom.
The most overt changes that occur during early organogenesis are the 
initiation of the vitelline circulation (described in the mouse by 
Haar and Ackerman,- 1971a-,b), and the occlhsion of the yolk stalk 
following rotation and detachment of the embryo so that the yolk 
sac completely envelops the embryo. Another interesting change has 
recently been discovered by Gupta and associates (Gupta et al., 1981).
A stereological study has shown that the ratio of volume of pinocytic 
vesicles relative to the rest of the cell decreases between 9.5 and
11.5 days of gestation in culture, suggesting that the endoderm becomes 
less pinocytic at about the time the chorioallantoic placenta begins
to function.
1.5 Pinocytosis and lysosomal catabolism
Central to the theory of histiotrophic nutrition by the visceral yolk 
sac are the processes by which locally available macromolecules are 
taken up into the endodermal cells (pinocytosis) and subsequently 
degraded (lysosomal catabolism). It is relevant here, therefore, to 
outline some of the features of these processes, with specific 
reference to yolk sac.
Pinocytosis describes the entrapment of small droplets of extracellular
- 14 -
fluid by plasma membrane, and is distinct from phagocytosis which 
refers to the ingestion of micro-particulate matter such as bacteria 
and erythrocytes. Phagocytosis is not observed in yolk sac cells 
and the largest molecule which can enter the yolk sac by pinocytosis 
is of the order of 7 x 10^ molecular weight (Duncan et al., 1981). 
Pratten et al. (1980) have classified the sequence of events which 
characterise pinocytosis, into three groups (Figure 1.7). The first 
of these involves the internalisation of the plasma membrane, which 
may or may not be stimulated by the attachment of some substance to 
the membrane. Following invagination, the vesicle or pinosome 
containing fluid is 'pinched off' from the plasma membrane and is 
translocated deeper into the cell. During translocation a number 
of fusion events occur. Initially pinosomes fuse with each other 
to produce larger vesicles which fuse ultimately with primary 
lysosomes, giving rise to secondary lysosomes. Formation of a 
secondary lysosome thus exposes the pinocytosed material to the 
formidable battery of lysosomal hydrolases and results in the 
degradation of the exogenous substrate. The third feature of 
pinocytosis may be called lysosomal regression. Low-molecular 
weight catabolites diffuse out of the lysosome into the cytosol 
and this is accompanied by a shrinkage of the lysosome and its ultimate 
disappearance from the cell. Non-digestible material is not degraded 
within secondary lysosomes and is accumulated. Regurgitation of 
such undigested material is not a general property of mammalian 
cells.
Examination of the internalisation step of pinocytosis has led 
Jacques (1969) to describe two basic mechanisms of substrate capture 
(Figure 1.8). Substances with no affinity for the internalising
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plasma membrane are taken into the cell entirely in solution, 
so-called fluid-phase pinocytosis» In contrast to this, certain 
molecules bind strongly to the plasma membrane and are pinocytosed 
with almost total exclusion of fluid? adsorptive or receptor-mediated 
pinocytosis. Between these two extremes, a spectrum of mixed uptake 
modes exist, which vary the extent to which the substrate binds 
to the plasma membrane and the volume of fluid incorporated into 
the pinosome.
Active interest in pinocytosis over the last decade or so has produced 
a great deal of information on the process. For example, it is known 
that pinocytic uptake is energy-requiring in a number of different 
cell types (reviewed by Silverstein et al., 1977) and this is also 
true of the cells of the yolk sac endoderm (Duncan and Lloyd, 1978), 
There is a requirement too for cytoskeletal involvement in pinocytosis 
(Duncan and Lloyd, 1978)* However, identification of any control 
mechanism for pinocytosis has not thus far been achieved. Calcium 
and cyclic AMP have been proposed as regulators of pinocytosis, but 
definitive evidence is lacking (Pratten et al., 1980). Clues to the 
nature of the control mechanism might be provided by the discovery 
of substances that modify the rate of pinocytic uptake. Both poly­
anions (Cohn, 1966) and polycations (Ryser and Hancock, 1965*
Seljelid et al., 1973» Pratten et al., 1978» Shen and Eyser, 1978) 
have been observed to enhance pinocytic uptake in various cells. An 
important distinction is to be made here however. A stimulation of 
pinocytosis may be due to either an increased rate of formation of 
pinosomes, or to an increased affinity of the reference substrate 
for the internalising membrane. Conceivably, an altogether 
different pinocytic mechanism may be induced to operate by these
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apparent stimulators. It is significant that none of the enhanced 
pinocytic rates observed with polyanions and polycations have been 
attributed to accelerated pinosome formation and that all are 
explicable by other means. Concanavalin A has been reported to 
stimulate the uptake of markers, normally pinocytosed in the fluid- 
phase, by macrophages (Edelson and Cohn, 1974)» though it must be 
said that this is part of a wider effect that includes an inhibition 
of pinosome-lysosome fusion and the induction of lysosomal enzyme 
synthesis. The rat yolk sac has proved obstinately refractory to 
stimulation and the pinocytic rate, at least during the latter 
third of gestation, appears to be a constitutive phenomenon 
(ibbotson, 1977)»
The uptake step is rate-limiting in the overall process of uptake, 
digestion and catabolite release of protein by rat yolk sac* The 
evidence for this is as follows. It has been repeatedly observed 
that the yolk sac accumulates non-digestible substances such as 
12^I-labelled polyvinylpyrrolidone, colloidal [l98Au] gold and 
l?<<3 .sucrose from the culture medium. In contrast, the yolk 
sac-associated radioactivity measured when a digestible protein 
substrate (^2^I-labelled bovine serum albumin) is present in the 
medium, quickly reaches a steady state. Simultaneously, ^^I-labelled 
catabolites are released back into the culture medium at a constant 
rate (Moore et al., 1977» Uoyd -W* IticLniS» 1978)* This pattern 
indicates that pinocytosis, rather than digestion, is the rate- 
limiting step.' The formation of secondary lysosomes results in 
the confrontation between pinocytosed material and the hydrolytic 
enzymes of the lysosome. Lysosomes are known to contain hydrolases 
whose activity is directed against many classes of biological
- 17 -
macromolecule. Included is a great variety of proteinases, some with 
quite specific cofactor requirements. Lysosomal enzymes have in 
common a low pH optimum, and the acidic milieu of the lysosome not 
only maximizes the catalytic activity of the enzymes but also serves 
to partially denature macromolecular substrate, particularly protein, 
increasing its susceptibility to attack.
Two major types of lysosomal proteinase are recognised. The cysteine 
proteinases (recently reviewed by Kirschke et al., 1980), such as 
cathepsins B, H, L and N, require the presence of a thiol group of 
a cysteine residue in the active site, and the aspartic proteinases, 
most notable among which is cathepsin D, require the carboxyl group 
of an aspartic acid residue for activity (Barrett, 1980). Voluminous 
literature describes the properties and characteristics of the 
lysosomal proteinases, and this has been lucidly summarised (Heath 
and Barrett, 1977» Barrett and Macdonald, 1980).
Alas little information exists on the lysosomal proteinases of the 
yolk sac. Beck et al. (1967b) studied the inhibitory action of 
trypan blue on the activities of several enzymes, including cathepsin 
D, of a lysosomal fraction of rat yolk sac homogenate. Using rabbit 
yolk sac, Jones and Hemmings (1971) reported considerable proteolytic 
activity of a lysosomal fraction against a number of specific peptides 
and serum proteins, hydrolysis of the latter being attributed to the 
action of cathepsin D. More recently Sherman and Atienza-Samols (1979) 
have measured the activities of a number of lysosomal enzymes (though 
not proteinases) in a crude homogenate of mouse yolk sac. Additionally, 
histochemistry has identified several lysosomal enzymes in rat yolk 
sac (Padykula, 1958? Bulmer, 1963. 1965; Christie, 1967).
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The proposed mechanism of histiotrophic nutrition by the visceral 
yolk sac requires, amongst other things, that the yolk sac cells 
are able to pinocytose and intralysosomally digest macromolecules. 
The evidence presented here demonstrates that the yolk sac is 
capable of both functions.
1.4  Aims of this Thesis
It is clear from the foregoing discussion (Section 1.1) that much 
remains to be learnt about the precise nature of any involvement 
of the visceral yolk sac in the mediation of the nutritional supply 
to the developing rat embryo, and the broad objective of this study 
is to further this understanding.
Subsequent chapters describe experiments specifically designed to 
answer questions posed by the gap in our understanding of this 
proposed process. These questions are as follows:
1. Do macromolecules reach the embryo directly without the 
involvement of the visceral yolk sac, or does pinocytosis 
by the yolk sac provide the only possible route of access 
to the embryo for exogenous macromolecules?
2. If the latter is the case, are macromolecules taken up by 
the yolk sac then delivered directly to the embryonic 
tissues intact, or are they immobilised in the yolk sac?
5. What is the digestive capacity of the visceral yolk sac?
And are degradable compounds pinocytosed by the yolk sac 
catabolised there also?
4. Assuming that macromolecules are taken up and degraded by 
the yolk sac, are the products of digestion assimilated 
by the rapidly growing embryo?
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5. Is the embryo dependent on macromolecular sources of nutrient, 
or axe micromolecular nutrients capable of sustaining it during 
the early organogenetic phase? In other words, is the postulated 
mechanism of histiotrophic nutrition of quantitative significance?
Answers to these questions, provided from observations of the early
rat conceptus in vitro, should dispel some of the uncertainty
surrounding the visceral yolk sac's function, with respect to 
hu.tr t^ion
histiotrophic^ during early organogenesis.
With the data from these experiments in hand, further experiments 
investigate the claim that the aetiology of certain teratogen-induced 
congenital malformations may be a disturbance of the nutritional aspect 
of yolk sac function. This is achieved by studying the effects of 
five compounds of proven or suspected teratogenicity, all of which 
are known to be lysosomotropic and therefore dependent upon pinocytosis 
for entry into cells, on the established properties of yolk sac 
nutritional function.
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Figure 1.1 Schematic diagram of head-fold stage rat egg cylinder 
at 9*5 days of gestation
Figure 1.2 Rat conceptuses explanted from the mother at 9.5 days 
of gestation. The head-fold stage embryo is indicated by an arrow. 
Other details of morphology are given in Figure 1.1 and Table 1.1. 
The conceptus on the left hand side has been divested of Reichert's 
membrane and underlying parietal ¿niegen* These two membranes 
stand clear of the conceptus at the embryonic pole as can be seen 
in the right hand conceptus. Scale x30.
Figure 1.3 9.5-Day rat conceptus cultured for 12 hours (equivalent
to gestational day-10). Considerable growth and development of the 
embryo has occurred. Conceptus is now more spherical. Other details 
given in Figure 1.1 and Table 1.1. Scale x30.
J> r
Figure 1.4 9.5-Day rat conceptus cultured for 24 hours (equivalent
to gestational day-10.5). Embryo has begun to rotate to the 
characteristic dorsally-convex fetal position, detaching from the 
visceral yolk sac which now envelops the embryo. Other details 
given in Table 1.1. Scale x30.
Figure 1.5 9.5-Day rat conceptus cultured for 48 hours (equivalent
to gestational day-11.5). The embryo has now completely rotated.
The choriovitelline circulation is well established. Other details 
given in Table 1.1. Scale xl2.5.
Yolk sac cavity
j,isure 1 .5  Schematic diagram of visceral yolk sac 
endodermal cell
cell exterior
Figure 1.7 Diagram to show the pathway of pinocytosis, leading 
to degradation of pinocytosed substrates within 
secondary lysosomes and the release of catabolites 
into the cell cytoplasm
Figure 1.8 Types of pinocytosis (after Jaques, 1969)
G e l i  e x te r io r
2. Adsorptive uptake
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Table 1.1 Normal Development of the Rat Embryo up to 11.5 days of 
Gestation
External Appearance
Kay 9.5-10.5 Somites 1-15 are Identifiable; embryo is bent
dorsally; first branchial arch appears.
Day 10.5-11.5 Somites number 22-28; embryo rotates to dorsally
convex position; second and third branchial arches 
appear; tail fold and lateral body wall folds 
form; maxillary processes appear; anterior limb 
buds appear.
Nervous System
Day 8-9 Neural plate appears.
Day 9-10 Neural folds form and begin fusing; neural crest
formed at junction of neural folds and surface 
ectoderm; optic évaginations appear from 
prosencephalon.
Day 10-11 Three brain vesicles present, prosencephalon,
mesencephalon and rhombencephalon; infundibulum 
originates in floor of prosenchephalon; otic placodes 
form; cranial ganglia begin formation; optic vesicles 
contact surface ectoderm; neural tube closed but for 
anterior and posterior neuropores; Rathke's pouch 
begins outgrowth from roof of future mouth.
Day 11-11.5 Five brain vesicles present, telen-, dien-, mesen-, 
meten- and myelencephalon; closure of anterior and 
posterior neuropores; optic cups begin to form two 
layers; otic vesicles close; olfactory placodes 
appear.
Circulatory System
Day 8-9 
Day 9-10
Day 10-11
Day 11-11.5
Cardiogenic primordia appear.
Fusion of cardiogenic primordia with formation of 
simple tubular heart which begins sporadic 
contractions; aortic arch I is forming.
S-shaped tubular heart forms; aortic arches II and 
III appear; cardinal, umbilical and vitelline veins 
can be recognised; atrium, ventricle and sinus 
venosus formed; embryonic circulation is established.
Aortic arches III and IV are well developed while 
arches I and II regress; interatrial septum begins 
to form.
Digestive System
Day 9-10 Foregut begins to form.
Day 10-11 Oral membrane ruptures} liver diverticular formed} 
first pharyngeal pouch is present} thyroid primordia 
appear in pharynx} hindgut begins formation.
Day 11-11.5 Laryngo-tracheal groove appears} primordium of dorsal pancreas present} stomach recognisable.
Respiratory System
Day 11.5 Paired lung buds formed.
Urogenital System
Day 8-9 Intermediate mesoderm (precursor of urogenital system) 
forms.
Day 9-10 Germ cells observed in yolk sac epithelium.
Day 10-11 Nephrogenic ridges appear in intermediate mesoderm} 
(pro)nephric ducts begin formation} germ cells 
migrate from yolk sac, entering hind gut and 
mesenteries.
Day 11-11.5 First mesonephric tubules develop} gonadal ridges 
appear.
(After Christie, 1964} Edwards, 1968} Nishimura and Shiota, 1977, 
Beaudoin, 1980).
CHAPTER TWO
THE UPTAKE OF NON-DIGESTIBLE SUBSTRATES ~BY T1&RT.Y 
ORGANOGENESIS-STAGE RAT CONCEPTUSES
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2.1 Introduction
The question of whether or not uptake by the yolk sac is an obligatory 
step in the passage of macromolecules to the embryo is fundamental to 
the proposed role of the yolk sac in mediating histiotrophic nutrition, 
and must be resolved at the outset. This can be done simply, by the 
use of the whole-embryo culture technique. Experiments are described 
in this chapter in which non-digestible macromolecules, ^5j_pyp 
M  dextran, were added to the culture medium in which conceptuses 
were growing. The distribution of radioactivity in the yolk sac 
and embryo after a given time interval was determined.
From the average molecular weights of these two compounds (125i_pyp 
a 3 0 ,0 0 0 - 4 0,00 0, [?h 1 dextran ^ 7 0,000) it may safely be assumed 
that any uptake will be by pinocytosis. Both macromolecules have been 
shown to be accumulated by the 17 .5-day rat yolk sac in culture 
Williams et al., 1975a; Roberts et al., 1976). Accumulation of 
1 25i-PVP has also been observed in the villous epithelial cells 
of the small intestine of the neonatal rat (Clarke and Hardy, 19 6 9), 
the rat peritoneal macrophage (Pratten et al., 19 7 8) and everted rat 
intestinal sacs in vitro (Bridges and Woodley, 1978). Dextran 
accumulation has been demonstrated in mouse liver parenchymal and 
Kupffer cells (De Man et al., 1960; Daems and van Rijssel, 1 9 6 1), 
proximal kidney tubule cells (Maunsbach, 19 6 9), spleen red pulp 
macrophages (Bowers, 1969)* J7742 mouse macrophages (Berlin and 
Oliver, 1980; Walter et al., 1980), mouse peritoneal macrophages 
and BHK21 cells (Geisow et al., 1981) and rat peritoneal macrophages 
(Pratten, unpublished data).
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Studies of pinocytosis are simplified by the use of non-digestible 
substrates. The difficulties of measuring uptake of digestible 
macromolecules, where digestion products may be re-utilised in 
cellular biosynthetic processes, are avoided and since, as has 
already been mentioned, pinocytosed macro-molecules are not significantly 
released from the cell, uptake can be measured as an accumulation of
substrate.
2.2 Materials 
Culture Eauipment
Roller incubator BTC Engineering Ltd., Cambridge
Culture bottles Baird and Tatlock Ltd., London
Silicone rubber bottle stoppers 
Counters
Gallenkamp & Co. Ltd., Brimingham
Packard auto-gamma scintillation 
spectrometer 5136 Packard Instruments Ltd., Caversham,
Packard 2425 liquid scintillation 
spectrometer
Other Eauinment
Berks.
CE 272 linear readout spectro­
photometer Cecil Instruments Ltd., Cambridge
Super minor bench centrifuge MSE Ltd., Loughborough, Leics.
Coolspin centrifuge MSE Ltd., Loughborough, Leics.
Disposable syringes Sterilin Products Ltd, Middlesex
Disposable syringe needes Sterilin Products Ltd, Middlesex
Sterile conical test tubes 
Sterile plastic 30ml universal
Sterilin Products Ltd, Middlesex
containers Sterilin Products Ltd, Middlesex
Plastic disposable ¿ml tubes Luckham Ltd, Burgess Hill, Sussex
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Radiochemi c als
”'^I-FVP (preparation IM.33P)
dextran (preparation TRA.3 8 2)
Other Reagents
Hanks balanced salt solution
Antibiotic mixture
Lumagel scintillation fluid
Folin Ciocalteau reagent
Bovine serum albumin (product A.3478)
Radiochemical Centre, Amersham, Berks 
Radiochemical Centre, Amersham, Berks
Flow Laboratories Ltd, Irvine,
Scotland
Flow Laboratories Ltd, Irvine,
Scotland
Lumac Systems Ltd, Basle,
Switzerland
Fisons Ltd, Loughborough, Leics.
Sigma Chemical Co. Ltd, Poole, Dorset
Gas Mixtures
5 % 02/5% 002/9096 N2 British Oxygen Corporation, Special
2096 02/5%  C02/7596 ^ 2 Gases Division, Deer Park Road,
40^0 02/5% 002/55% n2 London.
2. 5_____Methods
2.5.1 Whole-Embryo Culture
2.5.1.1 Preparation of Culture Medium
Homologous serum from either male or female rats was used as a culture 
medium. The procedure for serum preparation was as follows:
The animal was firstly anaesthetised with diethyl ether. It was then 
laid on the bench and a beaker of ether-soaked cotton wool was placed 
over its head to maintain anaesthesia. Care was taken that the 
animal did not die from ether overdose before the blood was removed.
A large opening was then made in the ventral body wall using clean
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instruments, and the intestines displaced to one side, except for the 
descending colon which was clamped with a haemostat and moved in the 
opposite direction, tearing away the mesentery that attached it to 
the rest of the intestine and to the posterior tody wall. To expose 
the dorsal aorta the mesentery (peritoneum) covering the posterior 
tody wall was gently rutted away with surgical swabs. Blood was 
withdrawn from the aorta with a 10 ml syringe and a 40 mm x 8 / 1 0  needle. 
The needle was inserted into the aorta at the point of bifurcation 
into the iliac vessels, and carefully pushed up the aorta for an 
inch or so. The heart usually stopped beating after about 8-10 ml of 
blood had been collected. The syringe was then removed, the needle 
discarded and the blood transferred to a sterile 15 ml plastic conical 
test-tube, which was immediately centrifuged at 2 ,0 0 0 g for 10 minutes. 
Centrifugation precipitated the blood cells and a fibrin clot formed 
in the supernatant plasma. After allowing at least an hour for the 
clot to form completely, the clot was squeezed with forceps to remove 
the contained serum, and the blood recentrifuged at 2 ,0 0 0 g for 10  
minutes.
The clear serum, which constitutes about half the volume of the
Wealoriginal blood, from all rats - in a session was pooled in 30ml 
sterile plastic universal containers, antibiotics added and stored 
at -20°C until required. The antibiotics added were a mixture of 
penicillin (5>000 i.u./ml) and streptomycin (5 ,0 0 0/ig/ml) at a ratio 
of 0 .2ml antibiotic solution to 10ml serum.
Before use for embryo culture, the serum was thawed, heat-denatured 
at 56°C for 30 minutes to inactivate the complement, and centrifuged 
at 2 ,0 0 0 g for 5 minutes to precipitate any particulate matter. The 
clear serum was then decanted into a fresh vessel and maintained at 
370c until culture commenced.
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2. 5.1.2 Explantation of the Conce-piuses
D a y  O w*« consH&reM to be d a y  ©n bWe ofwlUcJ* a.
WflA fcvmfl*/ (Jay 0-5 *\oo* of- ¿c^me <Aay. J
Pregnant female rats of 9.5 days gestation were killed by a blow to 
the head. The ventral body wall was quickly opened and the uterus 
explanted into a petri dish containing Hanks balanced salt solution. 
Further dissection was carried out in a sterile laminar flow cabinet. 
First, the uterus was cut into portions each of which contained a 
single swelling. Then, each portion was stripped of uterus with 
a pair of fine watchmakers' forceps to reveal the pear-shaped 
decidual mass, containing the egg cylinder. In fresh Hanks and 
under a dissecting microscope, the decidua was carefully teased 
away and the egg cylinder dissected free. The outermost extra- 
embryonic membranes, the parietal yolk sac endoderm and the adherent 
overlying Reichert's membrane were excised. Thus the egg cylinder, 
with the visceral yolk sac endoderm layer exposed, was ready for 
culture.
2. 5.1.5 Culture of Rat Egg Cylinders
The egg cylinders explanted from all the pregnant females in an 
experiment, were shared evenly between culture vessels to minimise 
variation between experimental groups. For each egg cylinder 
cultured,1 ml of culture serum was added. Culture took place in 
either 60 or 50 ml bottles depending on the number of conceptuses 
to be cultured. Initially culture bottles were gassed 
for two minutes with a gas mixture comprising 5% Og/5% 002/90% U 2 *
At 24 hours of culture, bottles were re-gassed with 20% 02/5% CO2/
75% N2 and at 52 hours of culture with 4C% 02/5% 002/55% N2. After 
initial gassing, the culture bottles were placed on horizontal rollers, 
rotating at between 50 and 60 rpm, which were encased in a purpose-built
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thermostatted perspex box at 37°C.
Culture was maintained for 48 hours, during which time the development 
of the conceptus, from egg cylinder to advanced organogenesis, is 
apparently identical to in utero development during the same period.
In order to assess development at the end of culture, the following 
criteria of normal development were routinely applied to all 
conceptuses. Immediately upon removal from culture and while still 
warm, the presence of an embryonic heart beat and a yolk sac 
circulation was checked. The yolk sac diameter normally 3-4 mm, 
was measured under the microscope using an eyepiece graticule. Further 
checks included normal axial rotation of the embryo to the dorsally 
convex position, the presence of the forelimb buds, the fusion of the 
allantois with the chorion, closure of the neural tube, somite number 
(22-28) and embryonic protein content (120-240/ig). (Protein was 
estimated as described below, 2.3.4)* Conceptuses failing to satisfy 
any of these criteria, no more than 5% of all cultured, were discarded.
2.3.2 Studies on the Uptake on Non-digestible Radiolabelled 
Macromolecules by Rat Conceptuses
Cultures were established as already outlined. At different time 
points between 24 and 1 hour before harvesting, 125l-PVP was added to 
the culture medium at a final concentration of either 1. 35» 2.8 or
5 . 6  jag/ml or [j^ bQ  dextran at a final concentration of 2.0, 5.0 or 
10.0 yug/ml. All cultures were maintained for a total of 48 hours so 
that radiolabel was present in the culture medium, for different 
periods up to 24 hours.
At harvesting, conceptuses were washed in Hanks solution, yolk sacs 
and embryos dissected apart and washed separately in a further three
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changes of Hanks solution. Each tissue was then solubilised in 0.5ml 
of 0.25 M NaOH at 37°C for 1 hour. This solution was then neutralised 
by adding 0 .5 ml of 0 .2 5 M HNO^ and the volume brought to 1 . 1  ml by 
addition of distilled water. Protein assay (see Section 2 .3.4) was 
performed on duplicate 0.05 ml portions. The remaining 1.0ml was 
assayed for radioactivity (Section 2.5•5)• Duplicate samples of 
culture medium, 1 . 0  ml with "'^I-P'VP and0 .5 ml with [_3hJ dextran, 
were assayed for radioactivity.
2.5.5 Studies on the Growth of Conceptuses during the Culture Period
In order to interpret quantitative data on uptake of macromolecules, 
it is essential that the growth characteristics of conceptuses during 
the culture period are understood. A study was therefore made of the 
increase in protein content of yolk sac and embryo between 24 and 48 
hours of culture, the period during which uptake is being followed.
Groups of conceptuses were removed from culture at different times 
during the second 24 hours of the culture period. At harvesting 
conceptuses were washed, dissected and solubilised as outlined above. 
Protein assay was performed on duplicate 0.05 ml portions of the tissue 
solutions.
2.5.4 Estimation of Protein
Protein content of tissues was measured using the method of Lowry 
et al. (1951)* To 0 .0 5 ml portions of either yolk sac or embryo 
solution (see Section 2.3.2) was added 0.2 mlof M NaOH and 0.25 ml of 
distilled water. To this solution 2.5 mlof Folin A reagent (prepared 
by adding 100 mlof 2%  anhydrous sodium carbonate to 1.0 mlof 1% copper 
sulphate solution and 1.0 mlof 2P/ 0 potassium sodium tartrate solution) 
was added and the mixture left to stand at room temperature for 20 minutes.
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Following this, 0.25 ml of Folin B reagent (prepared by diluting Folin 
Ciocalteau solution with an equal volume of distilled water) was 
added with immediate mixing, and the colour allowed to develop at room 
temperature for a minimum of 45 minutes. The absorbances of the 
solutions were then measured at a wavelength of 7 5 0 nm.
In order to convert absorbance into protein concentration, a series of 
protein standards were prepared using bovine serum albumin (BSA) as 
reference protein. The standards were made up with different dilutions 
of a 0.1 mg/ml solution of BSA as outlined below.
Protein Çug) BSA Soin, (ml) Distilled Water (ml) M NaOH (ml)
0 0 0.3 0.2
2 0.02 0.28 0.2
5 0.05 0 .2 5 0.2
8 0.08 0.22 0.2
10 0.10 0.20 0.2
standards were in triplicate. Details of the addition of Folin A
and Folin B reagents were as described above. Absorbances at 750 nm 
of standard protein solutions are directly proportional to protein 
concentration, giving a straight calibration line. Estimation of 
tissue protein levels are therefore easily obtained by reference to 
this line. Since 0 .0 5 ml of tissue solution is used for protein 
estimation out of a total volume of 1.1 ml, multiplication of the 
observed figure by 22 gives the total protein content of the tissue.
2.5.5 Measurement of Radioactivity
^25i_pyp radioactivity was measured directly on a gamma scintillation 
counter. Either 1.0 ml of tissue solution or culture serum was placed 
in a 3 ml plastic disposable tube and counted. The only correction
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necessary for a gamma emitting sample, such as 125l, is to subtract 
background counts from the observed count. Tissue solutions were 
counted for 5 minutes and medium samples for 30 seconds. The tissue 
counts were corrected for background and multiplied by 1.1 (since 
radioactivity was measured in 1.0 ml of a solution, whose total volume 
was 1.1 ml) to give a value for the radioactivity of the whole tissue.
\}E~l Rextran radioactivity was measured in a liquid scintillation 
spectrometer. Of the 1.0 ml of tissue solution remaining after protein 
estimation, 0.5 ml was added to 4 .5 ml of Lumagel scintillation fluid and 
counted for 20 minutes. Buplicate0.5 ml samples of culture medium were 
prepared similarly and counted for 4 minutes. Background radiation 
was determined by counting duplicate samples of0 .5 ml of distilled water 
in4.5 ml of Lumagel. The observed count was corrected for quenching 
and background, and, in the case of tissue samples, multiplied by 2 . 2  
to give a value for the radioactivity of the whole tissue.
A series of quenching standards comprisingO.5 ml of different dilutions 
of serum containing a standard quantity of [^ h] dextran (giving 
approximately 10^ c.p.m.) in 4* 5 ml of Lumagel scintillant were counted, 
and the external standard number was plotted against the percentage 
counting efficiency, relative to water, for each standard. The resulting 
plot, or quench curve, was a straight line. Regression analysis of the 
quench curve established an equation of the type y = mx + c, where 
y = counting efficiency and x - the external standard number, to 
describe the curve. In order to determine the counting efficiency, y, 
of a given experimental sample, the external standard number generated 
from that sample, x, was substituted into the empirically determined 
quench equation. Thus the observed count of a sample that was counted 
with an efficiency of JCP/o, would be divided by 0 .7 to give a quench- 
corrected count.
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2.3.6 Quantitation of Uptake
To determine the uptake of radioactivity into the yolk sac and 
embryo, the following expression, described by Williams et al. (1975a), 
was..used:
U _ Y (or E)M x Py (or Pe)
where U = the uptake of radioactivity by either yolk 
sac or embryo in a given time,
Y =s the total radioactivity in the whole yolk 
sac in counts per minute, corrected for 
background, (and, in the case of M  dextran, 
quenching),
E s the total radioactivity in the whole embryo 
in c.p.m., corrected for background (and, 
in the case of [?h ] dextran, quenching),
M = the radioactivity per microlitre of medium 
in c.p.m., corrected for background (and, 
in the case of [^ hJ  dextran, quenching) ,
Py = the protein content in milligrams of the 
whole yolk sac,
and Pe = the protein content in milligrams, of the 
whole embryo.
Uptake thus expressed is a clearance, as the volume of culture medium 
whose contained substrate is internalised per milligram of yolk 
sac (or embryo) protein and has the units of microlitres of culture 
medium per milligram of protein.
The expression of uptake in this form has several advantages. First 
the effect of a variable quantity of tissue protein is eliminated as
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is the effect of radioactive decay of the isotope on the specific 
radioactivity of the substrate. This is particularly relevant to
of 60 days. Secondly, reproducibility of results between experiments 
can be assessed.
conceptuses were such as to cause no significant depletion of the 
substrates in the culture medium. The figure M in the uptake equation 
therefore refers to the radioactivity in the culture medium at the 
end of culture.
2.4 Results
2.4.1 Development of conceptuses in culture
Conceptuses grew and developed progressively throughout the 48 hour 
culture period. Fewer than 5% of conceptuses failed to satisfy the 
criteria for normal development (Section 2.3.1.3) and these were 
discarded.
Figure 2.1 shows the protein content of yolk sacs and embryos from 
24 hours to 48 hours of culture. It can be seen that the increase in 
protein content of both tissues was small lAtb^cUiy
Figures 2.2, 2.3 and 2.4 show how the amount of radioactivity found in 
the embryo and yolk sac at 48 hours varied with the time at which
5.6/ig/ml respectively, was added to the culture medium. It may be
substrates containing 125l which has a relatively short half-life
The rates of accumulation of both
but accelerated c  v f tKg. footer Stores of Culture.
1252.4.2 Uptake of ^I-PVP by Yolk Sacs and Embryos
"^I-FVP, at final concentrations in the medium of 1.35» 2.8 and
seen that no radioactivity entered the embryo. In contrast the yolk 
sacs contained significant amounts of radioactivity; the amount found
180
Figure 2.1 Increase in protein content of yolk sac (■), and embryo (□) of
conceptuses cultured in vitro. Each point represents mean (+ standard deviat
S.D.) of at least 6 determinations. ~
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Figure 2.2 Radioactivity associated with yolk sac(*K and embryo (□)
after incubation of conceptuses in the presence of i-PVP (1.35 ug/ml)
Each point represents mean (+_ S.D.) of at least 6 determinations.
Time of addition of substrate (h)
Figure 2.3 Radioactivity associated with yolk sac (■), and embryo (□)
125after incubation of conceptuses in the presence of I-PVP (2.8 jig/ml), 
Each point represents mean (_+ S.D.) of at least 6 determinations.
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Figure 2.4 Radioactivity associated with yolk sac (■), and embryo (□)
125after incubation of conceptuses m  the presence of I-PVP (5.5 p.g/ml) 
Each point represents mean (+_ S.D.) of at least 6 determinations
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Figure 2.5 Radioactivity associated with yolk sac (■), and embryo(D)
after incubation of conceptuses in the presence of dextran (2 jig/ml)
Each point represents mean (_+ S.D.) of at least 6 determinations.
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Figure 2.6 Radioactivity associated with yolk sac (■), and embryo (□)
after,incubation of conceptuses in the presence of phjdextran (5 jjg/ml).
Each point represents mean (_+ S.D.) of at least 6 determinations.
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Figure 2.7 Radioactivity associated with yolk sac (■), and embryo (□)
after incubation of conceptuses in the presence of {3h]dextran (10 jig/ml).
Each point represents mean (jh S.D.) of at least 6 determinations.
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was roughly proportional to the duration of exposure to "^i-pvp 
with the exception that little difference was seen between tissues 
incubated with radiolabel for 24 hours and those in which radiolabel 
was added at 30 hours.
Essentially identical data were obtained at each of the three different 
concentrations of ^ ^ 1 - V T P  used.
1 Uptake of dextran by Embryos and Yolk Sacs
Figures 2.5, 2.6 and 2.7 show how the amount of radioactivity found in the 
embryo and yolk sac at 43 hours varied with the time at which [%] dextran, 
at final concentrations of 2, 5 and 10/ig/ml respectively, was added 
to the culture medium. The pattern of uptake was essentially the 
same as that observed with -'I-FVP as substrate. Accumulation of radio­
activity in the yolk sac was slight between 24 hours and about 30 hours of 
culture and became apparently linear with time after about 30 hours 
of culture until harvesting. However, in contrast to the ^5j_pvp 
data, some radioactivity, but not progressive accumulation, was 
detected in embryos, at the two highest concentrations of (^ Hj dextran 
employed. Excluding the unlikely possibility of contamination of 
embryos with yolk sac that had been incompletely separated following 
culture, two reasons for this observation suggest themselves. Either 
the [ h^ ] dextran preparation supplied contained a small percentage of 
glucose, or the yolk sac is able to digest J h^ ] dextran at a 
low rate, releasing j^Hj glucose which is able to diffuse into the 
embryonic tissues.
2 . 5  Discussion
The accumulation of 1 2 5l-PVP by the yolk sac demonstrates the pino- 
cytic capacity of the early organogenesis-stage yolk sac. The inability
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of this substrate to penetrate into the embryo clearly indicates 
that the embryonic cells do not capture the macromolecule directly 
and also that indigestible macromolecules captured by the yolk sac 
are immobilised within this tissue, presumably within lysosomes, 
and are not transferred into the embryo.
Yolk sac accumulation of N  dextran follows a distinctly similar 
pattern to that observed with ^5x_pypt once more demonstrating that 
the yolk sac at this early stage in organogenesis has the ability to 
ingest very large molecules pinocytically. It is most unlikely, 
though not entirely impossible, that the low and irregular level of 
embryonic radioactivity observed in figures 2.6 and 2.7 is the 
result of a direct penetration of _^ hJ dextran.
These observations have several implications for histiotrophic 
nutrition. If the early organogenetic embryo is dependent to any 
major extent on macromolecular nutrient, then the yolk sac clearly 
has an important role to play in mediating the nutritional supply.
The postulated mechanism of histiotrophic nutrition by the visceral 
yolk sac (Beck et al., 19 6 7a; Williams et al., 1976) requires that 
this tissue is capable of pinocytosis. This has repeatedly been shown 
to be so with the 17.5-day rat yolk sac in culture (Williams et al., 
1975a; Roberts et al., 1977» Duncan and Lloyd, 1978), where 12^I-PVP 
uptake by yolk sac was linear with time, but has not hitherto been 
demonstrated in the yolk sac from early organogenesis when histio­
trophic nutrition is presumed to be of most importance to the embryo. 
The data reported here indicate that the early organogenesis-stage 
yolk sac is capable of pinocytosis.
An equal, if not more crucial,, requirement of the histiotrophic 
nutritional mechanism is that macromolecules are not taken directly
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into the embryonic tissues. The data show that this is indeed the 
case for 125l-PVP and (^ h J dextran and furthermore, 125l_PVP and 
[5h]  dextran pinocytosed by the yolk sac, are not transferred intact 
into the embryo. These data in themselves do not constitute proof 
that histiotrophic nutrition according to the mechanism of Beck 
et al. actually takes place. Rather, they dispel some of the scepticism 
that has surrounded the hypothesis, and as such provide direct 
biochemical support for the process.
An examination of the kinetics of the uptake of 125l_pvp and ¡^ h ] dextran 
by the yolk sac reveals some interesting facts. The time course of 
uptake of either substrate at all the concentrations used is almost 
identical. The amount of radioactivity present in the yolk sac at 
harvesting depended on the length of time the conceptúa had been 
exposed to radiolabel. A linear relationship between the amount 
captured and duration of exposure would not be expected, owing to 
the rapid growth of the tissue during the incubation period (Figure 2.1). 
Figures 2.2 - 2.7 show that there was little difference in tissue 
radioactivity at harvesting when the radiolabel was added at 24 hours 
or 30 hours of culture. However, to infer that the yolk sac is 
pinocytically inactive during this early phase of exposure would be 
erroneous. Figure 2.1 indicates that the amount of protein contained 
in the yolk sac between 24 and about 30 hours of culture was relatively 
small compared to later stages of culture. As the protein content of 
the yolk sac increased, apparently linearly, from about 30 hours of 
culture to 48 hours of culture, so the rate of pinocytic capture of 
substrates by yolk sac likewise increases. It is noteworthy that the 
pattern of glucose utilisation by rat conceptuses cultured by the 
New method (Sanyal, 1980) varied in a similar fashion to the pinocytosis
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of non-digestible radiolabelled substrates. Culturing 10.5-day rat 
conceptuses, it was observed that little depletion of medium glucose 
occurred between 0 and about 9 hours of culture (equivalent to 24 
and 33 hours in the present study). After this time glucose was 
rapidly utilised by the conceptuses up to 24 hours of culture 
(48 hours here). This pattern of glucose utilisation coincides with 
the increase in protein content of yolk sac and embryos shown in 
Figure 2.1, and the increase in pinocytic rates of yolk sacs shown 
in Figures 2.2 - 2.7.
In the 17.5-day yolk sac uptake of ^2^I-PVP ps by fiui^_phase non- 
adaorptive pinocytosis (Williams et al., 1975a; Roberts et al., 1977). 
Since the rates of uptake of dextran and 125i_pvp in the present
experiments are quantitatively similar, when expressed as clearances, 
it is likely that adsorption to plasma membrane does not occur with 
either substrate in the 9.5-11.5 ¿ay yolk sac. This conclusion is 
strengthened by the observation that uptake of both substrates 
appeared to be independent of substrate concentration.
The linear uptake of both 12^I-PVP and pH~| dextran by the yolk sac 
over the last 1 2 - 1 5  hours of culture enables a reliable rate of 
uptake of substrate to be calculated. Such a rate, termed the Endocytic 
Index by Williams et al. (1975a, b) allows direct numerical comparisons 
to be drawn between experiments performed with the same substrate at 
the same or different concentrations in the culture medium, and 
between experiments employing different pinocytic substrates.
The mean Endocytic Index of all experiments using 125l_pvp as pinocytic 
substrate was 1.387 _JJl/mg protein/hour and compares well with the mean 
Endocytic Index of % ]  dextran of 1.272 ^ l/mg/hour. These values, 
though slightly lower, also compare well with the mean endocytic
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indices of 125l-PVP "by 17.5-day yolk sacs of 1 .7 4  ¿Ll/mg/hour reported 
toy Williams et al., (1975a) and 1 . 5 7 ^l/mg/hour reported by Roberts 
et al. (1977), suggesting that .the pinocytic capacity of yolk sac is 
maintained at a similar level until late in gestation, and that in 
common with the 1 7 .5-day yolk sac, these substrates are taken into 
the early organogenesis-stage yolk sac in the fluid-phase. The 
similarity between the computed Endocytic Indices for the experiments 
reported here indicates further that the culture technique is capable 
of providing reliable and reproducible quantitative biochemical data 
on the pinocytic mechanisms of .the early organogenesis-stage conceptus.
CHAPTER THREE
THE DIGESTIVE.CAPACITY OF THE YOLK SAC OF THE 
EARLY ORGANOGENESIS-STAGE RAT COHCEPTHS
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5.1____ Introduction
The data presented in the last chapter demonstrated the pinocytic 
properties of the visceral yolk sac during early organogenesis. 
Pinocytosis by the yolk sac must function either to provide a barrier 
to potentially harmful macromolecular substances reaching the embryo, 
and/or as a mechanism by which macromolecules are gathered as a 
nutritional source for the embryo. In a' nutritional process, 
degradation of the pinocytosed material within the yolk sac would be 
necessary since it has already been shown that exogenous macromolecules 
do not penetrate into the tissues of the embryo.
Digestion by the yolk sac during this early period of gestation has 
never been adequately demonstrated. Beck et al. (1967a) suggested 
that the disappearance of horseradish peroxidase from yolk sac cells 
during early organogenesis was due to digestion, and hence loss of 
enzymic activity, of the protein, although other explanations (see 
Section 1.1) account equally well for this observation. The presence 
of only two acid hydrolases, acid phosphatase and P-glucuronidase, 
has been demonstrated histochemically in the 9.5-1 1 .5-day yolk sac 
(Bulmer, 1963» Beck et al., 1967a).
In contrast to the paucity of data for early organogenesis yolk sac, 
the 1 7 .5-day rat yolk sac in culture has been shown to degrade pino­
cytosed protein to the level of amino acids (Williams et al., 1971» 
Williams et al., 1975h; Livesey and Williams, 1979). In addition to 
these studies which used 125l-labelled bovine serum albumin as 
pinocytic and proteolytic substrate, the near-term yolk sac has been 
observed to degrade in vitro 125j_human serum albumin (Goetze et 
al., 1975), 125j_rat gammaglobulins (ibbotson, 1977)» deglycosolated 
yeast invertase (Brown et al., 1979) nn^ - haemoglobin (Fridhandl er
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and Zipper, 1964). Also the activities of several lysosomal hydro­
lases have been demonstrated in homogenates of near-term rat 
(Beck et al., 1967b; Lloyd et al., 1968) and rabbit (Jones and Hemmings, 
19 71) yolk sac.
The aim of the experiments described in this Chapter was to establish 
the digestive capacity of the yolk sac from the early organogenesis 
conceptus. A dual experimental approach was adopted. In the first 
series of experiments a protein, formaldehyde-denatured 125l-bovine 
serum albumin (125l-dBSA) was added to the culture medium in which 
conceptuses were being cultured. The distribution of both tri­
chloroacetic acid-insoluble radioactivity (indicating intact radio- 
labelled protein and -soluble radioactivity (indicating radiolabelled 
breakdown products of protein) were measured in yolk sac and embryo 
tissues, and in the culture medium. This particular protein was 
chosen for two reasons. Firstly, it has been found that formaldehyde- 
denatured BSA, when compared with native BSA, is rapidly ingested, 
by adsorptive pinocytosis in the 17.5-day yolk sac in culture 
(Moore et al., 1977). In the present study, the culture medium 
comprised 10<# homologous serum, and it was therefore desirable to use 
a substrate which would be pinocytosed in measurable quantities in 
the presence of a very high concentration of competing protein, as 
was present in the culture medium. Secondly, since radioiodination 
of BSA preferentially labels tyrosine residues and (^ 25lJ iodotyrosine 
released upon hydrolysis of the protein is not accepted by any tRKA 
(Alexander, 19^4; Cartouzou et al., 1964), radiolabelled digestion 
products are not re-utilised in de novo protein biosynthesis, thus 
simplifying the quantitation of proteolysis.
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The second approach used to assess the digestive capacity of yolk sac 
was by direct assay of several lysosomal hydrolases in yolk sac 
homogenates. Yolk sacs were obtained from 9-5-day conceptuses that 
had been cultured for 48 hours, and hydrolase activities were 
compared to those of 11.5-day yolk sacs removed directly from the 
mother.
^.2 Materials
Radi o chemi c als 
Na N  iodide (preparation IMS?*) The Radiochemical Centre, Amersham,
Chemicals
Bovine serum albumin (-Of42t)
4-methylumbel1iferyl-2-acetamido- 
2-deoxy-B-D-glucopyranoside 
4-methylumbelliferyl-D-glucoside
Bucks,
Koch-Light Laboratories Ltd, Coin- 
brook, Bucks
Koch-Light Laboratories Ltd, Coin- 
brook, Bucks
Koch-Light Laboratories Ltd, Coin- 
brook, Bucks
Sigma Chemical Co., Poole, Dorset
Sigma Chemical Co., Poole, Dorset
Sigma Chemical Co., Poole, Dorset
Chloramine-T
Benzoyl-D, L-Arginine-Napthylarnide 
Fast Garnet (4-amino-2;3-dimethyl- 
azobenzene)
Mersalyl Acid (2-|^3-(hydroxymercuri) Sigma Chemical Co., Poole, Dorset 
-2-methoxypropylj carbamoyl phenoxy- 
acetic acid)
Brij 35 (polyoxyethylene lauryl ether)Sigma Chemical Co., Poole, Dorset 
p-nitropheny1 phosphate Boehringer-Mannheim Ltd, West
Germany
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Equipment
Vertis homogeniser "45' Tertis Research Equipment, New York,
USA
i i Methods
3.5.1 Culture of Conceptuses in the Presence of 1 2 ^I-d£SA
5.5.1.1 Preparation of 1^5l-dBSA
Radiolahelling of BSA was performed according to the method of Williams 
et al. (1971). Bovine serum albumin (20 mg) was dissolved in 9.0ml 
of phosphate buffer (0.05 M NapHOP^-E^PO^, pH 8.0) and cooled in an 
ice-bath. Sodium jj^l] iodide (1 mCi) was added using a1 ml disposable 
syringe and the ampoule rinsed with phosphate buffer(l. 5 ml) and the 
washings added to the reaction vessel. After stirring for 2 minutes, 
chloramine-T solution (4 ml of a 1 mg/ml solution) was added and the 
reaction allowed to proceed for 8 minutes before being stopped by the 
addition of sodium metabisulphite solution (3 ml of a 2 mg/ml solution). 
After stirring for a further 2 minutes, solid potassium iodide (100 mg) 
was added to the reaction mixture to aid displacement of unreacted 025i3 iodide during the subsequent dialysis. An equal volume of 
formalin (1C% formaldehyde in 0.5 M NapCO^, pH 10) was added and the 
resulting solution allowed to stand for 72h at 4°C (Moore et al., 1977). 
The solution was then freed of inorganic iodide and formaldehyde by 
dialysis (7 2h at 4°C) in Yisking tubing against at least four changes 
of aqueous sodium chloride w/v); the initial dialysate contained
0 .05%  sodium iodide to ensure complete removal of unreacted [1 2 5i] 
iodide from the reaction mixture. The protein concentration of the 
final preparation was determined by absorbance at 280nm using a 
standard curve prepared in saline (1%, w/v).
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3.5.1.2 Culture Experiments
Cultures were established as already outlined (Section 2.3.1 ). 125i_d£SA 
at a final concentration of 5 . 5 or 11.0;ug/ml was added to the culture 
medium at some time-point between 12 and 0.5 hours before harvesting. 
Uptake of substrate was measured during the last 12 hours of culture 
because only during this time is uptake demonstrably linear (see 
Chapter 1). At harvesting, conceptuses were solubilised, neutralised 
and diluted as described.
Following assay of 1.0 ml samples of tissue solutions for total 
radioactivity, 0.5 ml of 2Q$ TCA and0.1 ml of carrier protein (calf 
serum) was added. The solution was then centrifuged for 20 minutes 
at 2,000 g, the supernatant (1. 5 ml) decanted into a fresh tube and its 
radioactivity re-measured to give the TCA-soluble count. Duplicate 
1.0 ml fractions of culture medium were assayed for total and TCA- 
soluble radioactivity in the same way, but without carrier protein. 
TCA-insoluble radioactivity was determined by substracting the 
TCA-soluble counts from the total counts. Total radioactivity in 
each yolk sac and embryo was calculated by multiplying the observed 
count for that tissue by 1.1.
Owing to the increase in volume of the TCA-soluble count and the 
occlusion of some TCA-soluble material within the precipitate, the 
observed TCA-soluble count was multiplied by a correction factor to 
give a more accurate value. The correction factor was determined 
empirically as follows. To sextuplícate samples of either yolk sac 
solution, embryo solution or culture medium was added a small quantity 
of [1 25 i  iodotyrosine (10^ cpm) to give a final volume of 1.0ml.
The total and TCA-soluble radioactivity of each sample was measured
3,3 &6SC2TÍl!)6(l 3l¡)OV6« Th.©OX‘6 * t Í C 3 l l y » "ttl6S6 CO UIl'ts S l lO l l ld  ID© 6CJU.3X»
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However, for the reasons stated, the TCA-soluble counts were seen to 
be lower than the total counts. The ratio of total radioactivity to 
TCA-soluble radioactivity, a value greater than unity, was the correction 
factor employed.
3. 3.1.3 Q.uantitation of Uptake
When 1 2 5l-cLBSA is used as substrate, the yolk sac is found to degrade 
the pinocytosed protein to the level of its constituent amino acids. 
One of these, [ ^ i ]  iodotyrosine, is largely released back into the 
culture medium. This digestion product appears as the TCA-soluble 
radioactivity which was estimated as described above. The equation 
expressing uptake, U, the quantity of radioactivity that would have 
accumulated in the yolk sac in the absence of any proteolysis, 
becomes:
U = Y + (S-F)
M x Py
As with non—digestible substrates, the numerator represents the total
radioactivity taken up by the yolk sac. In the case of a digestible
substrate such as a protein this is the sum of two terms; Y, the total
radioactivity taken up and retained in the whole yolk sac (c.p.m.,
corrected for background) and (S-P), the TCA-soluble radioactivity
generated by the yolk sac and released into either the culture medium
or the embryo. S is the sum of the TCA-soluble radioactivity found
in the culture medium and the embryo at harvesting (c.p.m., corrected
for background). F is the amount of TCA-soluble radioactivity present
i.e.
that has been generated elsewhere than in the yolk sac,|TCA-soluble 
radioactivity present initially in the substrate preparation and 
any TCA-soluble radioactivity generated by proteolysis within the
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culture serum. This latter component was shown to be essentially 
zero (Figure J.l) and F was therefore determined by measuring the 
TCA-soluble radioactivity in the substrate preparation before 
culture.
Since the only radioactivity found in the embryo was TCA-soluble, 
the yolk sac was considered to be the only site of pinocytosis (and 
degradation) of the radiolabelled protein. The expression of uptake 
of radioactivity into the embryo was, therefore,
II = E 
M x Pe
5.2.2 Enzyme Analyses of 11.5-day Yolk Sac
5.2.2.1 Preparation of Yolk Sacs for Assay
Yolk sacs were obtained either from 9 .5-day conceptuses cultured for 
48 hours (gestational age at harvesting = 1 1 . 5  days) or direct from 
the mother at 11.5 days of gestation. All yolk sacs from a single 
mother were explanted into an ice-cold 5 ml disposable tube and 
washed by centrifugation in 1 ml of distilled water at 2 ,0 0 0 g at 
4°C for 10 minutes. The washings were discarded and yolk sacs were 
homogenised in 1 ml of distilled water in a Yirtis homogeniser. The 
resulting yolk sac homogenate was used immediately in enzyme assays. 
Duplicate 0.05 ml portions of homogenate were assayed for total protein 
as described in Section 2 .3.4.
5 .2.2.2 Measurement of Acid Phosphatase
Acid phosphatase was assayed by the method of Torriani (i960) using 
20mM p-nitrophenyl phosphate as substrate in 0.2 ml of citrate buffer, 
pH 5.0 (0.1M citric acid, pH adjusted with 1 M NaOH). To this was 
added 0.05 ml of yolk sac homogenate and the mixture was incubated
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at 37°C for 4 hours. The reaction was terminated by the addition 
of 2.75 ml of Tris-phosphate buffer, pH 8.5 (0 .4M Tris and 0 . 4  M 
sodium dihydrogen phosphate, pH adjusted with 1 M NaOH). Liberated 
p-nitrophenol was measured at 400nm. A standard curve was drawn 
of absorbances of different concentrations of p-nitrophenol in 
Tris-phosphate buffer, and was used to calculate the extent of 
substrate hydrolysis by the yolk sac homogenate. Blanks were performed 
by incubation of substrate and homogenate separately, mixing immediately 
prior to addition of Tris-phophate buffer. Specific enzyme activity 
was expressed as nmoles of p-nitrophenol released per hour per mg 
of homogenate protein.
^.2.2.3 Measurement of N-acetyl-P-glucosaminidase
N-Acetyl-P-glucosaminidase was assayed using the method described by 
Griffiths et al. (1978) using 2.5 mM 4-methylumbelliferyl-2-acetamido- 
2-deoxy-p-D-glucopyranoside as substrate in 0.1 ml of citrate-phosphate 
buffer, pH 4«3 (0.1 M sodium citrate adjusted to the appropriate pH 
with 0.2 M sodium phosphate). To this was added0.05 ml of a 1 in 10 
dilution of yolk sac homogenate and the mixture was incubated for 
10 minutes at 37°C. The reaction was terminated by the addition 
of 2.85 ml of 0.17 M glycine-sodium carbonate buffer, pH 10.5 . The 
fluorescence of liberated 4-methylumbelliferone was determined 
using an excitation wavelength of 365 nmand an emission wavelength 
of 450 nm. A standard curve was drawn of fluorescence of different 
concentrations of 4-methylumbelliferone and was used to calculate the 
extent of substrate hydrolysis by the homogenate. Blanks were 
performed as described for acid phosphatase. Specific enzyme activity 
was expressed as nmoles of 4-methylumbelliferone released per hour
per mg homogenate protein.
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3.2.2.4 Measurement of P^-glucosidase
o<-Glucosidase was assayed using the method described by Griffiths et 
al. (1978) using 5 mM4-methylumbelliferyl-o<-D-glucoside as substrate 
in 0.1 ml of citrate-phosphate buffer, pH 5.2. To this was added 
0.05 ml of homogenate and the mixture was incubated at 37°C for 30 
minutes. Other procedures were as for N-acetyl-P-glucosaminidase. 
Specific enzyme activity was expressed as nmoles of 4-methylumbelliferone 
released per hour per mg homogenate protein.
3.2.2.5 Measure of Cathepsin D
Cathepsin D was assayed by the method described by Barrett and Heath 
(1977) using bovine haemoglobin as substrate. Haemoglobin powder 
was mixed to a paste with water, dialysed for 2 days against distilled 
water at 4°0, centrifuged and diluted to 8 .C$> (w/v) solids for storage 
at -20°C. To 0.05 ml of haemoglobin substrate was added 0.1 ml of 
homogenate and0 .0 5 ml of assay buffer, prepared by mixing 1 . 0  M sodium 
formate with 1.0 M formic acid as required to give a pH of 3*0 (rising 
to 3 . 2  in the incubation mixture), and the mixture was incubated 
at 45°C for 60 minutes. The reaction was terminated by adding 1.0 ml 
of j/o (w/v) trichloroacetic acid. After 5 minutes the mixture was 
centrifuged at 2 ,0 0 0 g for 20 minutes andT.O ml of the clear super­
natant was transferred to a clean tube. To it was added 2 . 5  ml of 
modified alkaline copper reagent which was prepared as follows.
Stock (a) contained!.0 g of trisodium citrate dihydrate with 0.50g 
of CUSO4.5H2 ) in 100 ml of water. Stock (b) containedl6.0 g of NaOH 
with 50 gof Na2C0j in 500 ml of water. Working solution was prepared 
by adding!. 0 ml of stock (a) to a 100 ml measuring cylinder and 
diluting to 80 ml with water and making up to 10 0 ml with the addition of 
20 ml of stock (b). Following addition of the modified alkaline copper
reagent, the mixture was allowed to stand for 10 minutes at room 
temperature. To this was added 0 . 2 5 ml of diluted Folin-Ciocalteau 
reagent (1 : 2  with distilled water) with immediate mixing. After 50 
minutes the absorbance of the blue solution was measured at 700 nm. 
Standards were made containing different dilutions of tyrosine in 
2.5$ (w/v) TCA and a standard curve was drawn to calculate the extent 
of substrate hydrolysis by homogenate. Blanks were performed by 
delaying the addition of the homogenate until the end of the 
incubation, mixing it in just before the addition of TCA. Enzyme 
activity was expressed as nmole of tyrosine released per hour per mg 
homogenate protein.
5.2.2.6  Measurement of Cathepsin B
Cathepsin B was assayed by the method of Barrett (1972) using 
benzoyl-D, L-arginine-2-naphthylamide hydrochloride as substrate in 
dimethylsulphoxide (40mg/ml). To 0.1 ml of homogenate was added 0.3 ml 
of "buffered activator. The latter was prepared by dissolving 32 mg of 
cysteine in 100 ml of EDTA-phosphate buffer (KH2PC>4 , 12.0 g; Ka2HP0^. 12H20, 
4 . 3  g; disodium EDTA.2H20, 0.495 g)> and making up to 1 litre with distilled 
water to a pH of 6.0. The mixture was incubated for 5 minutes at 40°C 
before adding 0 .0 1 of substrate stock with mixing and incubating for 
10 minutes at 40°C. Substrate hydrolysis yielded 2-naphthylamine 
which was assayed colorimetrically by coupling with a diazonium 
salt, Past garnet. The coupling reagent was added to the incubation 
mixture to terminate the reaction. (Termination was effected by a 
mercurial compound included in the coupling reagent). The coupling 
reagent was made up of two solutions, a base stock solution and 
Mersalyl-Brij reagent. Base stock solution was prepared by dissolving 
225 mg of Past garnet (4-amino -2', 3-dimethylazobenezene) in 50 ml of
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ethanol. To this was added 30 ml of M HCI with stirring, and the 
solution diluted to 100 ml with distilled water. Mersalyl-Brij reagent 
was prepared by dissolving 2 . 4 3 gof Mersalyl acid (2- [3-(hydroxymercuri) 
-2-methoxypropylJ carbamoyl phenoxyacetic acid) in 60 ml of 0.5 M NaOH.
To this was added 0.3 g°f disodium EDTA and the solution diluted to 
450 ml with distilled water, adjusting the pH to 4 .0 by slow addition 
of M HCI before making up to a final volume of 500 ml with water. To 
this solution was added 500 ml of 4% (w/v) Brij 35 (polyoxyethylene 
lauryl ether) in water. The coupling reagent was prepared as follows: 
1 . 0  ml of base stock solution was pipetted into a test-tube standing 
in a beaker of ice and water. To it was added 0.1 ml of 0.2 M NaH02 
and the mixture was left to stand for 5 minutes before diluting with 
Mersalyl-Brij reagent to a final volume of 100 ml.
After adding the coupling reagent to the incubation mixture colour 
was allowed to develop for 10 minutes before measuring the absorbance 
of the final solution at 520nm. Standards were prepared by replacing 
the homogenate of the original incubation mixture with 0 . 1 ml of a 
solution of 2-naphthylamine. Blanks were performed by adding the 
homogenate, which had been incubated separately, after the coupling 
reagent. Specific enzyme activity was expressed as nmoles of 
2-naphthylamine released per hour per mg of homogenate protein.
3.4_____Results
3.4.1 Culture Experiments
The amount of radioactivity present in yolk sacs and embryos at 
harvesting following culture in the presence of 5 . 5  or 1 1 . 0  /ig/ml 
1 2 5l-dBSA is shown in Figures 3.2 and 3 . 3 respectively. The results 
are essentially identical at both concentrations used. In the yolk 
sac the level of radioactivity was independent of duration of
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Figure 3.1 Increase in TCA-soluble radioactivity after incubation
o 12 5at 37 C in roller culture apparatus of I-dBSA in 0.25 M NaOH ( A ) ,
water (A), and heat-denatured whole rat serum (o). Each point
represents mean of at least H separate determinations.
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Figure 3.2 Radioactivity associated with yolk sac (■), and embryo (□)
■j r y  r
after incubation of conceptuses in the presence of 1-dBSA (5 .5 ug/ml) 
Each point represents mean (jf S.D.) of at least 6 determinations.
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Figure 3.3 Radioactivity associated with yolk sac (■), and embryo(n) 
after incubation of conceptuses in the presence of 12 5I-dBSA ( 1 1  ug/ml) 
Each point represents mean (+ S.D.) of at least 6 determinations.
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exposure to "*^i_dBSA, except for durations of exposure of less than 
2 hours. A qualitatively similar pattern was observed for radioactivity 
in the embryo, though at a much lower level. The percentage of yolk 
sac and embryo radioactivity that was TCA-soluble is shown in Figures
3 . 4  and 3 .5 . The small quantity of radioactivity reaching the embryo is 
all in TCA-soluble form. The percentage TCA-soluble radioactivity, in 
the yolk sac was, like total yolk sac radioactivity, independent of 
duration of exposure to radiolabelled protein, except where this 
duration was less than 2 hours, and levelled off at about 50^*
Analysis of the medium at harvesting revealed that the amount of 
TCA-soluble radioactivity had progressively increased with time of 
exposure of conceptuses to substrate. This TCA-soluble radioactivity 
must have been released from the tissues following hydrolysis of 
radiolabelled protein, and must properly be included in any calculation 
of uptake. The pattern of total uptake of radioactivity by yolk sacs, 
including that which is retained within the yolk sac tissue and that 
released back into the medium and the embryo, is shown in Figures 3.6 
and 3.7. Uptake was linear over the 1 2 hours. That this TCA-soluble 
radioactivity was generated by conceptuses is clearly shown in 
Figure 3.1. In the absence of conceptuses, there was essentially 
no increase in TCA-soluble radioactivity in the culture medium with time.
The solubilisation of tissues after harvesting involves digestion of 
the tissues in 0.25 M NaOH. Since peptide bonds are alkali-labile, 
it was important to measure the effect of NaOH on the stability of 
1 2 5i-£BSA. Hydrolysis of tissue-associated radiolabelled protein 
during tissue solubilisation would lead to a falsely high percentage of 
TCA-soluble radioactivity. Figure 3.1 shows that only after 1 hour 
of incubation of 0.1 ml^^I-dBSA with 0.5 ml 0.25 M NaOH at 37°C does
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Figure 3.H Percentage of tissue radioactivity soluble in TCA
after incubation of conceptuses in the presence of 125I-dBSA (5.5 jag/ml)
Each point represents mean (+S.D.) of at least 6 determinations.
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Figure 3.5 Percentage of tissue radioactivity soluble in TCA
125after incubation of conceptuses m  the presence of I-dBSA 
(11 jig/ml). Each point represents mean (_+ S.D.) of at least 6 
determinations. (■) Yolk sac, (□) embryo.
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Figure 3.6 Total radioactivity taken up by yolk sac after incubation
125of conceptuses in the presence of I-dBSA (5.5 Jig/ml). Each point 
represents mean (_+ S.D.) of at least 6 determinations.
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Figure 3.7 Total radioactivity taken up by yolk sac after
125incubation of conceptuses in the presence of I-dBSA (ll^ig/ml). 
Each point represents mean (_+ S.D.) of at least 6 determinations.
Enzyme
CULTURED YOLK SAC NON-CULTURED YOLK SAC
Specific Activity ± SE Range of Activity Specific Activity - SE Range of Activity
DC -glucosidase 57.00 ± 9.09 23.33 - 46.67 49-35 ± 11.93 35.17 - 62.50
N-Acetyl-P-
glucosaminadase 2 5 7 2 . 3 1 i 3 0 2.9 9 2025.5 - 2852.0 2818.71 i 7 7 2 .8 8 1948.17 - 3574.2
Acid phosphatase 1 7 7 1 . 2 0  t 240.19 1425 - 2067 2005.60 t 148.57 1831.0 - 2 2 3 7 .0
Cathepsin I) 604.4 - 81.10 543 - 738 4 4 9 .0 i 5 5 . 1 408 - 543-0
Cathepsin B 989.00 t 20 4 .0 0 798 - 1 1 2 9 856.0 - 26.0 818.0 - 885.0
Table J.1 Comparison of lysosomal hydrolase activities in cultured and non-cultured
11.5-day yolk sac. Each specific activity is the mean of groups of 
yolk sac from 5 animals. Units of activity are described in the text.
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the increase in percentage TCA-soluble radioactivity in the mixture 
begin to depart from control values, obtained by incubating 125x_d3SA 
in water.
5.4.2. Enzyme Analyses
Table 3.1 shows the specific activities of five lysosomal enzymes 
measured in homogenates of 11.5-day yolk sacs, explanted from the 
mother at 11.5 days, or at 9 . 5 days and cultured for 48 hours. In all 
assays, depletion of the substrate was less than 1%. For all enzymes 
assayed considerable activity was measured in both groups of yolk sacs, 
under the assay conditions described. The acid phosphatase activity 
recorded here compares well with the only other reported value (Beck 
et al., 19 6 7a) for 11.5-day yolk sac of 2,310 nmoles/hour/mg protein, 
obtained from a single animal. The 11.5-day yolk sac possesses 
considerable proteolytic activity as judged by the specific activities 
of cathepsins D and B. Cathepsin D activity in cultured yolk sacs was 
about 1^ times that in the non-cultured tissue, but the ranges of 
activity of the enzyme in each group overlapped.
It is notable that little difference existed in hydrolase activity 
between cultured yolk sac and non-cultured yolk sac. Evidently, the 
conditions under which conceptuses were cultured did not lead to an 
altered level of hydrolase activity in yolk sac such as might have 
occurred for example through exocytosis of lysosomal enzyme.
5. 5_____Discussion
The data presented in this chapter demonstrate the ability of the early 
organogenesis-stage yolk sac to digest pinocytosed protein. When 
conceptuses were cultured in the presence of 125j-dBSA, there was little 
accumulation of radioactivity by the conceptus (Figures 3 . 2  and 3.3 ),
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tut a considerable release of TCA-soluble radioactivity into the 
culture medium was observed, the extent of which depended on the 
duration of exposure to radiolabelled protein. Except for very 
short exposures, the amount of radioactivity in the tissues did not 
depend on the duration of exposure to substrate. This pattern is 
noticeably similar to results obtained using the 17.5-day yolk sac 
in culture (Williams et al., 1975^5 Moore et al., 1977) and indicates 
that the substrate is being pinocytosed and hydrolysed within the 
tissues.
The demonstration of both TCA-soluble and -insoluble radioactivity in 
the yolk sac, but only TCA-soluble radioactivity in the embryo 
(Figures 5 . 4  and 5.5 ), strongly suggests that 125l-dBSA is being both 
taken up by, and digested in the yolk sac, the TCA-soluble radioactivity 
in the embryo deriving from the products of digestion within yolk sac 
lysosomes. The known inability of iodotyrosine to participate
in protein biosynthesis (Alexander, 1964; Cartouzou et al., 19 6 4) 
renders it of no value to the tissues and it is released back into the 
culture medium. In addition to demonstrating yolk sac proteolysis, the 
data also indicate that the embryo is unable to capture directly, or 
receive intact from the yolk sac, undigested radiolabelled protein, 
thus confirming and extending those observations made using 1 25p_pyp 
dextran as substrates.
If it is assumed that the"yolk sac alone is responsible for the 
hydrolysis of 1 2 ^I-dBSA, the total uptake of substrate by the yolk sac 
can be calculated. Figures 5 .6 and 5 . 7 show that total uptake of 
radioactivity is linear over the time period studied. The calculated 
Endocytic Indices are 5 . 4 3 and 5.73 ^ il/mg protein/hour at substrate 
concentrations of 5 . 5 and 11.0/ig/ml respectively. These values of
and 3h
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Endocytic Index are very much lower than those obtained for 1 7 .5-day 
yolk sac of 6 5 .0 — 11.0 (Moore et al., 1977) and 6 8 .1 i 10.6 (ibbotson 
and Williams, 1979)- The difference can probably be explained by the 
use in the present study of 1 0($> serum as the culture medium.
Ibbotson and Williams (1979) showed that when 10%  calf serum, normally 
present in the culture medium of the 1 7 .5-day yolk sac, was removed, 
the Endocytic Index of 125l-cLBSA rose to an average value of 2 5 5.0 ± 
95.2. These workers concluded that the protein present in calf serum 
competed with I-cLBSA for the adsorptive sites on the plasma membrane 
of yolk cells that facilitate the relatively rapid pinocytosis of this 
substrate. Removal of the competing serum proteins resulted in a 
somewhat faster and more effective clearance of 1 2 5i_<IBSA from the 
culture medium. That pinocytosis of "'^I-dBSA by the early organo- 
genetic yolk sac is aided by adsorption to the plasma membrane seems 
most probable. The Endocytic Index of ^ i-dBSA is about 4 times that
be pinocytosed in the fluid-phase.
The uptake and digestion of protein by yolk sac, and the inability of 
the embryo to acquire intact protein, either directly or by transport 
through the yolk sac, are observations entirely consistent with, and 
providing direct experimental support for, the postulated mechanism 
of histiotrophic nutrition. However, it is acknowledged that the data 
presented here for a single heterologous protein need not necessarily 
extent to other, particularly homologous, proteins. Indeed several 
reports have presented evidence that both homologous and hetèrologous 
proteins are transported across the yolk sac into the embryo without 
undergoing digestion within yolk sac lysosomes. This evidence is discussed 
later in this Thesis (Chapter 10).
of both both of which were considered to
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Additional evidence that the yolk sac possesses considerable digestive 
capacity comes from the assay of lysosomal acid hydrolases in tissue 
homogenates (Table 3-1)• A H  of the enzymes assayed were found to be 
active in the 11.5-day yolk sac.
The characteristics of these lysosomal enzymes have been extensively 
reviewed by Barrett and Heath (1977) and it would be inappropriate to 
discuss these characteristics here. However, it is worth recording that 
one of the five enzymic activities assayed here is also present in 
non-lysosomal sites in the cell. Acid phosphatase has been demonstrated 
in other membrane systems of cells (Neil and Homer, 1964a, b), and 
furthermore Beaufay (1972) has pointed out that para-nitrophenyl 
phosphate, which was used as substrate in the present study, is 
hydrolysed by non-lysosomal acid phosphatase. However, non-lysosomal 
acid phosphatase is relatively unstable at 37°C and the long incubation 
period of 4 hours used in this study would minimise the contribution of 
this enzyme to the extent of substrate hydrolysis measured.
The data presented in Table 3.1 further demonstrate that lysosomal 
mzyme activities measured in 11.5-day yolk sac taken directly from 
the mother, are not noticeably different from those measured in 
11.5-day yolk sacs of conceptuses which had been cultured for 48 hours. 
This most likely indicates that cultured yolk sac develops a normal 
complement of lysosomal enzymes and also that these lysosomal enzymes 
are not secreted into the culture medium. This latter point is important 
when one considers that the hydrolysis of -'i-dBSA in culture described 
in this study, might have occurred as a result of the release of 
proteolytic enzyme(s) by tissues into the culture medium. That this is 
clearly not the case reinforces the conclusion that the early 
organogenesis yolk sac is capable of digesting macromolecules.
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CHAPTER POUR
UTILISATION OF EXOGENOUS PROTEIN BY THE 
EARLY ORGANOGENESIS-STAGE RAT CONCEPTUS
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4.1____ Introduction
It has never "been demonstrated that the products of yolk sac lysosomal 
protein digestion, amino acids, are utilised in the biosynthesis of 
embryonic protein. That such a process operates is central to the 
model of histiotrophic nutrition proposed by Beck et al. (19 6 7a), 
which is, in view of this lack of definitive data, seriously 
weakened.
The culture technique affords an excellent opportunity to investigate 
this problem, and the experiments of this Chapter have attempted to 
provide a solution.
products capable of being incorporated into newly-synthesised protein.
The distribution of TCA-insoluble and -soluble radioactivity in the 
conceptus was monitored, and an attempt was made to separate the tissue 
proteins to examine the distribution of radiolabel among the protein 
fractions.
The demonstration that embryonic proteins contain amino acids supplied 
by yolk sac proteolysis does not, in itself, indicate whether the process 
is of quantitative significance in embryogenesis. A preliminary 
investigation was therefore performed in which an excess of non- 
radioactive amino acid was included in a culture medium already 
containing radiolabelled protein. The effect of the excess amino 
acid upon the incorporation of radioactivity into the conceptus was
Conceptuses were cultured
proteins which, unlike 125l-dBSA, would yield radiolabelled digestion
measured.
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A .2 Materials 
Radiochemicals
L-J4,5-5h } leucine (preparation TRK.510) The Radiochemical Centre,
Amersham, Bucks.
Chemicals
Heparin (5.000 i.u./ml)
2-mercaptoethanol
TEMED (NNN'N'-Tetramethylethylene
diamine)
Sodium dodecyl sulphate 
Ammonium persulphate 
Acpylamide
Me thylenebi sacrylami de 
Bromophenol blue
Other chemicals were of analytical grade.
Boots Co. Ltd, Nottingham 
Calbiochem, USA
Hopkins and Williams, Chadwell 
Heath, Essex
BDH Chemicals Ltd, Poole, Borset 
BDH Chemicals Ltd, Poole, Dorset 
BDH Chemicals Ltd, Poole, Dorset 
BDH Chemicals Ltd, Poole, Dorset 
E. Merck AG, Darmstadt, W. Germany
Equipment
T,K~R 2117-501 Multiphor basic unit
LKB 2117-201 Multiphor Electrophoresis
Kit
LKB 2117-601 Multiphor Electrophoresis 
Kit for SDS polyacrylamide gels 
T.KB 2209 Multitemp Cooling Unit 
LKB 2197 Power Supply
LKB Ltd, Bromma, Sweden
LKB Ltd, Bromma, Sweden
LKB Ltd, Bromma, Sweden
LKB Ltd, Bromma, Sweden
LKB Ltd, Bromma, Sweden
4.5 Methods 
4 .5 .I Preparation of Rat Serum in which Proteins
with
have been labelled
M leucine
Male rats weighing approximately 250 g received an intraperitoneal
- 57 -
injection of leucine contained within 1 . 0  ml of Q . %  saline, at 
a dosage of 40yuCi/lOOg tody weight. After 2 hours, at which time 
incorporation of radioactivity into serum proteins is maximal 
(Schreiber et al., 1966), serum was collected as described in 2.3.1.
To remove free ^ h J leucine the serum was dialysed at 4°C for 4 days 
against four changes of a balanced salt solution (Cockroft, 1979).
The balanced salt solution contained, per litre of water, 6 .9 g KaCl,
0.3 g KC1, 0.1 gMgS04.7H20, 0.05 g MgCl2 .6H20, 0.1 g NaH2PQ4 .2H20,
2.0 g NaHCO^ and 0 . 2 g CaC^* The dialysed serum contained approximately 
1% of its total radioactivity in a form soluble in 6.7% (w/v) TCA.
The dialysed serum was stored at -20°C until use, whereupon it was 
heat-denatured and centrifuged as previously described. In order to 
support normal embryonic development in culture,1 . 5  mg/ml of D-glucose 
and 1 0 /il/ml of vitamin concentrate were added to the serum 
(Cockroft, 1979)*
The effect of incubation in the presence and absence of 0.25 M NaOH 
at 37°C on the stability of protein-bound radioactivity was studied 
as described for 1 2 ^I-dBSA. In order to assess whether the N  leucine 
was incorporated into the primary structure of the radiolabelled protein 
and not non-covalently bound, J^ h J leucine-labelled serum from the same 
batch was divided into several portions and dialysed in the presence 
of different concentrations of non-radioactive L-leucine. The latter 
would compete with any non-covalently bound leucine thereby
decreasing the specific radioactivity of the TCA-insoluble radioactivity 
of the serum after dialysis.
taA.'o<u> > ' À ©(■ se.Yu** woa 3, too jmjj 3e/u
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4.3.2 Preparation of leucine-labelled Haemoglobin
Leucine-labelled haemoglobin was prepared from rat reticulocytes 
according to the unpublished procedure of Ballard. Reticulocytosis 
was produced in 2 male adult rats by daily injections over 5 days of 
a 1% solution of phenylhydrazine. Phenylhydrazine hydrochloride was 
dissolved in water and neutralised to pH 7.0 1 0.5 with 10% Na2C0^.
To this solution was added 0.9% saline to give a final concentration 
of phenylhydrazine of 10 mg/ml. The dosage employed was 0.2 ml of 
phenylhydrazine solution per 200 g-body weight per day. After the 
last injection the animals were rested for two days. Blood was 
then collected from aorta of the ether-anaesthetised animals using 
a 10 ml syringe and a serum needle that had been filled with heparin 
solution to prevent clotting of blood. Approximately 7 ml of blood 
were withdrawn followed by 2 ml of air and the barrel of the syringe 
was gently rolled to allow mixing of blood with the heparin. All the 
blood collected from both animals was pooled. Aliquots of 2 ml of 
pooled blood were placed in 50 ml glass centrifuge tubes and to each was 
added 50 ml of ’reticulocyte washing solution’ prepared as follows by 
a modification of the method of Burka and Marks (19 6 4). To500 ml of
distilled water was added 4-24 g NaCl, 0 . 1 8 7 g KC1 , O . 1 5 3  g MgCl2 .6H2 0 
and0.229 g of TES. The pH of the solution was adjusted to 7 . 5  with 
M NaOH. Each tube was centrifuged at 2000 g for 3 minutes at 4°C.
Following centrifugation the washing solution was decanted and the 
procedure repeated twice more. To the pelleted material (reticulocytes) 
remaining after three washes was added 10 ml of 'reticulocyte incubation 
medium’ containing 100 jiCi of leucine. The incubation medium
was made up by adding to 50 ml of distilled water 349 mg Nacl, 18.7g KC1, 
15.3 mg MgCl2 .6H2 ), 229 mg TES, 49-5 mg glucose and 3 .9 mg Fe(HH4)2S04 .6H20
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and adjusting the pH to 7 .5 . The ungassed, uncapped tubes were 
incubated in a water bath at 37°C for 1 hour, shaking at 5 minute 
intervals throughout this period. At the end of the incubation period, 
30 ml of'reticulocyte washing solution' was added to each tube and 
the mixture was centrifuged at 2,500g for 5 minutes at 4°C. The 
washing procedure was repeated twice more. The remaining pelleted 
reticulocytes were haemolysed by adding2 ml of distilled water to each 
tube and freezing and thawing through 4 cycles using liquid nitrogen and 
a 37°C water bath. The free haemoglobin was separated by centrifuging 
this solution at 3>000g for 45 minutes at 4°C. The clear solution 
was decanted from the pellet and dialysed overnight against distilled 
water at 4°C, after which less than 1% of the total radioactivity in 
the solution was TCA-soluble. In order to check radiolabelling of 
haemoglobin, the dialysed solution was subjected to chromatography 
on a Sephadex G-75 column (2.2 cm x 45 cm, 100 ml bed volume) and 
eluted with Q . %  saline. Blue dextran was added to the radiolabelled 
haemoglobin solution to indicate the elution position of the void 
volume. Successive 2 ml fractions of the eluant were assayed for 
haem absorbance at 5701™  and for total radioactivity.
4.3.3 Culture Experiments
4 .3.3.1 Experiments using leucine-labelled serum proteins as
substrates
Conceptuses were transferred from a culture medium of homologous 
serum to one of dialysed |^h] leucine-labelled serum, at different 
intervals between 12 and 0.5 hours before harvesting. At harvesting, 
conceptuses were washed as before, and tissues solubilised, 
neutralised and diluted as before. The 1.0 ml of tissue solution for 
radioactivity counting was divided into two 0 . 5 ml fractions, one of
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which was added to 4 . 5 ml of Lumagel scintillation fluid and assayed 
for total radioactivity. To the remaining 0 . 5 ml of tissue solution 
was added 0.25 ml of 2CP/o TCA and 0.05 ml of carrier protein. After 
centrifugation at 2 ,0 0 0 gfor 20 minutes, the supernatant (0 . 7 5 ml) 
was added to 4*5 mlLumagel scintillation fluid and counted to give 
the TCA-soluble radioactivity. This figure was adjusted as for 
1 2 5x_dBSA by multiplication by an empirically determined correction 
factor. Appropriate adjustments were also made to allow for background 
and quenching. A quench curve equation was calculated as described 
in 2 .5 . 5 only using [%] leucine rather than [%] dextran.
Duplicate 0.5 ml samples of culture medium were similarly assayed for 
total and TCA_soluble radioactivity, with the omission of carrier 
protein.
In order to assess any effect that the dialysed serum might have upon 
pinocytosis by the yolk sac, a culture was performed in which the 
culture medium comprised non-radioactive dialysed serum supplemented 
with the necessary glucose and vitamins, and "*^I-PVP Was use(j ag 
pinocytic substrate following the procedure described in 2 .3.2 .
4. 3. 3.2 Experiments using M  Leucine-labelled Haemoglobin as Substrata
The experimental protocol was identical to that described for 1 2 5i_<j3sa 
(3 *3 *2 ), with the exception that the culture medium.comprised 5Q^ 
homologous serum, 5C% Hanks Balanced Salt Solution. Conceptuses 
develop equally well in this medium with respect to protein 
content and the chosen developmental criteria (2 .3 .1 ) as in 
10CP/a homologous serum. Haemoglobin solution was added at a ratio of 
0.05 ml per ml of culture medrum. At harvesting, conceptuses were 
treated as previously described and total and TCA-soluble radioactivity 
of tissues and culture medium was assayed as described in 4 3 3 1
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¿.5.4 Quantitation of Uptake
In experiments in which both leucine-labelled, serum proteins and.
¿Hjleucine-labelled haemoglobin were used as substrates, no significant 
depletion of radioactivity in the culture medium following culture 
was observed. Furthermore there was no significant alteration in the 
percentage of TCA-soluble radioactivity in the culture medium during 
culture. Uptake was therefore calculated in the same way as 
described in 2.3.6.
4.5.5 SPS-polyacrulamide gel electrophoresis of tissues following 
culture in the presence of _^h! leucine-labelled haemoglobin
SDS-polyacrylamide gel electrophoresis was performed according to the 
method of Fehmstrom and Moberg (1977)> using a phosphate buffer 
system. Phosphate buffer stock solution (0.2 M, pH 7.1) containing 
SDS was prepared by dissolving in 5 litres of distilled water 39.0 g 
NaH2p04*H20* 258.0 g Ha2HP04.12H20 and 10.0 g SDS. The gel was 
prepared by adding 33.0 ml of phosphate buffer stock solution to
22.2 ml of acrylamide solution and 7 . 5  ml of distilled water.
Acrylamide solution was prepared by dissolving 22.2 gacrylamide and 
0.6 g methylenebisacrylamide in 100 ml of distilled water. The gel 
mixture was then deaerated for about 2 hours by connecting to a 
vacuum pump and periodically shaking. Following deaeration, 3.2 ml 
of a 1*5 mg/ml solution of ammonium persulphate and 0.1 ml of TEMED 
were added to the gel mixture to effect polymerisation. The gel 
mixture was poured into the gel moulding set and allowed to polymerise 
for 45 minutes. The moulded 7 .5%  gel was then placed in a fridge for 
5 minutes to facilitate removal of the mould and the gel was stored 
on a glass plate overnight at room temperature. For electrophoresis 
the gel was placed on a cooling plate in the centre of the apparatus
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to which had been added a few drops of 0.1% Triton X-100 to improve 
thermal conductivity. Each of the buffer reservoirs were filled with 
1 litre of electrode buffer, a 1:1 dilution with distilled water of 
phosphate buffer stock solution, and electrode wicks, seven strips of 
Whatman No. 1 filter paper on each side, were dipped into the electrode 
buffer and positioned along each side of the gel, overlapping it by 
about 15 nm- Before applying samples to the gel pre-electrophoresis 
of the gel was performed at a constant current of 150mA for 30 minutes. 
Samples (0.01 ml) were then applied to the pre-formed slots at the 
cathodic pole of the gel using a Hamilton syringe. Samples were 
concentrated by running at a low current of 20mA for 10 minutes. 
Electrophoresis was then started by adjusting the potential difference 
to give a current of 195mA> and the system was run at this current 
for about 4 hours.
The samples were prepared as follows. A culture was performed using 
t%] leucine-labelled haemoglobin as substrate. The substrate was 
present in the culture medium for either the last 12 hours of culture 
or the last hour of culture. At hairvesting conceptuses were washed 
as usual and the yolk sacs dissected from the embryos. All yolk sacs 
and embryos from a single experiment were pooled separately. Pooled 
tissues were homogenised in 0.25 M NaOH and once completely solubilised 
were neutralised with an equal volume of 0.25 M HNO^. Samples were 
then dialysed overnight to remove non-protein-bound radioactivity.
To 0.2 mlof dialysed sample solution was addedO.1 ml of sample buffer, 
a solution comprising 6% SDS and 30% 2-mercaptoethanol in 0.01M 
phosphate buffer stock solution, and the mixture was heated at 100°C for 
5 minutes in a water bath. This latter step promoted dissociation of 
proteins into sub-units with a rod-like shape of constant diameter, the 
long axis of the rod varying in proportion to the molecular weight.
The binding of the SDS to the protein sub-unit introduced one negative 
charge per bound molecule of SDS. Thus proteins carried a net negative 
charge and migrated in one direction only, towards the anode, migrating 
a distance which was related to their molecular weight. Following 
heat treatment of the sample 0 .0 0 5 ml of 0.25%  (w/v) bromophenol blue 
in sample buffer was added. The bromophenol blue acted as front 
marker and indicated when the run was complete. In addition to tissue 
samples a sample of dialysed [*] leucine-labelled haemoglobin was 
treated with SDS/2-mercaptoethanol, as described, and electrophoresed.
Following electrophoresis, the gel was immediately sliced. Each lane 
was first excised from the gel slab using a razor blade and the strip 
was then sliced with a purpose-built gel-slicer. The thickness of 
each gel slice was 1.8 mm. Each slice was individually homogenised 
in distilled water (0.5 ml) and the homogenate was added to 4 .5 ml of 
Lumagel scintillant and counted for total radioactivity.
4.5.6 The effect of L-leucine on the incorporation of radioactivity 
bv conceotuses following culture in the presence of %-labelled 
serum proteins
Conceptuses were cultured for the last six hours of a 48 hour culture 
period in dialysed [%] leucine-labelled serum to which had been added 
L-leucine at a concentration of 50, 100, 500 or 1,000 jag/ml. A control 
group of conceptuses received no L-leucine in their culture medium.
At harvesting, conceptuses were washed, dissected and solubilised as 
described previously and assayed for total and TCA-soluble radioactivity 
as described in 4* 3-3-1 -
Results were expressed graphically as the uptake of radioactivity 
{pi/mg protein) in 6 hours as a function of L-leucine concentration
in the culture medium.
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A. A Results
A. A. 1 Stability and authenticity of radiolabelled substrates
Figure 4*1 shows that the increase in TCA-soluble radioactivity when 
both [%] leucine-labelled serum proteins and leucine-labelled
haemoglobin were incubated separately under standard culture conditions 
in the absence of conceptuses was negligible. In contrast, the 
percentage of TCA-soluble radioactivity released when 0.1 ml of 
radiolabelled serum or 0 .1 ml of radiolabelled haemoglobin were 
incubated with 0.5 ml of 0.25M NaOH at y]°C rose appreciably after 1 
hour of incubation. It was for this reason that tissues were 
solubilised in 0.25 M NaOH for no longer than 1 hour.
The incorporation of N  leucine into the primary structure of serum 
proteins following its injection into a rat is demonstrated by the data 
of Table 4.1. The addition of a different concentration of L-leucine 
to each of 3 .0  ml aliquots of radiolabelled serum led to there being 
no significant difference in the total radioactivity of the serum 
following dialysis for 4 days at 4°C. Evidently the protein-bound 
[%] leucine in the radiolabelled serum cannot be displaced by the 
addition of an excess of non-radioactive L-leucine.
The authenticity of M  leucine-labelled haemoglobin is demonstrated 
in Figure 2. Haemoglobin and radioactivity were eluted simultaneously 
from a Sephadex G-75 chromatography column.
4,4.2 Culture experiments
When conceptuses were cultured in vitamin- and glucose-supplemented 
dialysed serum containing radiolabelled proteins, the level of 
radioactivity in both the yolk sac and the embryo increased linearly 
with time of exposure to substrate (Figure 4 .3). Following short periods
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Figure 4.1 Increase in TCA-soluble radioactivity after : . '
incubation at 37 C in roller cultures apparatus of vitamin- 
and glucose-supplemented dialysed J^ Hj leucine-labelled serum 
in 0.25 M NaOH (■), water (O) or alone (□), and of [ h] leucine- 
labelled haemoglobin in 0.25 M NaOH (A) and rat serum (A).
Each point represents mean of 4 separate determinations.
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Figure 4.2 Co-elution from Sephadex G-75 column of haem, 
estimated by absorbance (a ) at 570 nm, and radioactivity (A) 
after application to column of {^njleucine-labelled 
haemoglobin. Vq indicates void volume.
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of exposure to radiolabelled substrate, uptake of radioactivity into the 
yolk sac exceeded that into the embryo; this trend was reversed after 
longer exposures to substrate. The percentage of tissue radioactivity 
that was TCA-soluble is shown in Figure 4 .4. After short periods of 
exposure to substrate, a high percentage of yolk sac radioactivity was 
TCA-soluble. On longer exposures, this percentage steadily declined, 
apparently tending towards a minimum value of 3<$. A qualitatively 
similar pattern was observed in the embryo, where the percentage of 
TCA-soluble radioactivity was higher than in the yolk sac at short 
exposures and declined more rapidly with longer exposures to a steady 
level of about 2CP/o, lower than that seen in the yolk sac. Assuming
by the yolk sac, the clearance of radiolabelled proteins from the 
culture medium can be calculated. Figure 4-5 shows that this clearance 
is linear with time over the 1 2 hours incubation period studied, and 
has an Endocytic Index of 2.19.
The necessary use of dialysed serum as a culture medium in these 
experiments raises the question of whether dialysis of the serum 
affects the conceptuses' ability to capture macromoleculre substrates. 
Therefore the uptake of ^5j_pvp was studied following exactly the 
same procedure described in 2 .3 -2 .1 , but using glucose- and vitamin- 
supplemented dialysed serum as a culture medium. At a concentration 
of 2 .8  jug 1 2 5i_pvp/ml, the pattern of uptake of radioactivity 
(Figure 4 .6) did not differ from that observed when whole serum was 
used as culture medium (Figure 2.3).
The pattern of uptake of total radioactivity by yolk sac and embryo 
(Figure 4 .7 )» and the percentage of this radioactivity that was TCA-
ts
that the radioactivity in the entire derived from initial uptake
soluble (Figure 4 .8) when haemoglobin was used
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Figure 4.4 Percentage of tissue radioactivity soluble in TCA after 
incubation of conceptuses in the presence of [ HJ leucine-labelled 
serum proteins. Each point represents the mean (_+ S.D.) of at least 
6 determinations. (■) yolk sac, (□) embryo.
Time of addition of substrate (h)
Figure 4.5 Total radioactivity taken up by yolk sacs after incubation 
in the presence of [3h] leucine-labelled serum proteins. Each point 
represents the mean (+^  S.D.) of at least 6 determinations.
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Figure 4.6 Radioactivity associated with yolk sac (■) and 
embryo (□) after incubation of conceptuses in the presence of
T O C
I-PVP (2.3 pg/ml). Conceptuses were cultured in vitamin- and 
glucose-supplemented dialysed rat serum. Each point represents 
the mean (+ S.D.) of at least 6 determinations.
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Figure 4.7 Radioactivity associated with yolk sac (■) and 
embryo (□) after incubation of conceptuses in the presence of 
t h} leucine-labelled haemoglobin. Each point represents the 
mean (_+ S.D.) of at least 6 determinations.
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Figure 4.8 Percentage of tissue radioactivity soluble in TCA 
after incubation of conceptuses in the presence of M  leucine- 
labelled haemoglobin. Each point represents the mean (+ S.D.) 
of at least 6 determinations. (■) Yolk sac, (□) embryo.
100
Time of addition of substrate (h)
Figure 4.9 Total radioactivity taken up by yolk sacs after 
incubation of conceptuses in the presence of ^hJleucine- 
labelled haemoglobin. Each point represents the mean (_+ S.D.) 
of at least 6 determinations.
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as substrate, was qualitatively similar to that described for 
^H-labelled serum proteins. Quantitatively however, the uptake of
[3h] haemoglobin by both yolk sac and embryo, expressed as a function 
of yolk sac and embryo protein respectively, was about 2 -^ times 
greater than was %-labelled serum protein uptake. Clearance of 
radiolabelled haemoglobin by conceptuses is shown in Figure 4.9 . On
of yolk sac protein, was about 3 times that observed with ^H-labelled 
serum proteins.
4.4.3 Electrophoretic Separation of Conceptus Tissue Proteins following
In order to gain further information on the mechanism of accumulation 
of radioactivity by yolk sac and embryo following culture in the
to SDS-polyacrylamide gel electrophoresis. Figure 4.10 shows the 
electrophoretic profile of the sample of |~^hJ haemoglobin used in 
this study. Radioactivity was concentrated in a single peak. The profile 
of radioactivity associated with yolk sac proteins after 1 hour of 
exposure to substrate (47 "to 48 hours of culture; Figure 4 . 1 1 ) shows 
a single peak coincident with that of the substrate sample. Embryonic 
proteins under the same incubation conditions demonstrated no radio­
activity. These observations indicate that the yolk sac pinocytoses 
radiolabelled haemoglobin and that this process precedes the uptake of 
radioactivity by the embryo, confirming the data of Figure 4.7 . After 
exposure to haemoglobin for the last 1 2 hours of culture, both
yolk sac and embryo display a whole range of radiolabelled proteins 
(Figures 4.12 and 4*13). These spectra of radiolabelled proteins clearly
Culture in the Presence of leucine-labelled haemoglobin
haemoglobin, tissues were solubilised and subjected
demonstrate that radioactivity from
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Figure 4.10 Profile of protein-associated radioactivity after 
SDS polyacrylamide gel electrophoresis of £3h]leucine-labelled 
haemoglobin. Details of method are given in the text.
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Figure 4.11 Profile of protein-associated radioactivity after 
SDS polyacrylamide gel electrophoresis of yolk sac proteins(*) 
and embryo proteins (A ) from conceptuses that were incubated 
in the presence of [3h] leucine-labelled haemoglobin for the last 
hour of a 48-hour culture period. Details of method are given 
in the text.
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Figure 4.12 Profile of protein-associated radioactivity after 
SDS polyacrylamide gel electrophoresis of yolk sac proteins from 
conceptuses that were cultured in the presence of |^ hJ leucine- 
labelled haemoglobin for the last 12 hours of a 48-hour culture 
period. Details of method are given in the text.
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Figure 4.13 Profile of protein-associated radioactivity after
SDS polyacrylamide gel electrophoresis of embryo proteins from 
conceptuses that were cultured in the presence of leucine- 
labelled haemoglobin for the last 12 hours of a 48-hour culture 
period. Details of method are given in the text.
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haemoglobin, has become incorporated into a large array of tissue 
proteins in both the yolk sac and the embryo. Among the radiolabelled 
yolk sac proteins three major peaks predominate (labelled A, B and C 
in Figure 4.12), while a single major peak is observed among embryonic 
proteins, corresponding to peak C of the yolk sac. All of these major 
bands of radioactivity are quite distinct from haemoglobin.
4.4.4 The Effect of L-leucine on the Incorporation of Radioactivity by 
Conceptuses following Culture in the Presence of ^H-labelled Serum Proteins
Figure 4.14 shows that L-leucine reduced the extent of incorporation of 
radioactivity into both yolk^and embryo when conceptuses were cultured in 
the presence of ^H-labelled serum proteins for the last 6 hours of 
culture. This reduction was proportional to the concentration of 
L-leucine in the culture medium. At all concentrations of L-leucine 
used, there was no observed increase in TCA-soluble radioactivity in 
the medium during culture, and the protein content of conceptuses at 
harvesting were not noticeably different from that of control conceptuses 
incubated in the absence of L-leucine (Table 4.2 ).
The percentage of yolk sac- and embryo-associated radioactivity that 
was TCA-soluble is shown in Figure 4.15. It may be seen that the 
proportion of TCA-soluble radioactivity increases as the concentration 
of L-leucine in the culture medium increases. At low L-leucine 
concentrations the percentage TCA-soluble radioactivity rises rapidly 
in both yolk sac and embryo. At L-leucine concentrations of more than 
lOO^jug/ml, percentage TCA-soluble radioactivity increases more slowly, 
the yolk sac TCA-soluble radioactivity increasing rather more slowly 
than that in the embryo. At L-leucine concentrations of 1,000;ug/ml, 
all of the embryo radioactivity is TCA-soluble while more than 80%  of 
yolk sac radioactivity is TCA-soluble.
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Figure 4.14- Radioactivity associated with yolk sac (B)and 
embryo (□), and total radioactivity taken up by yolk sac (O) 
after incubation of conceptuses in the presence of N  leucine- 
labelled serum proteins and L-leucine for the final 6 hours 
of culture. Each point represents the mean of 4 separate 
determinations.
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Figure 4.15 Percentage of tissue radioactivity that was soluble 
in TCA after incubation of conceptuses in the presence of leucine- 
labelled serum proteins and L-leucine for the final 6 hours of 
culture. Each point represents the mean of 4 separate determinations. 
(■) Yolk sac, (□) embryo.
Mean radioactivity of dialysed 
serum (c.p.m. per 0.5 ml)
Concentration of 
added L-leucine (pg/ml)
0 6488 + 187 (6)
1 6389 + 122 (6)
2 6317 + 158 (6)
5 6367 + 149 (6)
Table 4.1 The effect of adding L-leucine to Ph]leucine- 
labelled rat serum before dialysis on the level of radioactivity 
associated with serum after dialysis. Details of procedure 
for dialysis are given in the text. Figures in brackets 
indicate the number of determinations performed. No 
significant difference ( p > 0 .1 ) exists between values as 
judged by students t-test.
Concentration of TCA-soluble radioactivity Protein contents
L-leucine in culture 
medium (pg/ml)
in culture medium after 
culture (% total radio­
activity)
of embryos/ yolk 
sacs at harvest­
ing (^g)
0 0.65 192.4/117.3
50 0.73 174.6/113.0
100 0.74 217.0/121.8
500 0.73 187.0/125.2
1000 0.60 189.2/120.2
Table 4.2 Lack of effect of L-leucine present in culture for the
final 6 hours on the percentage TCA-soluble radioactivity in the 
culture medium and the protein contents of embryos and yolk sacs 
at harvesting. Values are the means of 4 determinations.
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A.5 Discussion
j^sj Leucine-labelled proteins yield a radiolabelled digestion product, 
|5H] leucine, which cells are able to utilise in the de_ novo biosynthesis 
of proteins. It is interesting to note therefore that when such proteins 
were presented to conceptuses in culture, radioactivity was accumulated 
in the yolk sac and the embryo, the extent of the accumulation being 
directly proportional to the duration of exposure of the conceptúa to 
the radiolabelled proteins.
The percentage of this radioactivity that was TCA-soluble decreased with 
increasing duration of exposure to substrate, to steady levels. These 
data are consistent with the embryo drawing for its amino acid require­
ments on the products of yolk sac lysosomal proteolysis, although other 
explanations are possible. For example, proteins may be taken up by 
the embryo either directly, or by a route through the yolk sac that 
avoids lysosomal action. In any such event it must be further postulated 
that proteins are rapidly degraded by the embryo, and the amino acids 
generated progressively re-utilised in the synthesis of new protein. 
Alternatively, radioactivity accumulated by the embryo might derive from 
a combination of the latter pathway and a mechanism involving yolk sac 
proteolysis. However, in the light of observations made using the non-
(1979) that FITC-serum proteins could only be detected by fluorescence 
microscopy, in the endoderm of the visceral yolk sac and not in the 
subjacent mesoderm, any mechanism postulating uptake of intact protein 
by the embryo is much less plausible than one in which proteolysis by 
the yolk sac is necessary for biosynthesis of embryonic protein.
Taken together, these data provide the first direct experimental
dextran, and the digestible
protein 1 2 5i_cLBSA, together with the observations of Sharma and Peel
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evidence for the mechanism of histiotrophic nutrition postulated by 
Beck et al. (1967a), described earlier.
Certain quantitative differences are apparent between the uptake of 
5H-labelled serum proteins and haemoglobin by conceptuses. The 
total quantity of radioactivity pinocytosed by yolk sac when 
[¿h ] haemoglobin was present in the culture medium for 1 2 hours 
(Figure 4*9) was about 3 times that when conceptuses were exposed to 
3H-labelled serum proteins for the same period (Figure 4.5), giving an 
Endocytic Index of 7.25 for haemoglobin and 2.19 for ^H-labelled
serum proteins. However, direct comparison of these figures is mis­
leading, owing to the differences in the culture medium used in the two 
experiments. The discussion to the last chapter drew attention to 
the importance that the protein concentration of the culture medium 
has upon the extent of pinocytosis of a single protein. The relatively 
high Endocytic Index reported here with pn| haemoglobin is probably 
due, at least in part, to the reduced protein content (and hence 
competition) in the culture medium. This explanation assumes that 
haemoglobin uptake is to some extent an adsorptive process.
Fridhandler and Zipper (1964) measured haemoglobin uptake by
1 7 .5-day yolk sac cultured in serum-free medium. From their data an 
Endocytic Index of 4*06 can t>e calculated, which is approximately twice 
the fluid-phase rate of capture of 1 25l-PVP by the 17.5-day yolk 
sac in serum-free culture medium reported by Ibbotson and Williams (19 7 9) 
This suggests that haemoglobin uptake by the near-term yolk sac is 
assisted by some, adsorption to the plasma membrane.
The separation of yolk sac and embryo proteins by gel electrophoresis 
following exposure of conceptuses to haemoglobin for the last 12
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hours or the last hour of culture, has been described. Although the 
data arising from this study contribute little to the understanding of 
the mechanism of protein assimilation by yolk sac and embryo, certain 
qualitative conclusions can be drawn. Firstly, if the embryo does 
receive intact jj-lij haemoglobin from the culture medium, then either 
the process is slow or the protein is rapidly degraded and re-utilisation 
of the generated amino acids is slow. Either way, no radioactivity would 
be demonstrated in the proteins of the embryo after 1 hour of exposure 
to radiolabel, confirming the kinetic data of Figure 4 .7 . The yolk sac 
on the other hand, after a 1 hour exposure to radiolabel, contained a 
single peak of radioactivity with a slightly higher electrophoretic 
mobility than the radiolabelled substrate. It is quite probable that 
this yolk sac radioactivity is derived from pinocytosed haemoglobin
that has been partially hydrolysed. Secondly, both yolk sac and embryo 
display a whole range of radiolabelled proteins, or protein sub-units, 
after a 12 hour exposure to J3h \ haemoglobin. This conclusively 
demonstrates that a single protein captured by the conceptus can be 
utilised by the tissue to form many and varied cellular proteins.
The evidence presented so far all indicates that the yolk sac, through 
pinocytosis and catabolism of protein, is able to supply the conceptus 
with amino acids during early organogenesis. Whether or not this process 
contributes significantly to histiotrophic nutrition in vivo is less 
certain. It may well be that the conceptuses’ requirements for amino 
acids are met largely by diffusion of exogenous amino acids into 
embryonic and yolk sac cells, the yolk sac —mediated pathway of 
protein utilisation being of only supplementary value. Certainly, 
exogenous amino acids are incorporated into yolk sac and embryonic
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protein during early organogenesis (Kemis, 1971; Payne and Deuchar, 
1972). On the other hand, the very fact that conceptuses develop 
normally in vitro in a culture medium of dialysed serum, which contains 
minute quantities of amino acids, between 9 ,5 and 11.5 days gestation 
(Gunberg, 1976; Cockroft, 1979) indicates that protein alone can 
provide the amino acids necessary for development and growth.
In the present study, the effect on protein utilisation by conceptuses of 
an excess of L-leucine in a dialysed culture medium containing ^H-labelled 
serum proteins, was investigated. Over the 6 hour incubation period 
studied, L-leucine reduced the quantity of radiolabel measured in the 
yolk sac and embryo tissues by an amount proportional to the concentration 
of L-leucine in the culture medium. Furthermore, the percentage of tissue- 
associated radioactivity at harvesting that was TCA-soluble, increased 
with increased concentration of L-leucine. Indeed, at the highest 
concentration of L-leucine employed, 1,000yug/ml, all of the embryo 
radioactivity and more than QCP/o of the yolk sac radioactivity was 
TCA-soluble. At all concentrations of L-leucine used there were no 
noticeable differences in the protein contents of yolk sacs and embryos 
at harvesting, compared with controls cultured in the absence of L-leucine. 
These data are interpreted as follows: pinocytosis of serum proteins 
and their intralysosomal catabolism in yolk sac, proceed at a normal 
rate. The generation of J^hJ leucine by yolk sac proteolysis provided 
a source of radiolabelled amino acid for protein synthesis in the cells 
of the conceptus. However, this pool of leucine is diluted by
L-leucine which has diffused into the cells from the culture medium, 
and which competes with J^ h J leucine for the appropriate tENA.
The greater the concentration of L-leucine, the greater the dilution 
of leucine in the intracellular leucine pool, and the less the
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radiolabelled amino acid will become incorporated into synthesised 
protein. Evidently, not all the free j^HJ leucine has remained 
within the tissues of the conceptus and must have been lost, although 
no increase in the TCA-soluble radioactivity of the medium was 
observed at the end of culture. Either the small amount of 
radioactivity lost was excreted into the culture medium and was not 
detected, or more likely, M  leucine diffused out of the tissues 
during washing (see Wheatley, 1980). Since all tissues were washed 
in an identical manner, the extent of the diffusion would depend 
entirely on the concentration of free pnj leucine within the tissues 
which, as already explained, increases with increased concentration 
of L-leucine. This effect could be eliminated by the addition of 
an excess of L-leucine to the washing medium.
The reduced re-incorporation of proteolytically-derived |^ 3hJ leucine 
into new protein as a result of the presence of an excess of unlabelled 
L-leucine in cells, has been observed in isolated rat hepatocytes 
(Hopgood et al., 1977)» BHK21 fibroblasts (Hendil, 1980) and mouse 
peritoneal macrophages (Ehrenreich and Cohn, 19 6 8) and is commonly 
used in studies of cellular protein degradation of |^3h | leucine- 
labelled proteins to specifically prevent underestimation of proteolysis 
due to re-utilisation of [^h ] leucine.
In the present study, the data demonstrate that free amino acid in 
the culture medium successfully competes with that amino acid derived 
from proteolysis in the yolk sac for incorporation into yolk sac and 
embryonic proteins. Therefore, the source of amino acids for protein 
synthesis in the conceptus is most probably determined by the 
composition of the histiotroph that bathes the early organogenesis 
conceptus in útero. This topic is further discussed in Chapter 10.
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CHAPTER FIVE
THE EFFECT OF TRYPAN BLUE ON YOLK SAC-MEDIATED NUTRITION
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5.1____ Introduction
Throughout the preceding chapters reference has been made to the 
mechanism of histiotrophic nutrition, postulated by Beck et al. (19 6 7a) 
to function during early organogenesis in the rat. In a companion 
paper the same authors (Beck et al., 19 6 7b) suggested that the bisazo 
dye trypan blue might elicit congenital malformations in the offspring 
of rats treated with the dye by disturbing this nutritional process, 
a hypothesis that was subsequently modified in detail (Williams et 
al., 1976). This evidence, along with the corroborative observations 
of other workers, was described in Chapter 1. However, although the 
balance of evidence favours yolk sac function as the primary site of 
teratogenic action of trypan blue, other (less well-formulated) 
theories have proposed that some aspect of maternal metabolism or 
the embryo itself might be the principal target of trypan blue's 
action.
Gilbert and Gillman (1954) suggested that trypan blue-induced 
teratogenesis in rats was due to erythrophagocytosis in the mother, 
leading to an acute anaemia and consequent hypoxia. Hommes (1959), 
citing the observation of Gillman et al. (19 4 8) that trypan blue 
injection brought about adrenal hypertrophy in the pregnant rat, 
proposed that embryonic development might in some way be impaired by 
a disturbance of the maternal hypophyseo-adrenal system. The well- 
documented alterations in maternal serum proteins occasioned by 
trypan blue treatment (reviewed by Beck and Lloyd, 1966) led Beaudoin 
and Kahkonen (19 6 3) "to suggest that in rats these changes, generally 
a fall in the absolute levels of serum albumin and a rise in tx- 
and (3-globulins, might in themselves be the principal cause of 
congenitally malformed offspring, particularly since the composition 
of yolk sac fluid (Beaudoin and Ferm, 1961) and fetal serum (Beaudoin
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and. Kahkonen, 19 6 3) are a1 so altered. In a subsequent study however, 
Beaudoin and Roberts (1965) observed that injection of <X- and P-globulins 
from trypan blue-treated pregnant rats into 8-day pregnant rats did 
not cause fetal malformations. These workers concluded that the 
alteredoir and p-globulins were not, in themselves, responsible for 
teratogenesis. Christie (19 6 4) postulated that maternal thyroid 
dysfunction following trypan blue administration may cause a decrease 
in oxidative metabolism and a consequently reduced supply of oxygen 
and essential metabolites to the embryo. But in a later publication 
the same author (Christie, 19 6 5) observed that, although thyroidectomy 
potentiated the teratogenicity of trypan blue in rat, thyroidectomy 
alone failed to produce malformations. Furthermore, Beck and Lloyd (19 66) 
administered excess thyroxine between 8 .5 and 10.5 days of gestation 
to trypan blue-injected rats and failed to reduce the dye’s teratogenicity. 
Therefore the teratogenic effect would seem not to be mediated, directly 
at least, through the thyroid gland.
Wilson et al. (1959) correlated the end of the teratogenic period of 
trypan blue in rats with the closure of the yolk stalk and hence the 
complete surrounding of the embryo by the yolk sac. It was suggested 
by these authors that trypan blue might act directly on the embryo 
in some way, and that sensititivy to trypan blue abruptly ceased once 
this route of access to the embryo was closed, a suggestion also 
advanced by Greenhouse et al.(l969). However, in a subsequent study 
using ^C-labelled trypan blue (Wilson et al., 19 6 3), contrary to 
expectation, no radioactivity above background levels could be detected 
in the embryo following maternal injection, though the yolk sac 
contained high levels. Even so there are reports in the literature 
(Barber and Geer, 1 9^ 4» Davis and Gunberg, 1968; Greenhouse et al, 19 6 9; 
Bavis and Sauter, 1977? Dencker, 1977) that demonstrate trace quantities
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of the dye in the embryonic endoderm. Furthermore Turbow (19 6 6) 
wag able to show that rat conceptuses explanted at 1 0 - 1 1 days of 
gestation with.the yolk sac intact, and cultured for periods up to 
48 hours on plasma clots, were more susceptible to the toxic effects 
of trypan blue when the dye was injected, at low concentrations, into 
either the amniotic cavity or the extra^-embryonic coelom, than when 
it was present solely in the culture medium and thus in contact 
with the yolk sac only. Interestingly, at higher concentrations of 
trypan blue abnormal development was more common when the dye was 
present in the culture medium only. (The in vitro toxicity of trypan 
blue, present in the culture medium, to the day 10 rat conceptus has 
recently also been observed by Beaudoin and Fisher, 1981). All of 
these observations lend support to the theory of direct action of the 
dye on the embryo and, as Hamburgh et al. (1975) have pointed out,
"the cells of the head process, early notochord and possibly the 
primitive streak are exposed to fluids in the yolk sac cavity prior 
to the complete envelopment of the embryo by the yolk sac", suggesting 
that a surface action of the dye on embryonic cells might well be a 
causative factor in teratogenesis. Hamburgh et al. (1975) were also 
perplexed by the fact that only a fraction of those conceptuses 
exhibiting impaired yolk sac lysosomal enzyme function (indicated as 
a reduced acid phosphatase activity) as a result of exposure to trypan 
blue, actually went on to develop abnormally, and they suggested that 
the effect of trypan blue on the yolk sac might not be the primary 
cause of teratogenesis.
Another reported effect of trypan blue on the developing rat conceptus 
was the increase in absorption of certain inorganic ions by the yolk 
sac, and in some cases by the embryo as well (Kemis and Johnson, '[969). 
This effect may be of importance in the production of the changes of
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volume and pressure of the circulating fluids of rat and chick embryos 
which Grabowski and his co-workers (Kaplan and Grabowski, 1$6j; 
Grabowski et al., 1971» Grabowski, 1977) have suggested as a mechanism 
of teratogenic action of trypan blue. Grabowski (1977) has observed 
similar effects in chick embryos resulting from hypoxia. This latter 
observation is of particular interest since Kaplan and Johnson (1968) 
suggested that trypan blue might produce hypoxia in chicks by 
uncoupling oxidative phosphorylation, a mechanism also proposed in rats 
by Christie (vide supra). Rogers (1978) observed that a teratogenic 
dose of trypan blue injected into 8 .5-day pregnant rats, resulted, 
by 11.5 days in a substantial increase in the osmolality of embryonic 
amniotic fluid which correlated closely with the abnormal development 
of the embryo.
That trypan blue can induce so many and profound effects in biological 
systems, together with its wide-ranging teratogenicity in many species, 
including amphibia and reptilia, makes it unlikely that a single 
mechanism of action of the dye is responsible for the production of 
malformations.
In the present study, the effect of teratogenic trypan blue on the 
pinocytic and proteolytic capacity of the yolk sac, and the ability 
of the conceptus to utilise [ % ]  leucine-labelled serum proteins, 
properties of the early organogenesis conceptus that were established 
in the preceding chapters, was investigated.
According to Williams et al. (1976), it is the pinocytic ingestion 
of nutrients by the yolk sac that is inhibited by trypan blue and 
probably constitutes the primary defect in trypan blue-induced 
teratogenesis. However, the evidence for this mechanism was obtained 
using the 17.5-day yolk sac in culture, and, as the authors recognise,
- 78 -
the dye has long ceased to he teratogenic in vivo by this stage. 
Furthermore, the composition of the culture medium used in this study 
probably differs greatly from the plasma transudate that bathes the 
early conceptus in vivo. The importance of the composition of the 
culture medium in in vitro studies upon the degree of uptake of 
macromolecules, has already been stressed. The New culture technique 
is therefore ideal to investigate the claim of Williams et al. (1976) 
since it uses entire conceptuses from early organogenesis, a stage of 
gestation which approximates to the period in vivo when trypan blue 
is teratogenic (Wilson et al., 1959)» and also since it uses as a 
culture medium 1OCP/o homologous serum, which probably resembles closely 
the environment of the conceptus in vivo during the period of 
teratogenic susceptibility to trypan blue.
Several factors are known to influence the teratogenicity of trypan 
blue in rodents. Wilson et al. (1959) demonstrated that the time 
during pregnancy at which trypan blue was administered to pregnant 
rats determined the frequency of malformations. These workers found 
that a maximum teratogenicity occurred following dye injection at
8.5 days of gestation, and no teratogenic activity was apparent when 
trypan blue given after day 10 of gestation. Several reports 
(Gunberg, 1958; Tuchmann-Duplessis and Mercier-Parrot, 1959; Beck 
et al., I960; Hamburgh and Callahan, 1967) have indicated that the 
teratogenicity of trypan blue varies with the strain of species used, 
while Beck (19 6 7) showed that the position in the uterus occupied 
by embryos influenced their susceptibility to trypan blue. Beck (1 9 6 1) 
made the interesting observation that different commercial samples of 
trypan blue produced varied response when equivalent doses (in terms 
of titratable azo linkage) were administered at the same stage of 
pregnancy to the same strain of rat. It was concluded that commercial
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preparations of trypan blue were mixtures of substances the proportions 
of which varied between commercial samples, and consequently doubts 
were raised as to whether trypan blue was the teratogenically active 
component of such mixtures.
Trypan blue, whose structure is shown in Figure 5 .1 , is synthesised 
by coupling tetrazotized o-tolidine to H-acid (8-amino-1-naphtho1 -3, 
6-disulphonic acid) in alkaline solution (Hartwell and Fieser, 19 3 6). 
During preparation of the dye, precipitation with NaCl removes trypan 
blue from solution, thus allowing it to be easily separated from the 
reaction mixture. However, this treatment can lead to considerable 
contamination of the dye with NaCl, which in the context of teratogenic 
testing is undesirable, since it can lead to a grossly inaccurate 
estimation of the teratogenic dose. In a survey of randomly selected 
commercial samples of trypan blue, Lloyd and Beck (19 6 3) showed that 
the NaCl content varied from less than 1CÇ6 in one sample to more 
than lü/o in another. Clearly, on a weight to weight basis, one 
preparation contains considerably more trypan blue than the other.
In addition to contamination with NaCl, moisture can account for up to 
1C% of the dye's weight, and a number of coloured impurities, generated 
through side reactions during synthesis, are also often observed in 
the dye preparation. Beck and Lloyd (19&3) isolated blue, red and 
purple fractions from one commercial sample of trypan blue by paper 
chromatography and found that only the blue fraction was teratogenic 
in rats. Barber and Geer (19 6 4) confirmed that the blue fraction of 
"trypan blue" was responsible for the production of deformed mouse 
fetuses, the red and purple fractions being at most only very slightly 
teratogenic. Only Bertini and Sacerdote (1970), using mice, have 
reported a teratogenic activity of the red fraction; Field et al. (1977)
Figure 5.1 Structural formula of trypan blue
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also using mice, were however unable to support this finding. The 
latter authors did however demonstrate a potent teratogenicity of the 
blue fraction in mice. Thus it seems reasonable to conclude that 
trypan blue itself, and not a coloured c o n t a m in a n t ,  is the active 
teratogenic component of commercial preparations of the dye, and that 
furthermore, the intact dye molecule and not a reduction product is 
necessary for this activity (Wilson, 1955; Turbow, 1966; Field et 
al., 1977).
In view of the above discussion, it is essential that the purity of 
the dye be evaluated before an accurate estimation of the dosage can be 
obtained.
9.2 Materials 
Chemicals
Trypan blue was a generous gift of 
Alizarin Red S
Dowex-1 (H+ form)(x4, 20-50 mesh)
Other chemicals were of analytical
Equipment
Lab. pH meter Model 7020
Shandon Electrophoresis Apparatus 
Model 477
Chromatography Tank 
Chandos power pack Model No. E 26 
Edwards Modulyo Freeze-Drier 
Cecil Scanning Spectrophotometer
Professor F. Beck, University of
Leicester
Koch-Light Laboratories Ltd, 
Colnbrook, Berks.
BDH Ltd, Poole, Dorset 
grade.
Electronic Instruments Ltd,
Chertsey, Surrey 
Shandon Ltd, Cheshire
Shandon Ltd, Cheshire 
Chandos, Stockport, Cheshire 
Edwards High Vacuum,Crawley, Sussex 
Cecil Instruments Ltd, Cambridge
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5 .5_____Methods
5.5.1 Estimation of purity of trypan blue preparation
5.5.1.1 Estimation of salt content of trypan blue preparation
Sodium chloride content of the dye sample was estimated using the 
method of Lloyd and Beck (19 6 3) - Dye sample ( 1 0  mg) was accurately 
weighed into a 25 ml beaker and dissolved in 5 ml of distilled water.
After 5 minutes of constant stirring,5 ml of glacial acetic acid was 
added, and the mixture, stirred throughout, was titrated with 
0.1 M AgN03 solution, using a 5 ml microburette and the electrode 
assembly described by Sanderson (1952). A pH meter was used as the 
millivoltmeter, and the end-point, always sharp, taken as 200mV.
A schematic diagram of the apparatus is shown in Figure 5.2.
5.5.1.2 Evaluation of coloured contaminants of trypan blue preparation
(a) Paper Chromatography
Dye sample was prepared as a 2% solution for ascending paper 
chromatography, according to the procedure of Lloyd and Beck (19 6 3). 
Chromatograms were prepared in cylindrical glass tanks by running 
the solvent for 16 hours after an equilibration period of 7 hours.
Spots were applied to 28 x 43cm sheets of Whatman No. 1 chromatography 
paper using a glass capillary tube. The solvent system used was 
n-butanol-pyridine-water, 1:5s4 by volume. A sample of trypan blue 
of known purity was included in the chromatogram for comparison.
(b) Paper Electrophoresis of Reduction Products of Dye
Dye sample (20 mg) was dissolved in 2 ml of water with stirring, and the 
solution heated to about 80°C. With stirring and temperature maintained 
throughout a freshly prepared 1 (% (w/v) aqueous solution of sodium 
dithionite (Na2S20^) was added in drops until the dye solution had
Figure 5.2 Apparatus of Sanderson (1952) for determination 
of chloride ions by potentiometric titration
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lost its blue colour. Electrophoresis was immediately performed 
using the method of Lloyd and Beck (19 6 4). Strips ( 1 6  x 4 inches) 
of Whatman No. 1 paper were dipped in 0.6 M sodium acetate-acetic 
acid buffer, pH 4*0, and excess solvent removed by dabbing with tissue. 
Spots of the reduced dye solution were applied to the paper with a 
glass capillary and electrophoresis carried out for 50 minutes with 
a field strength of 10 V/cm. The papers were dried, sprayed with 
Ehrlich's reagent (100 mg of p-dimethylaminobenzaldehyde in 5 0 ml of 
ethanol to which had been added 1 ml of concentrated HCl) and dried 
in an oven.
(c) Ion-exchange Chromatography of Reduction Products of Dye
Dye sample (5 mg) was dissolved in 2 ml of water and heated to 80°G before 
reduction with 2*/o (w/v) sodium dithionite. To remove anions the 
resulting colourless solution was acidified by the addition of 2 drops 
of concentrated HCl. Ion-exchange chromatography was then performed 
using the method of Field et al. (1977)* using a resin of Dowex-1 
(x4, 20-50 mesh) in a column 7cm long x 1.5cm diameter. The reduced 
and acidified solution was applied to the column that had been 
thoroughly washed with 0.01 M HCl, and eluted with 0.01 M HCl. Fractions 
(2 ml) were collected and the presence of biphenyl determined by spotting 
onto chromatography paper and spraying with Ehrlich's reagent. Those 
fractions with demonstrable biphenyl content were diluted with 0.1 M HCl 
and their ultraviolet absorption spectra obtained with a scanning 
spectrophotometer.
5.5.2 Purification of Trypan Blue for Teratology and Culture Experiments 
Crude trypan blue was made into a 1% solution and extensively dialysed
against running tap water. After 5 days of dialysis, the solution was
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concentrated by rotary evaporation before being evaporated to dryness 
using a freeze-dryer. The resulting powder was then heated in an 
oven at 110°C for 16 hours (Lloyd and Beck, 19 6 3) to remove moisture.
The NaCl content of the dialysed sample was then estimated as described, 
and found to be less than 1% (w/v).
■5.5 .5  Teratogenic Testing of Trypan Blue
Pregnant rats received a subcutaneous injection of purified trypan 
blue at a dosage of 10 0 mg/kg body weight contained within 1 . 0  ml of 
0.9% saline, at either 8 .5 or 9 .5 days of gestation. Animals were 
sacrificed at 2 0 .5 days of gestation and the-uterus examined for the 
number of implantations, viable young and resorption sites. All 
fetuses were weighed, examined for external malformations and were 
either fixed in Bouin's fluid (saturated picric acid solution- 
40^ formaldehyde-acetic acid, 1 5 s5 :1 ) or preserved in 70% alcohol.
Of every three fetuses, two were fixed in Bouin's fluid and one in 
alcohol. Following exposure to Bouin's fluid for 7 - 1 0  days, 
fetuses were sectioned free-hand with a razor blade to examine for 
visceral anomalies, according to the method outlined by Wilson (19 6 5), 
and depicted in Figure 5*3*
Those fetuses preserved in alcohol were subsequently transferred to 
acetone to defat for 24 hours, before further treatment with alcohol 
for 24 hours. Fetuses were then transferred to 2% K0H for clearing of 
soft tissues. The bones were usually visible after 4 days in K0H. 
Fetuses were then stained overnight in 0.01% alizarin red S in 
2% K0H, and subsequently destained in a solution of glycerol and 
2% K0H (at a ratio of 1*3). Fetuses were examined for skeletal defects. 
Pregnant control rats received an injection of 1.0ml of 0.9% saline.
Figure 5.3 20.5-Day rat fetus marked 
levels of freehand razor sections for 
examine for internal malformations
to show approximate 
preparing slices to
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5.5.4 Culture Experiments
All cultures were of 48 hour duration. For the last 6 hours of all 
cultures, either 1 2 5l-PVP (2.3/ig/ml) or 1 2 5l_d£SA (11 jug/ml) were 
added to the culture medium, or conceptuses were transferred to a 
culture medium of glucose- and vitamin-supplemented dialysed serum
containing 3h "| leucine-labelled proteins. In those experiments
12Swhich used as radiolabelled substrate -'I-PVP, trypan blue was 
added to the culture medium at the same time as the substrate at 
concentrations of 10, 20, 40, 6 0, 80, 100, 200 or 400 pg/wl. Control 
conceptuses were cultured in the presence of  ^25I-PVP only. On the 
basis of results of culture experiments using 1 2 5l-PVP as substrate, 
two concentrations of trypan blue (5 0 and 200 jug/ml) were chosen, 
to investigate the effect of the dye on the uptake and digestion of 
1 2 5i-dBSA. Trypan blue was added to the culture medium at either 
the same time, or 6 hours before, the addition of 1 2 ^i_dBSA. In 
those experiments in which the dye was added before the radiolabelled 
substrate, conceptuses were transferred into fresh medium containing 
no trypan blue, before the addition of "'^I-cLBSA. Therefore, the 
only trypan blue present during the last 6 hours of such cultures 
was either adsorbed onto the external surfaces of, or contained 
within, the tissues of the conceptuses. In cultures in which the dye 
was added to the culture medium at the same time as "^I-iBSA, a 
control group of conceptuses received only ^2^I-cLBSA, while in cultures 
in which trypan blue was administered to the culture medium prior to 
substrate, control conceptuses were not exposed to dye but were 
transferred into fresh medium and exposed to 1 2 5l_dBSA.
Precisely the same experimental protocol as that described for "^I-dBSA 
was followed in cultures which used as radiolabelled substrates ^H-labelled 
serum proteins. Uptake was measured as described in previous chapters.
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5.4_____Results
5.4.1 Estimation of Purity of Trypan Blue Preparation
Table 5.1 shows that the crude sample of trypan blue that was to be 
used in this study, contained an exceedingly high percentage, 83.2%, 
of NaCl. Paper chromatography of the sample indicated the presence 
of two coloured components, a major blue fraction (Rf value = O.5 3) 
and a faint purple fraction (Rf = O.7 3 ). Since the purple fraction 
evidently constituted a very small proportion of the total weight of 
the crude sample, the dye was purified by dialysis only. Dialysis 
of a 1% solution of dye against running tap water for 3 days, reduced 
the NaCl content to approximately V/o (w/w). Reduction of the dye 
sample by produced a biphenyl that had an electrophoretic
mobility identical to that of o-tolidine and the biphenyl of reduced 
pure trypan blue, and stained orange following treatment with 
Ehrlich's reagent. Since the electrophoretic mobilities of a number 
of aminobiphenyls are not dissimilar, the ultraviolet absorption 
spectra of the biphenyls were determined. In reduced crude trypan 
blue, reduced pure trypan blue and o-tolidine solutions, only one 
peak of maximum absorption, which was common to all three solutions, 
was seen. The wavelength at which this maximum occurred was 248nm, 
the ultraviolet absorption maximum of o—tolidine in acid solution 
(Field et al., 1977).
These observations were taken to indicate that the major coloured 
component of the dye sample used in this study was trypan blue.
5.4.2 Teratogenic Testing of Trypan Blue
Injection of the dialysed trypan blue (100 mg/kg) into pregnant rats 
at either 8 .5  or 9 .5 days of gestation resulted in the production of
Sodium chloride content Paper chromatography - . - . Biphenyl
(% of total weight) value of 
main blue spot
R value of 
other spots
colour on spraying 
with Ehrlich's 
reagent
Absorption 
maximum in 
0.1 M HC1
Crude trypan blue 83.2 0.53 purple, 0.73 orange 248 nm
Pure trypan blue - 0.53 - orange 248 nm
o-tolidine - - - orange 248 nm
Table 5.1 Estimation of the purity of a crude sample of trypan blue
used in the present study. A pure sample of trypan blue and 
the biphenyl of trypan blue, o-tolidine, were included in 
some of the analyses for comparison. Experimental details 
are given in the text.
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malformed fetuses (Table 5*2). Following injection at 8 .5 days, the 
number of resorption sites visible at 2 0 .5 days of gestation constituted 
14% of the total number of implantation sites. Following injection 
at 9 .5 days of gestation, the resorption rate had fallen to 6%, barely 
different from that observed in saline-injected controls. Of the 
surviving fetuses, some 42% of those from rats injected at 8 .5 days, 
and 22% at 9 .5 days, were malformed. The types of defects observed 
are listed in Table 5-3» In both the 8 .5  day- and 8 .5 day-injected 
groups, the most common defect noted was hydrocephalus. A high 
incidence of tail defects was also observed in both groups, while in 
the 8 .5 day-injected group there was a high frequency of kidney 
malformation. The occurrence of spina bifida in both groups was 
noted, and in addition the 8 .5  day group included one case of 
anophthalmia, and somewhat surprisingly, three fetuses with limb 
defects. The latter are very rarely described in mammals following 
trypan blue treatment. The average weight of surviving fetuses in 
both 8 .5  day- and 9 .5 day-injected groups was significantly different 
(p<, 0 .0 0 1) than controls injected with 0.9% saline at corresponding 
days of gestation.
5.4.5 Culture Experiments
The viability of conceptuses cultured in the presence of trypan blue 
for a period of 6 hours, either from 5 6 -4 2 hours of culture or 4 2 -4 8  
hours, did not differ from that in cultures in which trypan blue was 
absent from the culture medium, and was at least 95%. Furthermore, no 
developmental deviations were noted in conceptuses exposed to trypan 
blue during culture.
Mature and 
time of 
injection
Wo. of 0 
treated*’*
ho. of |/\v. weight 1 Ext 
implantations (surviving jiio, 
(% resorptns)jfetuses (g)i
ernal Abnorr 
^"surviving 
fetuses
vilifies [
% total 1 
implntns
No. of
fetuses
sectioned
No.(%) sectioned 
fetuses with 
anomalies
No.of fetuses 
stained with 
alizarin
No.(%) stained 
fetuses with 
anomalies
Trypan blue 
8.5 days 8 93 (14) 3.47 +.92* 8 10.00 8.60 53 22 (42) 27 0
Trypan blue 
9.5 days 8 85 (6) 3.36 +.65* 5 6.17 5.81 55 12 (2 2) 26 0
Saline 
8.5 days 4 45 (4) 4.19 + .42 0 0 0 28 0 15 0
Saline 
9.5 days 4 44 (5) 4.40 + .60 0 0 0 30 0 12 0
* significantly different from saline-injected controls (p<f0.0 0 1)
Table 5.2 Effects on offspring of s.c. injection of trypan blue (100 mg/kg) or saline (0.9%) into pregnant rats. 
Details of method are given in text.
Day of injection 
of trypan blue 8.5 9.5
Abnormality
Anophthalmia 1 (80) 0 (81)
Absent or
abnormal tail 5 (80) 5 (81)
Kidney (deformed) 8 (53) 1 (55)
Limb defects 3 (80) 0 (81)
Spins bifida 3 (80) 2 (81)
Hydrocephalus 13 (80) 10 (81)
Table 5.3 Abnormalities of fetuses after 
trypan blue treatment of pregnant rats. 
Figures in brackets indicate the size of 
the population examined for that particular 
defect'.
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When trypan blue, at concentrations of 100/ug/ml or more, was 
present in the culture medium for the last 6 hours of culture, the 
protein contents of yolk sacs and embryos did not differ from control 
levels (Figure 5-4). The same can he said to apply to the protein 
levels of conceptuses following exposure to trypan blue between 36 
and 42 hours of culture (Figure 5 .4).
The uptake of radioactivity by conceptuses, incubated for the last 6
hours of culture in the presence of 1 2 5l-FVP (2 .3 jag/m1 ) and different
concentrations of trypan blue, is shown in Figure 5 .5 . As previously
observed, essentially no radioactivity was present in the embryo at
harvesting. In the yolk sac, the uptake of radioactivity increased
with increased concentration of trypan blue up to dye concentrations
of 10 Jig/ml. At concentrations of trypan blue in excess of 200/ig/ml, 
125the uptake of I-PVP by yolk sac was approximately that of control 
levels.
When conceptuses were incubated for the last 6 hours of culture in 
the presence of I-dBSA ( 1 1 pg/ml) and trypan blue (5 0 or 200 y,gfml) 
(Figure 5 .6), little radioactivity was measured in the embryos at 
harvesting, and all of this was TCA-soluble. At a trypan blue 
concentration of 50 /ig/ml the total uptake of radioactivity by 
conceptuses (tissue-associated radioactivity plus TCA-soluble radio­
activity released back into the culture medium) was about 80% of the 
control value. Of this radioactivity, a larger proportion was associated 
with the yolk sac (12%  39% TCA-soluble) in experimental conceptuses, 
compared with controls (6%  43% TCA-soluble). A qualitatively and 
quantitatively similar effect was observed when tiypan blue at a higher 
concentration, 200 /ig/ml, was present in the culture medium. Total 
uptake of radioactivity by conceptuses was decreased to about 80% of
300
Trypan blue concentration (jig/ml)
Figure 5.4 Protein contents of yolk sacs (filled symbols) and 
embryos (open symbols) after incubation of conceptuses in the 
presence of trypan blue for either the final 6 hours (squares) 
or the penultimate 6 hours (triangles) of culture. Values are 
means of at least 5 determinations.
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Figure 5.5 Radioactivity associated with the yoUKsac (■) and 
embryo(D) after incubation of conceptuses in the presence of
TOR I-PVP (2.3 yg/ml) and trypan blue for the final 5 hours of 
culture. Values are means (jh S.D.) of at least 6 determinations
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Figure 5.6 Total radioactivity taken up by the yolk sac
(each left hand column) and embryo (each right hand column),
and the radioactivity associated with the yolk sac (total
shaded area of each left hand column) after incubation of
125conceptuses in the presence of I-dBSA (11 jig/ml) and trypan 
blue for the final 6 hours of culture. The proportions of 
yolk sac- and embryo-associated radioactivity that were TCA- 
and TCA-insolublesoluble are indicated. Values are means
(+ S.D.) of at least 6 determinations,
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the control value. The proportion of this radioactivity that was yolk 
sac-associated was again higher than in controls, 13% compared to 6%. 
About 36% of yolk sac-associated radioactivity was TCA-soluble 
(controls 43%). The differences between the total uptake of radio­
activity by. conceptuses at both concentrations of trypan blue and the 
control value were significant (p<0.02). The corresponding increases 
in yolk sac-associated radioactivity in these experiments were also 
significantly different from controls (p<(0 .0 2).
The uptake of radioactivity by conceptuses following incubation with 
trypan blue (5 0 or 200 jig/ml) between 36 and 42 hours of culture, and 
1 25i_£bsa tiut not trypan blue between 42 and 48 hours of culture, 
is shown in Figure 5.7. Little radioactivity, all TGA-soluble, was 
detected in embiyos at harvesting. Total uptake of radioactivity 
by conceptuses exposed to trypan blue at a concentration of 50 jug/ml 
was slightly higher than the control value, while those conceptuses 
exposed to 2 0 0jug/ml of trypan blue showed a slightly lower total 
uptake than controls. These differences were not statistically 
significant (p>0.l). At both concentrations of trypan blue employed, 
the proportion of the total radioactivity processed by conceptuses that 
was associated with the yolk sac at harvesting was also insignificantly 
¿¿Pferent from controls (p>0.05).
The effect of trypan blue at a concentration of 50 or 200 /ig/ml, present 
in the culture medium either between 36 and 42 hours of culture or 42 
and 48 hours of culture, upon the uptake of radioactivity by conceptuses 
when ^H-labelled serum proteins were present in the culture medium for 
the last 6 hours of culture, is shown in Figures 5 .8  and 5 .9 . It may 
be seen that the exposure of conceptuses to trypan blue during the 
periods described did not noticeably affect (p)>0 . 1 for all comparisons
70
a•H<D-HOPft
bOe
60
50
>>4->•H>•H4-*O05O• H'd
05
U
mo
a)AioJ■HP<
40
30 :
20
10 1« ■
YZZk
50 200
1
control (0)
Trypan blue concentration (jig/ml)
Figure 5.7 Total radioactivity taken up by the yolk sac (each 
left hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area 
of each left hand column) after incubation of conce/iptuses in 
the presence of I-dBSA (11 jig/ml) for the final 6 hours, and 
trypan blue for the penultimate 6 hours of culture. The 
proportions of yolk sac- and embryo-associated radioactivity that 
were TCA-soluble
are means (+ S.D.) of at least 6 determinations.
and TCA-insoluble are indicated. Values
rTrypan blue concentration (fig/ml)
Figure 5.8 Total radioactivity taken up by the yolk sac 
(each left hand column) and embryo (each right hand column), 
and the radioactivity associated with the yolk sac (total 
shaded area of each left hand column) after incubation of 
conceptuses in the presence of J^ hJleucine-labelled serum 
proteins and trypan blue for the final 6 hours of culture.
The proportions of yolk sac- and embryo-associated radioactivity 
that were TCA-soluble and TCA insoluble are indicated.
Values are means (+ S.D.) of at least 6 determinations.
cTrypan blue concentration fyug/ml)
Figure 5.9 Total radioactivity taken up by yolk sac (each left hand 
column) and embryo (each right hand column), and the radioactivity 
associated with the yolk sac (total shaded area of each left hand 
column) after incubation of conceptuses in the presence of [3h]leucine- 
labelled serum proteins for the final 6 hours, and trypan blue for the 
penultimate 6 hours of culture. The proportions of yolk sac- and 
embryo-associated radioactivity that were TCA-soluble ||| and TCA- 
insoluble [gj are indicated. Values are means (+ S.D.) of at least 5 
determinations.
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with control values) the uptake, digestion or distribution of 
radiolabel within the conceptus. In no instance was there an 
increase in the TCA-soluble radioactivity of the culture medium 
at harvesting over the initial level.
Ej.Ej Discussion
The preparation of trypan blue used in the present study was shown by 
paper chromatography to be substantially free of coloured contaminants. 
It did however contain a high salt content which was effectively removed 
by dialysis, to give a highly purified sample of dye.
Before proceeding to quantitative studies of the effect of trypan blue 
upon histiotrophic nutrition in the cultured 9-5-11*5 day conceptus, 
it was essential to establish the dye's teratogenicity in the strain of 
rats used throughout this study. Maternal injection of a teratogenic 
dose of trypan blue on days 8 .5 and 9-5 of pregnancy has been shown 
to produce the highest number of malformed offspring (Wilson et al., 
1959), and therefore these times were selected. Although the 
resorption rate observed in the present study is lower than has 
previously been reported (Beck and Lloyd, 19 6 3a,b; Beck et al., 1978), 
the percentage of survivors that were malformed (Table 5 .2 ) is 
comparable to those figures in the reports cited. The types of 
' malformation noted here have all previously been observed following
trypan blue tratement. In contrast to the findings of Jensh and 
Brent (19^7) and Berry (1970), but in agreement with Beaudoin and 
' Kahkonen (19 6 3), fetuses surviving trypan blue injection of the
mother showed a significant decrease in weight at 2 0 .5 clays ( p < 0 .00l).
The claims of Beck et al. (19 6 7b) and Williams et al. (1976) that the 
mechanism of teratogenic action of trypan blue is an inhibition yolk 
sac-mediated histiotrophic nutrition were investigated using the New 
culture technique.
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The protein contents of yolk sacs and embryos exposed to trypan blue 
for a period of 6 hours during culture are not different from those 
tissues cultured in the absence of any trypan blue. This is perhaps 
not surprising when it is considered that following trypan blue 
injection into day 7 pregnant rats, the embryonic protein content 
does not become significantly lower than that from untreated mothers 
until the 3 0 -3 5 somite stage (approximately gestational day 1 1 .5 )
(Berry, 1970). More recently Fisher (1981) observed that day-10 rat 
embryos, following a 4 hour in utero exposure to trypan blue, did not 
incur a protein deficit until after a further 24 hour period in culture. 
Therefore in the present study, it may well be that trypan blue was 
not present in culture for long enough, or that insufficient time 
was available after exposure to tiypan blue for alterations in yolk 
sac and embryo protein levels to become apparent.
Vhen trypan blue and 1 2 5l-PVP were present together in the culture medium 
for the last 6 hours of culture, there was no uptake of radioactivity 
into the embryo. In the yolk sac, the uptake of radioactivity at 
harvesting varied biphasically as a function of the concentration of 
trypan blue. At concentrations of dye below 100/Ug/ml, the pinocytosis 
f 1 2 5j_pyp was stimulated, while concentrations of dye above 200 jug/ml 
had little effect on the uptake of radioactivity. A similar biphasic 
effect of trypan blue on 1 2 5I-PVP uptake by the cultured 1 7 .5-day yolk 
sac has been reported (Williams et al., 1973). These authors however 
observed an inhibition of pinocytosis at concentrations of 2 0 0/ig/ml 
and above. No such inhibition of pinocytosis was seen in the present 
study Roberts et al. (19 8 0) demonstrated that the stimulation of 
I25p_pvp uptake into 17 .5-day yolk sac by trypan blue was not due to 
an enhanced rate of pinosome formation. Trypan blue was shown to enter 
the yolk sac by adsorptive pinocytosis, and by interacting with
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I-FVP ©n&blGd "tli© l&'t'tsr siibs'trcrt© also "to ©ntsi* ]by an ad-soi^ ptiv© 
mechanism; so-called piggy-hack pinocytosis.
When trypan blue and 1 2 5l_dBSA were present in the culture medium for 
the last 6 hours, little radioactivity, and all of it TCA-soluble, 
was detected in the embryos at harvesting. In the yolk sac, a trypan 
blue concentration in the culture medium of 5 0 ^ug/ml increased the 
tissue-associated radioactivity and reduced the total clearance of 
substrate by the yolk sac, relative to controls. A marginally higher 
tissue-associated radioactivity and lower total clearance of substrate 
by yolk sac was produced by 200 f.ig/ml of trypan blue. These data are 
consistent with both an inhibition of the yolk sac intralysosomal 
hydrolysis of 1 2 5l-£BSA by trypan blue, and with an inhibition of 
pinocytosis of the substrate.
Pre-loading of yolk sac with trypan blue for 6 hours before incubation
125of conceptuses with ^I-cLBSA for the last 6 hours of culture resulted 
in there being little radioactivity in the embryo at harvesting.
Again this was all in TCA-soluble form. At both concentrations of 
trypan blue used, the total clearance of radiolabelled protein by 
yolk sac was little affected. Though shown to be statistically 
insignificant, the yolk sac—associated radioactivity was reduced.
When trypan blue was presented to conceptuses in culture, either 
together with or before %-labelled serum proteins, the dye had no 
measurable effect on the pinocytosis, digestion or distribution 
of radiolabel within the conceptus, over the time periods studied.
Taken together, these data lend no support to the hypothesis that 
trypan blue inhibits pinocytosis by the yolk sac, thereby depriving the 
developing embryo of essential nutrients during this critical period of 
embryogenesis. Only when trypan blue and 1 2 5l-dBSA were added
125
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simultaneously to the culture medium, was the uptake of radioactivity
by conceptuses decreased. However, concentrations of trypan blue that
decreased the uptake of -'I-cLBSA did not inhibit pinocytosis of
1 2 5i_FVP or 3H-labelled serum proteins. Two explanations are
consistent with these observations. Either trypan blue competes for
those sites on the plasma membrane to which "l25i_(iBSA adsorbs and which
facilitate the more rapid entry of this substrate into yolk sac cells,
12 5or trypan blue interacts with I—dBSA to reduce the substrate's
affinity for these binding sites on the plasma membrane. This latter 
explanation would seem the more plausible in view of trypan blue's 
action in decreasing the hydrolysis of 1 2 5I-dBSA in yolk sac (see 
below). The stimulation of pinocytosis of 1 2 5l-PVP by trypan blue 
at concentrations of 100 jig/rsH or less, appears to be specific for that 
radiolabelled substrate since the uptake of 1 2 5l-£BSA and ^H-labelled 
serum proteins was not similarly enhanced by trypan blue. This 
conclusion agrees with that of Roberts et al. (1980) who found that in 
the cultured 1 7 .5-day yolk sac, trypan blue at concentrations that 
stimulated the pinocytosis of 1 2 5l_PVP had no effect upon the uptake 
of colloidal £ 98AuJ gold or 1 2 5I-dBSA.
The hypothesis of Beck et al. (19 6 7a) that trypan blue's teratogenicity 
is due to an inhibition of proteolysis by yolk sac lysosomal enzymes, 
receives only limited support from the data presented here. Only when 
trypan blue was added to the culture medium at the same time as 
1251-dBSA was there observed an increase in the yolk sac-associated 
radioactivity consistent with an inhibition of yolk sac proteolysis.
The simultaneous addition of the two substances makes it highly likely 
that both are taken into the yolk sac within the same pinocytic vesicle. 
Trypan blue is therefore on hand to inhibit the hydrolysis of ^^I-dBSA.
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However, such an explanation cannot apply in the case of ^H-labelled 
serum proteins. When the latter substrates were added to the culture 
medium at the same time as trypan blue there was no effect on their 
degradation. Trypan blue's inhibitory action would seem therefore 
to be confirmed to ■'I-dBSA. Two possible explanations could be 
advanced to account for this. Firstly, the proteinase responsible 
for the digestion of I-dBSA is different from the proteinase(s) 
that digests the bulk of the ^H-labelled serum proteins in being 
trypan blue-inhibitable. In view of the data presented in Chapter 9 , 
this explanation is most unlikely. Secondly, trypan blue interacts 
with 1 2 5 I-dBSA in such a way as to reduce the protein's susceptibility 
to degradation, an explanation advanced also to account for the 
decreased uptake of -'I-dBSA observed in these experiments (see above). 
The strongly anionic nature of trypan blue that promotes its binding 
to albumin (Rawson, 1943) makes this second explanation the more 
plausible. (Of course, ^H-labelled serum proteins will contain a 
large proportion of native homologous albumin which will also bind 
trypan blue. The binding of the.dye to the protein in this case 
though would appear not to affect its rate of degradation by the 
yolk sac). The observation that trypan blue, present in the culture 
medium between 56 and 42 hours of culture, has no effect on the 
uptake and digestion of yI-dBSA is also consistent with this 
explanation. Trypan blue, removed from the culture medium before 
the addition of 1 2 ^I-dBSA, would be unable to interact with the 
radiolabelled protein and thus reduce its rate of degradation, or 
even if the two substances became incorporated into the same 
he.terolysosomes, there may be insufficient free trypan blue available 
at this site to bind, in significant quantities, to any undegraded 
1 25j_dBSA that may also be present.
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The data of Williams et al. (1976), which show an inability of
trypan blue to inhibit the intralysosomal digestion of 1 2 5l_dBSA
by the cultured 1 7 .5-day yolk sac, though at first sight at variance
with the current observations, may reflect the different methods of
denaturation of the radiolabelled protein. In the present study,
12^I-dBSA was denatured by treatment with 1CP/0 formaldehyde, pH 10.0,
and in the study of Williams et al., ■'I-dRSA was denatured by
titrating with acetic acid to pH 3.5* These different denaturing
protocols confer on the protein different properties evident in
their rates of clearance by the cultured 1 7 .5-day yolk sac and in
their optical rotatory dispersion characteristics (Lloyd et al., 1 9 7 6).
It seems quite possible therefore that formaldehyde-denatured 1 2 5i_b sA
interacts with trypan blue in a way which the acid-denatured 1 2 5i_BSA
is unable to, and that this binding of the dye renders the protein
less susceptible to proteolytic attack, and less able to adsorb to the
plasma membrane. It must be emphasised here that such a specific
125action of trypan blue on I-dBSA uptake and digestion by the 
early organogenesis-stage yolk sac, though interesting in itself, 
is likely to be of no significance to any teratogenic action of the 
dye on yolk sac-mediated histiotrophic nutrition.
Another anomaly between the present data, which show no evidence of 
any inhibition by trypan blue of pinocytosis by the yolk sac, and those 
of Williams et al. (1973. 1976) and Roberts et al. (19 8 0) which clearly 
demonstrate the inhibitory action of the dye, at appropriate concentrations, 
on the pinocytosis by 17 .5-day yolk sac of 125I-PVP (and 125I-dBSA) 
is almost certainly due to the differences in serum concentrations of 
the culture medium used in these studies. Williams et al. (19 7 6) 
routinely included VJ/o fetal calf serum in their culture medium but
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reported preliminary findings that if the serum concentration was 
increased to 50% the inhibitory action of trypan blue was decreased 
compared with values from dye-free control experiments performed 
with the same elevated concentration of calf serum in the medium. In 
the present study, the culture medium comprises 100% homologous 
serum, and seemingly this prevents totally the inhibitory action of 
trypan blue, used at the same concentrations as by Williams et al., 
on pinocytosis. The implication is that free, and not protein-bound, 
dye is the active inhibitor, and that in a culture medium of 100% 
serum very little of the dye will be present in free form, when 
applied at these concentrations. One obvious alternative to these 
explanations of the different effects of trypan blue on the 1 7 .5-day 
yolk sac and the 9 .5- 1 '1‘5-day yolk sac is that the tissues function 
quite differently at these different stages of gestation, and 
consequently respond to tiypan blue in a dissimilar manner. Assuming 
that this is not the case, and the data of previous chapters would 
indicate that it is not, it is clear that the composition of the plasma 
transudate that bathes the extra-embryonic membranes during the period 
of teratogenic susceptibility to trypan blue, and in particular its 
protein concentration, is likely to be of critical importance to 
the effect, if any, of trypan blue on yolk sac-mediated nutrition.
This subject is further discussed in Chapter 10.
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CHAPTER SIX
THE EEPECT OF SURAMIN ON YOLK SAC-MEDIATED NUTRITTfW
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6 .1 Introduction
The trypanocidal drug suramin has many features in common with trypan 
blue. Although colourless and having no azo linkages, it does 
contain, in common with trypan blue, two polysulphonated naphthalene 
moieties (Figure 6.1) and has a very strong affinity for protein 
(Town et al., 1950; Muller and Wollert, 1976). Furthermore, suramin 
is taken up by cells, presumably by pinocytosis, and accumulates 
within lysosomes. Smeesters and Jacques (19^8) demonstrated a lysosomal 
location of suramin by subcellular fractionation of liver homogenates, 
following injection of the drug into rats two days previously.
Buys et al. (1978) inferred lysosomal storage of suramin from the 
electron microscopic appearances of liver Kupffer and endothelial cells 
from rats injected with the drug 24 hours previously. Perhaps of 
most relevance to the present study, Schultz (1970) observed that 
following injection of suramin into 1 1 .5-day pregnant rats, no 
suramin could be detected in the embryo 12 hours later. In contrast, 
the yolk sac (and to a lesser extent the chorioallantoic placenta) 
contained significant quantities of suramin which, in view of the 
highly developed nature of the vacuolar system of these cells, might 
be expected to be in the lysosomes.
These properties of suramin led Lloyd and Beck (1969) to theorise 
that the drug might be teratogenic in rats and might act by a 
mechanism similar to that proposed for trypan blue, a view made all 
the more plausible when one considers that suramin is a potent 
inhibitor of a number of enzymes, including some lysosomal hydrolases.
In the course of an extended study using suramin, Wills and Wormall 
and their colleagues (Town et al., 1950; Wills and Wormall, 1 9 5 0) 
discovered that suramin was a potent inhibitor of hexokinano
ï H
I
c=o
HN - C - NH
Figure 6.1 Structural formula of suramin
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dehydrogenase, urease, cytochrome oxidase, trypsin, pepsin and a 
number of other enzymes. Smeesters and Jacques (1968) observed 
inhibition of lysosomal P-glycerophosphatase, P-N-acetylaminodeoxy- 
glucosidase and p-glucuronidase, and Schultz (19 70) found a 
significant reduction in rat placental acid phosphatase activity 
in the presence of the drug. Additionally, Davies et al. (1 9 7 1) 
demonstrated that isolated rat liver lysosomes, pre-loaded with 
suramin and -'I-labelled albumin,on incubation in vitro released 
acid-soluble radioactivity more slowly than controls from which 
suramin was absent, a result since confirmed by Buys et al. (1975,
1978) and Korolenko et al. (19 8O, 19Ô1)-
However, there is some uncertainty surrounding the teratogenicity of 
suramin. Lloyd and Beck (19^9 ) claimed qn embryolethal, though not 
teratogenic, effect of suramin on rat embryos. These authors, it 
must be said, examined the surviving fetuses of suramin-treated 
mothers for external malformations only. Thus any malformed 
viscera would have gone undetected. Schultz and Neubert (in the 
discussion to Schultz, 1970) both claimed to have observed malformed 
fetuses as a result of injection of suramin into pregnant rats.
The present study has sought to establish whether or not suramin 
is teratogenic to rat embryos. Further experiments have concentrated 
on elucidating the effect of suramin on the nutritional properties 
of the visceral yolk sac established earlier, using the experimental 
pj»Q-fcocol described in the last chapter.
6.2 Materials 
Chemicals
Suramin BP ICI Pharmaceuticals Division, Alderley
Park, Macclesfield, Cheshire
All other chemicals not previously listed were of analytical grade.
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6.3 Methods
6.3.1 Teratogenic Testing of Suramin
The procedure was as described for trypan blue (5 .3 .3). Suramin was 
administered at a dosage of 250mg/kg.
6.3.2 Culture Experiments
The procedure was as described for trypan blue (5 .3 .4 ). In cultures 
which used as substrate 125i-pvp, suramin was added to the culture 
medium to a final concentration of 2 5 , 50, 100, 500, 1,000, 5,000 or 
10,000 pg/ml. For subsequent experiments with 125l-<iBSA and ^-labelled 
serum proteins as substrates, suramin was added to a final concentration 
of 50 or 5,000 jig/ml.
6.4 Results
6.4.1 Teratogenic Testing of Suramin
The injection of a teratogenic dose (250 mg/kg) of suramin into 
pregnant rats at both 8 .5 and 9-5 days of gestation resulted in the 
production of malformed fetuses (Table 6.1). In both the 8 .5  and 9 .5-day 
injected groups a high percentage (32%  and 39% respectively) of the 
total number of implantations were resorbed. Although none of the 
surviving fetuses showed any external malformations, sectioning of 
the fetuses that had been fixed in Bouin's fluid revealed some abnormal 
visceral organs (Table 6.2). In the 8.5-day injected group 2 types 
of malformation affecting eyes and kidney were noted. Malformed 
kidneys were observed in one third of all surviving fetuses sectioned.
In the 9.5-day injected group hydrocephalus and kidney defects were 
the most frequently observed malformations. In addition, one fetus 
had a megaureter and one fetus a grossly enlarged heart.
Nature and 
time cr 
m j  action
No. of Oj 
treated^
No. of i 
implantations 
(% resorptns)
Av. weight 
surviving 
fetuses (g)
No.
ernal ALncrr: 
1 surviving 
fetuses
alities [
o total 1 irrplntns
No. of
fetuses
sectioned
No.(%) sectioned 
fetuses with 
anomalies
No. of fetuses 
stained with 
alizarin
No.(fe) stained 
fetuses with 
anomalies
Suramin 
8.5 days 8 78 (32) 2.70 + 1.6* 0 0 0 36 13 (36) 17 0
Suramin 
9.5 days 8 90 (39) 2.22 + 0.4* 0 0 0 37 9(24) 18 0
Saline 
8.5 days i+ 45 (4) 4.19 _+ .42 0 0 0 28 0 15 0
Saline 
9.5 days 4 44 (5) 4.40 + .60 0 0 0 30 0 12 0
* significantly different from saline-injected controls ( p < 0.001)
Table 6.1 Effects on offspring of s.c. injection of suramin (250 mg/kg) or saline (0.9%) into pregnant rats 
Details of method are given in text.
Day of injection 
of suramin 8.5 9.5
Abnormality
Eye defects (anoph­
thalmia or microph­
thalmia
Kidney (deformed) 
Megaureter 
Hydrocephalus 
Heart defects
CO ( 36) 0 (37)
12! (36) 4 (37)
0 (36) 1 (37)
0 (36) 7 (37)
0 (36) 1 (37)
Table 5.2 Abnormalities of fetuses after 
suramin treatment of pregnant rats. Figures 
in brackets indicate the size of the 
population examined for that particular 
defect.
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The average weight of surviving fetuses in both 8.5- and 9.5-day 
injected groups was significantly different (p<_0.00l) from controls 
injected with 0.9^ saline at corresponding days of gestation.
g./|-? Culture Experiments
Viability of conceptuses exposed to suramin for a maximum period of 
6 hours, was at least 95%* No developmental deviations of conceptuses 
were observed at harvesting. The protein contents at harvesting of 
yolk sacs and embryos exposed to suramin at concentrations of the 
drug equal to or less than 5*000 p g / m l for the last 6 hours of culture 
were not noticeably different from controls cultured in the absence 
of suramin. (Figure 6.2). At concentrations of suramin above 
5 000 ^ ig/ml the protein contents of yolk sacs and embryos were lower 
than controls, although the ratio of protein in each tissue whether 
or not suramin was present was approximately the same. When suramin 
was presented to conceptuses in culture between 36 and 42 hours of 
culture, the protein contents at harvesting of yolk sacs and embryos 
was lower than controls. Again the ratio of protein in each tissue 
was about the same (Figure 6.2).
When conceptuses were incubated for the last 6 hours of culture in 
the presence of 1 25l-PVP (2 .3 /ig/ml) and various concentrations of 
suramin, there was no uptake of radioactivity into the embryo (Figure 6.3) 
At concentrations of 100 jag/ml or less, suramin neither stimulated nor 
inhibited the uptake of radioactivity by yolk sac. At suramin 
concentrations of greater than 100 )igfml however, the uptake of 
radioactivity by yolk sac at harvesting was inhibited, the amount of 
inhibition being proportional to the concentration of suramin in 
the culture medium. In subsequent experiments using the radiolabelled
300
01---- *-
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---------- 1-------- ------//----'— //-----*—50 75 100 500'1 1
(jig/ml)
Suramin concentration
> »
3 5 7
(mg/ml)
Figure 6.2 Protein contents of yolk sacs (filled symbols) and 
embryos (open symbols) after incubation of conceptuses in the 
presence of suramin for either the final 6 hours (squares) or the 
penultimate 6 hours (triangles) of culture. Values are means of 
at least 6 determinations.
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Figure 6.3 Radioactivity associated with the yolk sac (■) and 
embryo (□) after incubation of conceptuses in the presence of 
I-PVP (2.3 pg/ml) and suramin for the final 6 hours of 
culture. Values are means (_+ S.D.) of at least 6 determinations.
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substrates "^I-dBSA and. ^-labelled serum proteins, two concentrations
12 5of suramin were used, one of which (5 0 jug/ml) did not inhibit I-PVP 
uptake, and another (5,000/lg/rnl) which decreased 12^I-PVP uptake by
3 5 %
Following1 incubation of conceptuses with l25l-dBSA (11 /ig/ml) and 
suramin (5 0 or 5 ,0 0 0 Jig/ml) for the last 6 hours of culture, little 
radioactivity was detected in the embryo at harvesting (Figure 6.4).
The small quantity of radioactivity present in the embryo was all 
TCA-soluble. Suramin at a concentration of 50 /ig/ml decreased the 
total quantity of radioactivity processed by the yolk sac to a level 
significantly below (p<L0.0l) controls. Of this radioactivity, a 
larger proportion (9%, 33% TCA-soluble) was associated with the yolk 
sac than in controls (6%, 43% TCA-soluble). Suramin at. a concentration 
of 5,000jug/ml caused a pronounced reduction in the total quantity of 
radioactivity processed by yolk sac (20% of control, p<0.00l). The 
proportion of this radioactivity that was yolk sac-associated was 
again about 9%, though a very much smaller percentage (5%) was 
TCA-soluble.
V/hen suramin, at the same concentrations, was present in culture 
between 36 and 42 hours before exposure of conceptuses for the final 
6 hours of culture to "^I-dBSA in suramin-free medium, a qualitatively
f o rsimilar pattern to that described above radiolabel distribution 
in the conceptus was observed at harvesting (Figure 6.5 ). Quantitatively 
however, the degree of difference between experimental and control 
conceptuses was greater. Suramin at 50 ug/ml reduced the total 
clearance of radioactivity by yolk sac to about 42%  (p<0.001) of 
control values of which 15% (42% TCA-soluble) was associated with 
the yolk sac, compared with a control value of 5% (58% TCA-soluble).
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Figure 5.4 Total radioactivity taken up by the yolk sac (each left 
hand column) and embryo (each right hand column), and the radioactivity 
associated with the yolk sac (total shaded area of each left hand 
column) after incubation of conceptuses in the presence of 1 2 ^I-dBSA 
(11 jig/ml) and suramin for the final 6 hours of culture. The 
proportions of yolk sac- and embryo-associated radioactivity that
were TCA-soluble |%( and TCA-insoluble g g are indicated. Values are
means of at least 6 determinations.
80
c• H
+-*O
uft
bOG
+-»
>•H
4-»Ordo•rH-d
it!
U
l+Ho
<uAt(0•H
p .:o
70
60
50
M0
30
20
10
9  *»«V t3 V 3
wife
^ 2 3ES-ZL
50 5,000 control (0)
Suramin concentration (jig/ml)
Figure 6.5 Total radioactivity taken up by the yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area of 
each left hand column) after incubation of conceptuses in the presence 
of 125I -dBSA (11 Jig/ml) for the final 6 hours, and suramin for the 
penultimate 6 hours of culture.The proportions of yolk sac- and 
embryo-associated radioactivity that were TCA-soluble ||| and TCA- 
insoluble ki'il are indicated. Values are means (+ S.D.) of at least
6 determinations.
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A small amount of radioactivity, all TCA—soluble, was associated 
with the embiyo at harvesting. At a concentration of 5,000 jug/ml, 
suramin decreased the total quantity of radioactivity processed 
by the yolk 3ac to a mere 17% (p< 0.001) of the control value. All 
of this radioactivity was retained within the yolk sac (about 10% 
TCA-soluble) and no radioactivity could be detected in the embryo.
The uptake of radioactivity by conceptuses incubated for the last 
6 hours of culture in the presence of ^H-labelled serum proteins and 
suramin (50 or 5,000 ;ug/ml), is shown in Figure 6.6. The presence of 
50 jig/ml of suramin the culture medium did not affect the uptake 
or digestion of radiolabelled protein, or distribution of radio­
activity in conceptuses, relative to controls. At 5,000 jug/ml, 
suramin decreased the total uptake of radioactivity by conceptuses 
to about 20% (p<. 0.001) of the control value. Of this radioactivity, 
approximately 52% was associated with the yolk sac (9% TCA-soluble) 
compared with a control value of 39% (30% TCA-soluble). The proportion 
of the total radioactivity taken up by conceptuses that was associated 
with the embryo was 29% in the experimental group and 43% in controls.
The loading of suramin (50/ig/ml) for 6 hours into the yolk sacs of 
conceptuses that were immediately transferred to a suramin-free 
medium containing ^H-labelled serum proteins and cultured for a 
further 6 hours, did not result in a decrease in the uptake of 
radiolabel by conceptuses at harvesting, compared with controls 
(p> 0 .0 5)(Figure 6.7). However, the proportion of this radioactivity 
that was associated with the yolk sac at harvesting was significantly 
greater than in controls (pCO.01). Correspondingly, the embryo- 
associated radioactivity was decreased in the experimental group. 
Furthermore, the percentage TCA-soluble radioactivity in the yolk
Figure 6.6 Total radioactivity taken up by the yolk sac (each 
left hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area 
of each left hand column) after incubation of conceptuses in the 
presence of Pnjleucine-labelled serum proteins and suramin for the 
final 6 hours of culture. The proportions of yolk sac- and embryo- 
associated radioactivity that were TCA-soluble jj%j and TCA-insoluble
are indicated. Values are means (+ S.D.) of at least 6
determinations.
Figure 6.7 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area of 
each left hand column) affcfcr incubation of conceptuses in the 
presence of J^nJleucine-labelled serum proteins for the final 6 
hours, and suramin for the penultimate 6 hours of culture. The 
proportions of yolk sac- and embryo-associated radioactivity 
that were TCA-soluble and TCA-insoluble ^  are indicated.
Values are means (+^  S.D.) of at least 6 determinations.
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sac, 5C%, was much less than in controls, 79%» indicative of inhibition 
of proteolysis. Under the same experimental regime, 5,000 p g / m l of 
suramin reduced total uptake of radioactivity by conceptuses to 6C% 
of control values. Again experimental conceptuses possessed a higher 
proportion of this, compared with controls, within the yolk sac 
and also contained a higher percentage of yolk sac radioactivity in 
TCA-soluble form. These differences between experimental and control 
conceptuses were significant. (p<10.0l),
£.5 Discussion
The embryotoxicity and teratogenicity of suramin has not been fully 
reported in the literature. In this study, the limited investigation 
of the drug's effects on the developing embryo following maternal 
injection demonstrates that suramin is both embryolethal and teratogenic. 
In view of the drug's similarity in structure to trypan blue this 
property of suramin is not unexpected. In its mechanism of teratogenesis 
suramin could conceivably act on the yolk sac (where it has been shown 
to be localised - Schultz, 1970) by inhibiting the pinocytic ingestion 
of nutrients or by inhibiting the intralysosomal digestion of macro- 
molecular histiotroph. Another mechanism of action of suramin could 
h e to inhibit the fusion of the nutrient-bearing pinosomes with the 
digestive lysosomes, a property of the drug that has been observed 
in mouse peritoneal macrophages .(D'Arcy Hart and Young, 1975) and 
rat hepatocytes (Buys, 1976).
Suramin, at a concentration of 100 jig/ml or less, had no effect on 
the uptake of by yolk sac when both substances were present
together in the culture medium. At higher concentrations of suramin,
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uptake of "^I-PVP by yolk sac was inhibited by an amount proportional
to the concentration of suramin. In contrast to the effect of trypan
blue, 'piggy-back* pinocytosis of 125i_pv p at low concentrations of
suramin was not observed. This is also in contrast to the recent
finding (Pratten and Lloyd, 1981) that low concentrations of
suramin stimulate -'I-FVP uptake by rat peritoneal macrophages by a
mechanism specific for that radiolabelled substrate. In the same
report it was stated that the uptake and degradation of l25l-dBSA
was considerably decreased by suramin. It is interesting to note
therefore that suramin, at a concentration (5 0 jug/ml) that does
not inhibit pinocytosis of 125l-PVP, markedly decreases the uptake
and degradation of 125l-dBSA by conceptuses. The further observation
that this effect of suramin is enhanced when it is loaded into the
yolk sac before exposure of conceptuses to 12^I-<iBSA, suggests
that the drug is acting at an intracellular locus, presumably within
the vacuolar system. Buys et al. (1978) found that the isolated
perfused rat liver, loaded with suramin in vivo, pinocytosed
125i_dBSA, present in the perfusion medium, to a lesser extent
than control liver containing no suramin. The reduced uptake of
125i_dBSA observed in the present study must be specific for
that protein since the uptake of ^H-labelled serum proteins
by conceptuses was not decreased by 50 ¿ig/ml of suramin regardless
of whether the drug was presented to conceptuses at the same
time as or before the radiolabelled proteins. If suramin were
1 2 5acting only to inhibit the digestion of I-dBSA, an explanation 
consistent with the observed increased in the proportion of total uptake 
of radioactivity that was associated with the yolk sac (and the increased
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proportion of this radioactivity that was TCA-insoluble), then it 
would be expected that the total clearance of radiolabel would be 
unaltered by this concentration (5 0 /ig/ml) of suramin, unless of 
course one postulates some kind of feedback mechanism to prevent the 
further uptake of substrate. Assuming the latter not to be the case, 
two explanations can be advanced to account for these observations. 
Either suramin is irreversibly bound to those sites on the plasma 
membrane to which -'I-cLBSA adsorbs and also inhibits intralysosomal 
proteolysis, or suramin is taken into cells within pinosomes and 
inhibits the normal fusion of the pinosome with a lysosome. This 
may or may not involve an inhibition of digestion of 1 2 5i_dBSA.
Actively pinocytosing cells must possess the means to withdraw 
membrane from the vacuolar system and re-insert it into the plasma 
membrane. Normal fusion of incoming pinosomes with resident lysosomes 
probably affords the cell an opportunity to re-cycle membrane (Duncan 
and Pratten, 1977)» If suramin were inhibiting pinosome-lysosome 
fusion, the cell would be denied this opportunity and as a result the 
rate of pinosome formation at the cell surface may be decreased. 
Inhibition of fusion would also separate pinocytosed 1 2 5l-<lBSA from 
digestive enzymes and hence explain the increase in proportion of 
the total radiolabel processed by the yolk sac cells that was associated 
with the yolk sac at harvesting, although this may also be due in part 
to direct enzyme inhibition by suramin. However, if suramin at this 
concentration is inhibiting fusion of intracellular vesicles it is 
evidently only able to do this in combination with 1 2 5i_dBSA.
At a suramin concentration of 5> 000 ^ g/ml (which inhibits 1 25l-pvp
12Suptake by about 3(%) -'I-cLBSA uptake and digestion by yolk sac is 
decreased even further. When conceptuses were loaded with suramin prior
- 106 -
to incubation in a suramin-free medium containing 1 2 ^I-iBSA, degradation 
of substrate was completely abolished. All of the radioactivity 
taken up by the yolk sac remained within the tissue and nearly all of 
this was TCA-insoluble. The embryo contained no radioactivity.
That suramin (50 can inhibit intralysosomal proteolysis is
demonstrated by the observation that when the drug was loaded into yolk 
sacs before incubation of conceptuses in a suramin-free medium that 
contained ^H-labelled serum proteins, though the overall uptake of 
radiolabel, compared with controls, was unaltered, the proportion of 
the yolk sac radioactivity that was TCA—insoluble was considerably 
higher. Correspondingly the radioactivity in the embryo was decreased. 
Furthermore, these data provide powerful evidence that yolk sac 
proteolysis is a necessary step in the utilisation of exogenous protein 
by the conceptuses.
In contrast to experiments using 1 2 5i_dBSA as radiolabelled substrate, 
the effect of suramin (5,0 0 0/ig/ml) upon the uptake of ^H-labelled serum 
proteins by conceptuses was observed to be greater when the drug was 
present in the culture medium together with radiolabelled substrates 
than when it was loaded into yolk sacs before exposure to radiolabel, 
though under both regimes the total uptake of radiolabel by conceptuses 
was decreased and the proportion of this radioactivity that was 
associated with the yolk sac was the same (approximately 5CP/0). Suramin 
therefore cannot be acting upon the uptake and digestion of ^H-labelled 
serum proteins in the same way as it does with 1 2 5i_<iBSA. The fact that 
a very much larger proportion of yolk sac radioactivity was TCA-insoluble 
when conceptuses were exposed to drug and substrate at the same time 
indicates that under these conditions the drug is inhibiting proteolysis 
either directly or by preventing the confrontation of lysosomal enzymes
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and substrates through an inhibition of fusion of pinosomes and lyso­
somes. In the latter case membrane recycling would also be inhibited and 
might therefore explain also the very much lower total uptake of substrate. 
Why suramin should produce a greater effect on the uptake of ^-labelled 
serum proteins when presented to conceptuses at the same time as 
substrate, in contradistinction to the drug's effect on 1 2 5I-d£SA 
uptake and digestion, is difficult to explain, particularly since the 
same concentration of serum protein exists in the culture medium 
used in both sets of experiments. Part of the explanation is likely 
to lie in the difference in affinity of the drug for denatured bovine 
albumin and native homologous serum proteins, as was proposed for 
trypan blue in the preceding chapter.
In interpreting the data of these experiments, it cannot be ruled out 
that suramin, at a concentration of 5 ,0 0 0 jug/ml, is toxic to the conceptus. 
Although at harvesting conceptuses exposed to this amount of the drug 
appeared healthy, it has been shown (Wesolowski et al., 1 973) that 
levels of suramin required to inhibit the endocytosis of tiypan blue 
by mouse Kupffer cells are also toxic to these cells.
In conclusion it can be stated that suramin is able to inhibit, probably 
by a combination of actions, the nutritional function of yolk sac and 
as a consequence reduce the flow of nutrients reaching the embryo. In 
considering a mechanism of teratogenic action of suramin, other 
biological effects of the drug such as the inhibition of complement 
systems (Fong and Good, 1973) and fibrinolysis (Moroz, 1 9 7 7) should be 
taken into account. Only when such effects upon maternal metabolism to 
the well-being of the embryo have been evaluated will it be possible 
to fully appreciate the extent of the contribution made by induced yolk 
sac dysfunction to the mechanism of suramin's teratogenicity.
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CHAPTER SEVEN
THE EXPECT OF SODIUM AUROTHIOMALATE ON YOLK SAC-MEDIATED NUTRITION
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7.1 Introduction
The teratogenicity of the anti-rheumatic drug sodium aurothiomalate 
(Figure 1) has been demonstrated in rats (Lloyd and Beck, 196 9;
Kidston et al., 1971» Szabo et al., 1978a) and rabbits (Szabo et al., 
1978b). A recent report (Rogers et al., 1980) has also described 
the teratogenic effects of the drug in a human.
Morphological studies have shown that sodium aurothiomalate localises 
in lysosomes. Norton et al. (1968) and Strunk and Ziff (1970) found 
characteristic granular particles concentrated in the lysosomes of 
synovial membrane and kidney glomerular epithelial cells of rats 
and humans injected with the drug. Sodium aurothiomalate has also 
been shown to be an inhibitor of a number of lysosomal enzymes.
Persellin and Ziff (1966) observed that the drug inhibited, 
in vitro, acid phosphatase and p-glucuronidase activities of guinea 
pig peritoneal macrophages and suggested lysosomal enzyme inhibition 
as a mechanism for the anti-inflammatory action of the drug.
Inhibition by sodium aurothiomalate of these two enzymes and 'cathepsin', 
obtained from rabbit liver lysosomes and human synovial fluid, has 
also been described (Ennis et al., 19 6 8). An inhibitory action of 
the drug on lysosomal proteolysis was suggested (Davies et al., 1971) 
to account for a decreased release of TCA-soluble radioactivity observed 
when liver lysosomes isolated from rats injected with ^5i_labelled 
BSA and sodium aurothiomalate were incubated at 22°C in osmotically- 
protected medium.
In the light of these studies, it was suggested (Lloyd and Beck, 1969) 
that the embryopathic effects of sodium aurothiomalate, injected into 
pregnant rats during the early organogenesis period of embryonic 
development, might be caused by a mechanism of action similar to the
Au - S
Hi
- C
i
H - Ci
H
Na
Na
Figure 7.1 Structural formula of 
disodium aurothiomalate
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one proposed for trypan "blue (Beck et al., 1967b), a hypothesis that 
was strengthened by the finding (Kidston et al., 1971) that auro- 
thiomalate accumulates in visceral yolk sac lysosomes following 
injection into pregnant rats between 7 .5  and 1 1 . 5  days of gestation.
The present experiments were undertaken to examine the effects of 
sodium aurothiomalate on the already established nutritional function 
of the visceral yolk sac in cultured early organogenesis-stage 
conceptuses.
7.2 Materials 
Chemicals
Disodium aurothiomalate (Myocrisin) was a generous gift of May and 
Baker Ltd., Dagenham, Essex.
All other chemicals used have been listed previously.
7.5 Methods
7.5.1 Teratogenic Testing of Sodium Aurothiomalate (Mvocrisin')
The procedure was as described for trypan blue. Sodium aurothiomalate 
was administered at a dosage of 10 0 mg/kg.
7.5.2 Culture Experiments
The procedure was as described for trypan blue. In cultures that used 
1 2 5i_pv p as substrate, sodium aurothiomalate was added to the culture 
medium to a final concentration of 2 5 , 50, 100, 200 or 500^ag/ml. Eor 
subsequent experiments with I-dBSA and -'H-labelled serum proteins as 
substrates, sodium aurothiomalate was added to a final concentration 
of 25 or 500 ^ ig/ml.
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J.A Results
y.4.1 Teratogenic Testing of Sodium Aurothiomalate
Injection of sodium aurothiomalate into pregnant rats at either 8 . 5  
or 9.5 days of gestation resulted in the production of malformed 
fetuses at term (Table 7*1)• Following injection at 8 . 5  days, a 
high rate (5 ^ 0) of fetal resorption was observed. Of the surviving 
fetuses, 37/o were abnormal, hydrocephalus and kidney malformation 
being the most common anomalies (Table 7-2). The average weight of 
fetuses surviving maternal treatment at 8 .5 days was significantly 
( p < 0.001) below that of controls. Maternal injection at 9-5 days 
resulted in a lower rate (3006) of fetal resorption but a higher 
proportion of the total number of implantations were malformed. Again 
hydrocephalus and kidney defects were the most common malformations 
observed (Table 7.2) and fetuses similarly incurred a significant 
(p< 0.001) weight deficit, compared with controls.
7.1.2 Culture Experiments
The inclusion of sodium aurothiomalate in the culture medium during 
either the final 6 hours, or the penultimate 6 hours of culture did 
not affect the viability of conceptuses or cause developmental 
deviations. When sodium aurothiomalate was present in culture for 
the final 6 hours, the protein content at harvesting, of embryos 
(Figure 7.2) was little affected. However in the yolk sac, an 
increase in protein content was observed which was approximately 
proportional to the concentration of sodium aurothiomalate in the 
culture medium, up to concentrations of 100 yug/ml. Concentrations of 
the drug above 100 jug/ml caused no further increase in the protein 
level of the yolk sac. When sodium aurothiomalate was present in culture 
between 36 and 42 hours, the protein contents of embryos and yolk sacs
Nature and 
time cf 
injection
No. of Oj 
treated*"!
No. of
implantations 
(% resorptns)
Av. weight 
surviving 
fetuses(g)
Ext
No.
'
ernal Abnorr, *. . . . -~ -¿surviving
fetuses
valities
% total impIntns
No. of
fetuses
sectioned
No. ( )  sectioned 
fetuses with 
anomalies
No.of fetuses 
stained with 
alizarin
No.(,%) stained 
fetuses with 
anomalies
Aurothiomal­
ate , 8.5 dys 8 86 (53) COCO
1 
+1 
CO rH •CO : 1 2.50 1.16 27 9 (33) 13 0
Aurothiomal­
ate, 9.5 dys 8 97 (30) 2.36 +.70* 1 1.47 1.03 46 17 (37) 22 0
Saline 
8.5 days 4 45 (4) 4.19 +.42 0 0 0 28 0 15 0
Saline 
9.5 days 4 44 (5) 4.40 +.60 0 0 0 30 0 12 0
* significantly different from saline-injected controls (p<0.001)
Table 7.1 Effects on offspring of s.c. injection of sodium aurothiomalate (100 mg/kg) or saline (0.9%) into pregnant rats 
Details of method are given in text.
Day of injection of 
aurothiomalate 8.5 9.5
Abnormality
Encephalocoele 0 (40) 1 (68)
Hydrocephalus 5 (27) 13 (46)
Anophthalmia 0 (27) 2 (46)
Kidney (deformed) 6 (27) 3 (46)
Megaureter 2 (27) 1 (46)
Gonad (absent or 
deformed) 1 (27) 0 (46)
Table 7.2 Abnormalities of fetuses after 
sodium aurothiomalate treatment of pregnant 
rats. Figures in brackets indicate the size 
of the population examined for that particular 
defect.
300i
Figure 7.2 Protein contents of yolk sacs (filled symbols) and 
embryos (open symbols) after incubation of conceptuses in the 
presence of sodium aurothiomalate for either the final 6 hours 
(squares) or the penultimate 6 hours (triangles) of culture. 
Values are means of a! least 6 determinations.
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at harvesting varied similarly with concentration of the drug (Figure 
7.2).
When sodium aurothiomalate, with  ^^ j-FVP, was present in culture for 
the final 6 hours, there was no radioactivity detectable in embryos 
at harvesting (Figure 7*3). In yolk sacs, the uptake of radioactivity 
was decreased, compared with the control value. This lower level of 
uptake was independent of the concentration of sodium aurothiomalate.
Y/ken 125i_cLBSA and sodium aurothiomalate were present in culture for 
the final 6 hours, little radioactivity, and all of it TCA-soluble, 
was detected in the embryos (Figure 7-4). The total amount of 
radiolabelled protein processed by yolk sacs was decreased, relative 
to the control. At a concentration of 25^ug/ml, sodium aurothiomalate 
reduced the total uptake by yolk sac to about 72^. However, the 
proportion that was associated with the yolk sac at harvesting was 
almost twice that seen in the control. The percentage of yolk sac- 
associated radioactivity that was TCA-soluble was also lower in 
conceptuses exposed to the drug. At a sodium aurothiomalate 
concentration of 500^ig/ml, the total uptake of radioactivity by yolk 
sac was reduced to AJ/o of the control value. This decrease was 
accompanied by an increase in the proportion that was yolk sac- 
associated, approximately 4 times the control figure, and a decrease 
in the percentage TCA-soluble radioactivity associated with the yolk 
sac (55% of the control value).
The effect of sodium aurothiomalate on the total uptake of radioactivity 
hy yolk sacs (Figure 7*5) when the drug was present in culture between 
36 and 42 hours and 12^I-dJBSA for the final 6 hours, was qualitatively 
similar, though of smaller magnitude, to that described above. However, 
in contrast to those data, the drug did not alter the proportion of the
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Figure 7.3 Radioactivity associated with yolk sac (■) and
embryo (□) after incubation of conceptuses in the presence of 
1 25I-FVP (2.3 ug/ml) and sodium aurothiomalate for the final 
6 hours of culture. Values are means (_+ S.D.) of at least 
6 determinations.
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Figure 7.4- Total radioactivity taken up by yolk sac (each left hand
column) and embryo (each right hand column), and the radioactivity
associated with the yolk sac (total shaded area of each left hand
125column) after incubation of conceptuses in the presence of I-dBSA 
( 1 1  jig/ml) and aurothiomalate for the final 6 hours of culture.
The proportions of yolk sac- and embryo-associated radioactivity that 
were TCA-soluble and TCA-insoluble are indicated. Values are 
means (+ S.D.) of at least 6 determinations.
Sodium aurothiomalate concentration (jig/ml)
Figure 7.5 Total radioactivity taken up by yolk sac (each left hand 
column) and embryo (each right hand column), and the radioactivity 
associated with the yolk sac (total shaded area of each left hand• I O Ccolumn) after incubation of conceptuses in the presence of I-dBSA 
(11 ^ ig/ml) for the final 6 hours, and sodium aurothiomalate for the 
penultimate 6 hours^culture. The proportions of yolk sac- and embryo-
associated radioactivity that were TCA-soluble and TCA-insoluble
are indicated. Values are means (+ S.D.) of at least 6
determinations.
3o r
Sodium aurothiomalate concentration (jig/ml)
Figure 7.6 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area of 
each left hand column) after incubation of conceptuses in the 
presence of I HIleucine-labelled serum proteins and sodium 
aurothiomalate for the final 6 hours of culture. The proportions 
of yolk sac- and embryo-associated radioactivity that were
are indicated. Values areand TCA-insolubleTCA-soluble
means (+ S.D.) of at least 6 determinations.
Sodium aurothiomalate concentration (jig/ml)
Figure 7.7 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the radioactivity 
associated with the yolk sac (total shaded area of each left hand 
column) after incubation of conceptuses in the presence of 
[3hJleucine-labelled serum proteins for the final 6 hours, and sodium 
aurothiomalate for the penultimate 6 hours of culture. The 
proportions of yofk sac- and embryo-associated radioactivity that 
were TCA-soluble j and TCA-insoluble 
are means (_+ S.D.) of at least 6 determinations.
^  are indicated. Values
k
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total radioactivity taken up that was, at harvesting, yolk sac-associated, 
or the percentage of the yolk-associated radioactivity that was TCA-soluble.
When sodium aurothiomalate was presented to conceptuses with ^-labelled 
serum proteins for the final 6 hours of culture, the uptake of 
radioactivity was not altered (Figure 7-6). There was however a 
slight, but significant (p < 0 .02), increase in the proportion of this 
radioactivity that was associated with the yolk sac at harvesting, 
and a concomitant decrease in embryo-associated radioactivity.
Essentially identical data were obtained (Figure 7-7) when the drug 
was present in culture from 56 to 42 hours, and the radiolabelled 
proteins from 42 to 48 hours.
7.5 Discussion
In agreement with previous reports (Kidston et al., 19 7 1. Szabo et al 
1978a) aurothiomalate was found in the present study to be teratogenic 
in rats. As in these studies, the most common defects observed were 
hydrocephalus and kidney malformation.
The observation (Figure 7.2) that the protein content of yolk sac is 
increased following exposure to sodium aurothiomalate in culture, is 
most readily explained by an induced lysosomal storage of protein due 
to an inhibition of lysosomal proteolysis by the drug. Indeed, this is
serum proteins were taken up by the conceptus, radioactivity was unevenly 
distributed between yolk sac and embryo in the presence of sodium 
aurothiomalate, a greater proportion being associated with the yolk
sodium aurothiomalate. Since, in the expression used throughout this 
study, uptake is inversely related to the quantity of tissue protein, an
clearly demonstrated by the finding that, when
sac (Figures J . 6  and 7.7). This must be borne in mind when considering
125the apparent inhibition of •'I-FVP uptake into yolk sac caused by
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increase in the amount of yolk sac protein through lysoscmal storage, 
will artificially decrease the calculated figure of uptake. The 
relationship of the concentration of sodium aurothiomalate in the 
culture medium ' fco. protein content of yolk sacs (Figure 7 .2), and 
. to 1 2 5l-FVF uptake by yolk sac (Figure 7-3), demonstrates that the 
decreased 'uptake' of radiolabel is entirely due to the elevated 
protein levels in the yolk sac, and not to an inhibition of pinocytosis. 
No inhibition of the uptake of ^H-labelled serum proteins was observed. 
This is to be expected. The stored protein in yolk sac lysosomes caused 
by the action of sodium aurothiomalate is of course derived from the 
serum protein in the culture medium. When this serum protein is 
radiolabelled, radioactivity will be accumulated in direct proportion 
to the stored serum protein.
125However, the decreased uptake of •'T-dBSA by yolk sac in the presence 
of aurothiomalate cannot be wholly explained on a similar basis. 
Certainly, at the lower concentration of sodium aurothiomalate used, 
the decrease in the total uptake of radioactivity is largely due to 
the increased protein content of yolk sac. At the higher concentration 
of the drug though, the extent of inhibition of uptake (more than 50% 
of the control value) is much more than would be expected simply 
on the basis of increased yolk sac protein. The drug would seem 
therefore to be causing a true inhibition of the pinocytosis of 
1 2 5i-£BSA. This observation is in agreement with the finding of 
Kidston (1974) that pinocytosis of -T-cLBSA is inhibited by 
aurothiomalate in the cultured 1 7 .5-day rat yolk sac. Kidston (1974) 
also observed that the drug did not affect the uptake of 1 2 5i_FVP by 
yolk sac. In the present study, aurothiomalate inhibited the uptake 
of 1 2 5l-dBSA both when present in culture at the same time as the
'■”Sii«SSS»<WG»«K
substrate and when loaded into conceptuses before their exposure to 
radiolabel. Evidently, the drug's effects on pinocytosis are exerted 
from within the cell and are not explicable on the basis of a competition 
for the binding sites on the plasma membrane to which the substrate 
normally adsorbs, or by an interaction between drug and substrate 
which modifies the latter's affinity for such binding sites.
The reason why sodium aurothiomalate inhibits the pinocytosis by 
yolk sac of 125I-dBSA but not 125I-PVP is not clear, but may relate 
to the different modes of uptake of the two substrates, fluid-phase
12 5in the case of ”*25i_pVP and adsorptive in the case of I-cLBSA. 
Silverstein et al. (1977) reported that the microtubule disaggregator 
cytochalasin B inhibited fluid-phase but not adsorptive pinocytosis 
by the mouse peritoneal macrophage. Hence, it would appear that the 
two types of uptake are not governed by exactly the same factors, and 
their different sensitivities to sodium aurothiomalate might be 
explained on that basis.
In addition to inhibiting the uptake of 125l-dBSA, sodium aurothiomalate 
also inhibited the yolk sac intralysosomal degradation of the radio- 
labelled protein. However, inhibition only occurred when the drug was 
present in culture for the final 6 hours, and not when loaded into 
yolk sacs before their exposure to radiolabel. In this respect, 
the data resemble those obtained using trypan blue (Chapter 5).
However, unlike trypan blue, sodium aurotfcomalate inhibited the 
degradation of ^-labelled serum proteins in yolk sacs. Furthermore, 
this inhibition occurred regardless of whether the drug was added before, 
or together with, the radiolabelled substrates. Taken together, these 
observations would seem to indicate that pinosomes containing ^E-labelled 
serum protein are able to fuse with heterolysosomes containing sodium
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aurothiomalate that had been previously taken up by yolk sac, while 
pinosomes containing 125x_cffiSA are not. This explanation again infers 
that differences exist in the intracellular processing of substrates 
pinocytosed adsorptively (such as "^i-cLBSA) and substrates (such as 
5H-labelled serum proteins) that are pinocytosed to a large extent in 
the fluid phase. Until such differences are characterised, it is not 
possible to draw a more definite conclusion.
The findings of Ennis et al. (1968) that the inhibitory action of 
sodium aurothiomalate on lysosomal enzymes resembled the action of 
enzyme inhibitors known to act by sulphydryl binding, and could be 
reversed by the addition of cysteine to the incubation medium, led 
these workers to propose that the biological effects of the drug 
were due to its sulphydryl reactivity. In support of this claim, 
the inhibition by sodium aurothiomalate of mitogen-induced human 
lymphocyte proliferation, in vitro, has been shown (McCormack and 
Palmer, 1980) to be sulphydryl-dependent. In view of this property 
of the drug, it is to be expected that lysosomal thiol proteinases 
(such as cathepsins B and L) would be inhibited by aurothiomalate 
(Davies et al., 1971). Inhibition of thiol proteinases is, most 
likely, the cause of the induced lysosomal storage of 125i_£BSA 
and 3ll-labelled serum proteins. However, sodium aurothiomalate 
binds strongly to native serum albumin (McQueen and Dykes, 19 6 9) and 
probably enters yolk sac lysosomes, in vitro, in this bound form.
Such binding will protect the yolk sac cells from too severe an 
inhibitory effect of the drug on lysosomal enzymes and would explain 
why the decrease in proteolysis, though significant, is only slight.
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From the foregoing discussion, it is once again clear that the 
composition of the fluid surrounding the conceptus during early 
organogenesis in utero will be of critical importance in determining 
the extent of the effect that sodium aurothiomalate is going to exert 
upon the lysosomal digestion of macromolecular nutrient, and hence the 
induction of embryonic malformation. In considering the mechanism of 
aurothiomalate-induced teratogenesis, the possible effects of the 
drug on the maternal organism which may secondarily affect the 
development of the embryo must also be evaluated before any firm 
hypothesis can be advanced to explain the drug's teratogenic action. 
Even so, the data presented here provide firm support for the proposal 
that aurothiomalate's primary target in teratogenesis is yolk sac- 
mediated histiotrophic nutrition, specifically the inhibition of 
proteolysis in yolk sac lysosomes which consequentially reduces the 
supply of amino acids for protein synthesis in the embryo.
CHAPTER EIGHT
THE EFFECT OF ANTI-YOLK SAC ANTISERUM 
ON YOLK SAC-MEDIATED NUTRITION
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In a long-running series of publications Brent and his associates 
have reported the teratogenic effects and tissue distribution in rats 
of maternally-administered heterologous antisera to various rat tissues. 
The finding (Slotnick and Brent, 19 6 6) that sheep anti-rat kidney and 
sheep anti-rat placenta antisera, when administered to pregnant rats 
at day 8 of gestation, localised strongly in the yolk sac but did 
not reach the embryo, together with the proposal (Beck et al., 1967a) 
that the yolk sac serves a nutritional function during early organo­
genesis, led to the suggestion (Lloyd, 1970) that the antisera caused 
malformations by interfering with this function of the yolk sac in 
the same way as proposed for trypan blue (Beck et al., 19 6 7b). This 
suggestion was strengthened further when it was discovered (Brent et 
al., 1 9 7O  that antiserum raised in sheep against rat visceral yolk 
sac was also teratogenic in rats, and showed a strong and lasting 
localisation in the yolk sac cytoplasm. Additional evidence that 
the yolk sac was the primary target in antiserum-induced terato- 
genesis came from experiments by New and Brent (1972). Using a 
whole-embryo culture technique they were able to demonstrate that the 
yolk sac endoderm was uniquely sensitive to the yolk sac antibody 
and that exposure of this membrane to the antibody caused growth 
and developmental retardation of the embryo.
In an effort to understand the mechanism of teratogenic action of 
antiserum better, the effect of a rabbit anti-rat yolk sac antiserum, 
of established teratogenicity, on pinocytosis and proteolysis by the 
early organogenesis-stage rat conceptus has been studied.
8.1 Introduction
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Chemicals
Rabbit Anti-Rat 18-day Visceral Yolk sac Antiserum was a generous gift 
of Dr. R. L. Brent, Thomas Jefferson University, Philadelphia, USA.
Other chemicals not previously listed were of analytical grade.
8.5 Methods
8.5.1 Preparation of Normal Rabbit Serum
A single Californian rabbit was bled from the marginal vein of the ear. 
The ear was shaved of hair, swabbed in alcohol and heated with a lamp 
to dilate the marginal vein. An oblique cut was made across the vein 
with a scalpel and blood was allowed to drip into a plastic centrifuge 
tube and clot. The clotted blood was refrigerated overnight and then 
re-mixed and centrifuged at 2,000 g for 10 minutes. The clear super­
natant serum was decanted and its protein content (approximately 
70 mg/ml) was estimated by the method of Lowry et al. (1 9 5 1), as 
described in Chapter 2.
8.5.2 Teratogenic Testing of Rabbit Anti-Rat Visceral Yolk Sac Antiserum
The procedure was as described for trypan blue (5»3«3)» Antiserum was 
administered by intraperitoneal injection at a dosage of 10 0 mg serum 
protein/kg body weight. Normal rabbit serum was administered, in an 
identical manner and at the same dosage, to a control group of 
pregnant rats.
8.5.5 Culture Experiments
The procedure was as described for trypan blue (5 .3.4). In cultures 
that used 1 2 5i_pvp as substrate, antiserum was added to the culture
8.2 Materials
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medium to a final concentration of 83, 1 6 7, 333, 1,667 or 3,333 /ig 
total serum protein/ml. For subsequent experiments with ^^^x—cLBSA 
and ^-labelled serum proteins as substrates, antiserum was added to 
a final concentration of 83 or 333 yug serum protein/ml. Control 
cultures tested the effects of normal rabbit serum at concentrations 
identical to those of antiserum employed. The effect of normal 
rabbit serum on pinocytosis and digestion when present in culture 
for only the last 6 hours, was investigated.
8-4 Results
8 .4 . 1 Teratogenic Testing of Anti-Rat Yolk Sac Antiserum
Intraperitoneal injection of rabbit anti-rat yolk sac antiserum 
(100 mg protein/kg) into pregnant rats at either 8 .5  or 9 .5  days 
of gestation resulted in the production of malformed fetuses (Table 8.1) 
Following injection of antiserum at 8 .5 days, the number of resorption 
sites visible at 20.5 days of gestation constituted 37% of the total 
number of implantations. An exceedingly high proportion, 87%, of the 
surviving fetuses were visibly externally malformed, and all of those 
fetuses sectioned exhibited malformation. Of the 18 fetuses assessed 
for skeletal development, 17 (94%) were malformed, though the single 
fetus whose skeleton was normally developed had been observed to be 
anophthalmic upon external examination. Hence all fetuses that 
survived maternal antiserum injection were malformed.
The types of defects observed and their frequencies are listed in 
Table 8.2. Anophthalmia and hydrocephalus were the most common mal­
formations noted and there was a high incidence also of absent or 
malformed kidneys and gonads. Among the skeletal defects, agenesis 
or malformation of the sternum was particularly common, while
Mature and 
time of 
injection
ho. of 0 
treated'’
No. of
implantations 
(% resorptions
Av. weight 
surviving 
Jfetuses (g)
External Abnormalities No. of
fetuses
sectionec
No.('o) sectioned 
fetuses with 
. anomalies
ho.of fetuses 
stained with 
alizarin
No.(%) stained 
fetuses with 
anomalies
N O. ^surviving
fetuses k total implntns
Antiserum 
8.5 days 8 87 (37) 2.18 +.59* 48 87.27 55.17 37 37 (100) 18 17 (94)
Antiserum 
9.5 days 8 84 (74) 3.65 +1.59 6 27.27 7.14 16 14 (88) 6 6 (67)
Normal rab. 
serum, 8.5 c 4 39 (3) 3.73 + .33 0 0 0 26 1 (4) 12 3 (25)
Normal rab. 
serum, 9.5 c 4 49 (2) 3.82 + .38 0 0 0 32 1 (3) 16 1 (6)
* significantly different from normal rabbit serum-injected controls (p<^  0.001)
Table 8.1 Effects on offspring of intraperitoneal injection of rabbit anti-rat visceral yolk sac antiserum (100 mg/kg) or 
normal rabbit serum (100mg/kg) into pregnant rats. Details of method are given in text.
Day of injection of 
antiserum 8 . 5 9 . 5
Abnormality
Anophthalmia 53 (55) 10 (22)
Hydrocephalus 31 (48) 9 (16)
Kidney (absent or 
deformed) 13 (48) 1 (16)
Gonads (absent or 
deformed) 15 (48) 3 (16)
Exencephaly 1 (55) 0
Limb defects 1 (55) 0
Spina bifida 2 (55) 0
Ventral hernia 1 (55) 0
Facial defects 2 (55) 0
Tail defects 2 (55) 0
Jaw defects 2 (18) 0
Spinal defects 8 (18) 1 (6)
Absent sternebrae 17 (18) 4 (6)
Ribs (absent or 
deformed) 8 (18) 1 (6)
Table 8.2 Abnormalities of fetuses after rabbit 
anti-rat visceral yolk sac treatment of pregnant 
rats. Figures in brackets indicate the size of the 
population examined for the particular defect.
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malformations of the spine and ribs were also frequent. Maternal 
injection of antiserum at 8 .5  days of gestation significantly (p<0.00l) 
reduced the average weight of surviving fetuses, compared with 
normal rabbit serum-injected controls.
Following injection of antiserum into 9.5-day pregnant rats, a very 
high level (74%) of fetal resorption was recorded. Of the 22 surviving 
fetuses, all but 4 were malformed. Though the range of malformations 
observed was not as extensive as in the 8.5-day injected group, the 
relative frequencies of the malformations observed in the 9*5-day 
injected group were similar to those in the 8.5-day injected group.
The average weight of fetuses surviving maternal injection of antiserum 
at 9.5 days of gestation was not significantly different from normal 
rabbit serum-injected controls (p)>0.1).
Control pregnant rats, injected with normal rabbit serum (100 mg 
protein/kg) at either 8.5 or 9.5 ¿Lays of gestation, did not 
resorb their embryos to any significant extent, though a few 
fetuses were malformed- (Table 8.1).
A zj. p Culture Experiments
The inclusion of anti-rat yolk sac antiserum in the culture medium 
during either the final 6 hours or the penultimate 6 hours of culture, 
did not affect the viability of conceptuses, which was at least 95%, 
or cause developmental deviations among cultured conceptuses. The 
protein contents at harvesting of yolk sacs and embryos of conceptuses 
incubated for the final 6 hours of the culture period (4 2 -4 8 hours)
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in a culture medium containing antiserum were decreased to a similar 
extent (Figure 8.1). The extent of the decrease was dependent on the 
concentration of antiserum protein in the culture medium. A decrease 
in protein content of conceptuses at harvesting was also observed when 
antiserum was present in culture between 36 and 42 hours (Figure 8.1).
The inclusion of normal rabbit serum in the culture medium, at the 
same concentrations as were used for antiserum, did not alter the 
protein contents of conceptuses at harvesting (Figure 8.2).
When antiserum and "'^j-FVP (2.3/ig/ml) were present in the culture 
medium for the final 6 hours of culture, there was virtually no uptake 
of radioactivity by embryos at harvesting (Figure 8 .3). The yolk sac 
however contained quantities of radioactivity that varied with the 
concentration of antiserum in the medium. Increasing the concentration 
of antiserum caused a progressive decrease in the uptake of radioactivity. 
The level of uptake by yolk sacs exposed to 167 pg/ml of antiserum 
was 57% of the control value. As the antiserum concentration was 
increased above 1 6 7 ^/ml, the uptake of radioactivity by the yolk sac 
was further decreased. At 3,333 ;ig/ml of antiserum (1.0 mg/ml of gamma 
globulin) the uptake of radioactivity by yolk sac was reduced to 40%  
of controls.
Interestingly, when conceptuses were exposed to antiserum concentrations 
of 85 /¿gA1 (which inhibited uptake to 69% of controls) and 3 3 3yug/ml 
(which inhibited uptake to 5&/o of controls) for a 6 hour period 
( 3 6 - 42 hours of culture) before being transferred to fresh medium 
containing 12^I-PVP (2.3/ig/ml) but no antiserum and cultured for a 
further 6 hours (42 - 48 hours of culture), the extent to which 
uptake of radioactivity by yolk sac was inhibited was virtually identical
Antiserum concentration (jig protein/ml x 10-2)
Figure 8.1 Protein contents of yolk sacs (filled symbols) 
and embryos (open symbols) after incubation of conceptuses 
in the presence of rabbit anti-rat visceral yolk sac 
antiserum for either the final 6 hours (squares) or the 
penultimate 6 hours (triangles) of culture. Values are 
means of at least 6 determinations.
Rabbit serum concentration (jig protein/ml x 10 2)
Figure 8.2 Protein contents of yolk sacs (■) and embryos (□> 
after incubation of conceptuses in the presence of normal rabbit 
serum for the final 6 hours of culture. Values are means of at 
least 6 determinations.
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Figure 8.3 Radioactivity associated with yolk sac (■) and embryo (□) 
after incubation of conceptuses in the presence of 125I-PVP (2.3 jig/mi) 
and rabbit anti-visceral yolk sac antiserum for the final 6 hours 
of culture. Values are means (+ S.D.) of at least 6 determinations.
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to that seen when antiserum and substrate were present in the culture 
medium at the same time (Figure 8 .4 ). No uptake of radioactivity by 
embryos at harvesting was observed, but yolk sac uptake was inhibited 
to levels of l&/° of controls at an antiserum concentration of 83 ;ug/ml 
(cf 69%) and 5&/o of controls at an antiserum concentration of 333/ig/ml 
(cf 56%).
In contrast to these data, antiserum (8 3 or 333 jag/ml) did not 
significantly affect (pj> 0 .0 5) the total uptake of radioactivity by 
conceptuses following their incubation for the final 6 hours of culture 
in a medium that contained both antiserum and 12^I-d£SA (11 jug/ml) 
(Figure 8 .5 ). However, the proportion of the total radioactivity 
processed by the conceptúa that was associated at harvesting with 
the yolk sac was significantly decreased (p< 0.001 at 83 ^ ag/ml and 
p < 0  02 at 333 ;ug/ml), both concentrations of antiserum, to less 
than half the control value. Furthermore, the proportion of yolk 
sac-associated radioactivity that was TCA-soluble was much lower in 
those conceptuses exposed to antiserum than controls. When antiserum 
was presented to conceptuses for 6 hours before a further 6 hour 
incubation in an antiserum-free medium containing 125i_dBSA, almost 
identical results were obtained (Figure 8.6). Again little radio­
activity, and all of it TCA-soluble, was detected in embryos at 
harvesting. Overall uptake of radioactivity by conceptuses was not 
different (p^O.1) from controls, but the proportion of the total 
radioactivity processed that was associated with the yolk sac at 
harvesting was less than one half the control value (p< 0.001 at 
83 jug/ml antiserum and p<0.01 at 333 /ig/ml antiserum). One 
difference between the two sets of data (Figures 8 .5  and 8.6) is the
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Figure 8.4- Radioactivity associated with yolk sac (each left hand
column) and embryo (each right hand column) after incubation of
125conceptuses in the presence of I-PVP (2.3 jjg/ml) for the final 
6 hours, and rabbit anti-visceral yolk sac antiserum for the 
penultimate 6 hours of culture. Values are means (+_ S.D.) of at 
least 6 determinations.
Antiserum concentration (jig protein/ml)
Figure 8.5 Total radioactivity taken up by yolk sac (each left hand 
column) and embryo (each right hand column), and the radioactivity 
associated with the yolk sac (total shaded area of each left hand 
column) after incubation of conceptuses in the presence of 
125I-dBSA (11 Y g/ml) and rabbit anti-visceral yolk sac antiserum 
for the final 6 hours of culture. The proportions of yolk sac- 
and embryo-associated radioactivity that were TCA-soluble and 
TCA-insoluble ^  are indicated. Values are means (_+ S.D.) of at 
least 6 determinations.
70
Antiserum concentration (|ig protein/m l)
Figure 8.6 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the radioactivity 
associated with the yolk sac (total shaded area of each left hand 
column) after incubation of conceptuses in the presence of 
125I-dBSA (11 ^ ig/ml) for the final 6 hours, and rabbit anti- 
visceral yolk sac antiserum for the penultimate 6 hours of culture.
The proportions o f yolk sac-  and em bryo-associated ra d io a c t iv ity  
th at were TCA-soluble " and TCA-insoluble ^ 3  are indicated. ¿ 2
Values are means ( t  S.D.) o f a t  le a s t  6 determ inations.
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high percentage of TCA-soluble radioactivity that was retained in the 
yolk sac at harvesting when conceptuses were exposed to antiserum 
before radiolabel as compared to the low TCA-soluble yolk sac- 
associated radioactivity when conceptuses were exposed to antiserum 
and radiolabel at the same time. However, it would be unwise to place 
too much weight on this observation since the standard deviations of the 
mean percent TCA-soluble radioactivity in the yolk sac were very large.
The uptake of radioactivity by conceptuses following simultaneous 
exposure for the final 6 hours of culture to antiserum (83 or 333_^ig/ml) 
and ^-labelled serum proteins, is shown in Figure 8.7. At the lower 
antiserum concentration, the uptake and digestion of radiolabel within 
conceptuses was not noticeably different from controls. At the higher 
concentration of antiserum, total uptake of radioactivity into the 
conceptus was reduced to 62%  of the control value, but the distribution 
of this radioactivity between yolk sac and embryo and the percentage 
radioactivity that was TCA-soluble, was not altered. When antiserum 
was loaded into conceptuses before exposure to ^H-labelled serum proteins 
almost identical data were obtained (Figure 8.8). Antiserum at a 
concentration of 83 yug/ml produced no difference in the levels and 
distribution of radioactivity in conceptuses at harvesting compared with 
controls. At a concentration of 333/1§/nil, total incorporation of 
radiolabel into the conceptus was decreased to 55% of the control value. 
However the distribution of radiolabel and the proportion that was 
TCA-soluble was not altered.
The inclusion of normal rabbit, serum in the culture medium for the final 
6 hours of culture, at the concentrations employed with rabbit anti-rat 
yolk sac antiserum, together with either 125I-PVP (2.3 /ig/ml)(Figure 8.9),
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Figure 8.7 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area 
of each left hand column) af£®r incubation of conceptuses in the 
presence of HJ leucine-labelled serum proteins and rabbit anti- 
visceral yolk sac antiserum for the final 6 hours of culture.
The proportions of yolk sac- and embryo-associated radioactivity 
that were TCA-soluble and TCA-insoluble ^  are indicated.
Values are means (+^  S.D.) of at least 6 determinations.
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Figure 8 .8  Total ra d io a c tiv ity  taken up by yolk sac  (each l e f t  
hand column) and embryo (each righ t hand column), and the 
ra d io a c tiv ity  asso c ia ted  with the yolk sac  ( t o t a l  shaded area o f
each l e f t  hand column) a f te r  incubation o f conceptuses in the
13. "presence of £ h|leucine-labelled serum proteins for the final 6 
hours, and rabbit anti-visceral yolk sac antiserum for the 
penultimate 6 hours of culture. The proportions of yolk sac- and
'A*.*. andembryo-associated radioactivity that were TCA-soluble 
TCA-insoluble ^  are indicated. Values are means (+ S.D.) of at 
least 6 determinations.
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Rabbit serum concentration (jig protein/ml)
Figure 8.9 R adioactivity  a sso c ia ted  with yolk sac  (■ ) and 
embryo (□) a f te r  incubation o f conceptuses in the presence o f
1 QC *I-PVP (2.3 jig/ml) and normal rabbit serum for the final 6 
hours of culture. Values are means S.D.) of at least 6 
determinations.
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Figure 8.10 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area of 
each left hand column) after incubation of conceptuses in the 
presence of I-dBSA (11 jig/ml) and normal rabbit serum for the 
final 6 hours of culture. The proportions of yolk sac- and embryo- 
associated radioactivity that were TCA-soluble and TCA-insoluble 
m  are indicated. Values are means (_+ S.D.) of at least 6 
determinations.
15
Rabbit serum concentration (jig protein/m l)
Figure 8.11 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area of 
each left hand column) after incubation of conceptuses in the 
presence °f leucine-labelled serum proteins and rabbit serum 
for the final 6 hours of culture. The proportions of yolk sac-
and embryo-associated radioactivity that were TCA-soluble
and T C A - insoluble are indicated. Values are means (_+ S.D.) of
a t  le a s t  6 determ inations.
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125i_cQ3SA (11yug/ml)( Figure 8.10) or ig - la b e lle d  serum p ro te in s (Figure 
8 . 1 1  ) ,  did not lead to any apparent d iffe ren ces in  the le v e ls  o f 
r a d io a c t iv ity  e ith er a sso c ia ted  with or processed by conceptuses, when 
compared with contro ls that were not exposed to normal rab b it serum.
8 , 8  D iscussion
The te ra to g en ic ity  in  r a t s  o f heterologous a n tise ra  ra ise d  aga in st 
v ariou s r a t  t is su e s  has frequently  been reported in  the l i t e r a tu r e .
Brent e t a l .  (1961) and Barrow and Taylor (1971) described the 
teratogen ic  e f fe c t s  in  r a t s  o f a n ti- ra t  kidney antiserum obtained from 
ra b b it s .  In subsequent stu d ie s , rab b it a n t i- r a t  p lacen ta  antiserum 
(Brent, 1967; Barrow and Taylor, 1971)» sheep a n t i- r a t  v is c e r a l  yolk 
sac antiserum (Brent et a l . ,  1971) and rab b it a n t i- ra t  R e ic h e rt 's  
membrane antiserum (Jensen e t a l . ,  1975) were shown to be teratogen ic  
in  r a t s .  With the exception o f the an ti-R e ic h e rt 's  membrane antiserum, 
these an tise ra  have a l l  been observed by immunofluorescence to lo c a l is e  
in  the same t is s u e s  o f the pregnant r a t ,  p a r t ic u la r ly  the kidney and 
the v isc e r a l  yolk sac , in d icatin g  that they share a number o f common 
antigens (Pressman and Komgold, 1957; S lo tn ick  and Brent, 1966;
Brent and Johnson, 19^7)*
The terato g en ic ity  and em bryolethality o f rab b it a n t i- r a t  v isc e ra l  
yolk  sac antiserum, obtained using yolk sac s from a d iffe re n t population 
o f r a t s  to the one used in  the present study, i s  c le a r ly  evident from 
the data  (Tables 8.1 and 8.2). The spectrum and incidence o f the 
d e fe c ts  observed agreed with those previously  reported (Brent et a l . ,
1970-
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The observations that an tise ra  did not lo c a l is e  in  the embryo 
(S lo tn ick  and Brent, 1966) suggested that the teratogen ic  e f fe c t  was 
due ¿ ith e r  to an in terference with the normal function o f ex tra-  
embryonic membranes, s p e c if ic a l ly  the yolk sac , or to immunological 
d ise a se  o f the mother which secondarily  a ffe c te d  the embryo. This 
l a t t e r  p o s s ib i l i ty  merited in v estig a tio n  since i t  had been shown 
(B re n t,1971) that both anti-kidney and a n t i-v isc e ra l  yolk sac 
antiserum induced maternal n e p h ritis . However th is  p o ss ib le  mechanism 
o f  action  was made much l e s s  p lau sib le  by the fin d in g  (Leung e t a l . ,
1 9 7 4 ) that two separate pools o f an tibodies ra ise d  aga in st r a t  kidney 
in  r a b b its , were responsib le  fo r  te ra to g en ic ity  and nephrotoxicity , and 
th at only the teratogen ic antibodies lo c a lise d  in  the v isc e r a l  yolk 
sac . The v is c e r a l  yolk s a c 's  claim  a s  the s i t e  o f primary teratogen ic  
action  was fu rth er strengthened by the observations (New and Brent, 1972) 
th at when sheep a n ti- ra t  v isc e ra l  yolk sac antibody was added to the 
cu lture  medium in  which 9 . 5  o r 1 0 . 5  day ra t  conceptuses were developing 
so th at only the v isc e ra l  yolk sac endoderm was d ire c t ly  exposed to 
antibody, the antibody caused retarded growth and development o f the 
embryos. When, however, the antibody was in je c te d  in to  the amniotic 
cav ity  so that the embryo was d ire c t ly  exposed to i t ,  or in to  the 
extra-embryonic coelom which exposed the mesodermal surface  o f the 
yolk sac to antibody, l i t t l e  or no e f fe c t  on embryonic development 
was noted.
In  the present study, the e f fe c t  o f a n t i-v isc e ra l  yolk  sac antiserum 
on the n u tr itio n a l p rop ertie s o f the yolk sac was in v e stig a te d . Anti- 
v is c e r a l  yolk sac antiserum, added to the cu lture  medium with "^I-FV P  
fo r  the l a s t  6 hours o f cu ltu re , decreased the uptake o f ra d io a c t iv ity  
by conceptuses. The decrease was dose-dependent a t  antiserum concentrations
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of 167 ug/ml or less, but approached a maximum level as the antiserum 
concentration was increased. The "levelling off" of inhibition of 
pinocytosis at higher concentrations of antiserum would seem to 
indicate that pinocytosis cannot be totally abolished by antiserum. 
When the antiserum was loaded into conceptuses before exposure to 
125j_pvp, almost identical inhibition of uptake of radiolabel was 
observed. The effect of antiserum on the protein contents of yolk 
sacs and embryos at harvesting was qualitatively similar to that 
described for uptake of vI-PVP, A noticeable reduction in conceptos 
protein levels at low concentrations of antiserum was observed. As the 
antiserum concentration was raised, the protein levels were reduced 
further but the decrease was less marked.
In contrast to these observations, the antiserum had no effect on the 
uptake of 1^5i_cLBSA by conceptuses, regardless of whether it was 
presented to conceptuses before, or together with, the radiolabelled 
substrate. However, although the total amount of radioactivity 
processed by conceptuses was unaffected by antiserum, the proportion 
that at harvesting was associated with the yolk sac was reduced. This 
suggests that the antiserum in some inexplicable way enhances the rate 
of release of ^5j_iabelled digestion products from the tissues, an 
explanation that is also consistent with the observed reduced proportion 
of the yolk sac-associated radioactivity that was TGA-soluble.
It is interesting to compare these data with those of Goetze et al. 
(1975) who found that 19-day rat yolk sac, incubated in vitro for 
20 minutes with goat anti-rat placenta antibody, showed a decreased 
tissue-associated radioactivity following a further 20 minute 
incubation in antibody-free medium containing 1 25l_labelled human 
serum albumin. These workers ascribed this observation to an
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inhibition of pinocytosis of the radiolabelled protein. However, 
since in this study the release of TCA-soiuble radioactivity from 
the yolk sac into the medium was not monitored, a rapid release of 
digestion products from the yolk sac as postulated here would have 
gone unnoticed, and hence an erroneous conclusion may have been 
drawn. Furthermore, these workers used an exceedingly high 
concentration of antibody (30 mg/ml) which is approximately the 
equivalent of 100 mg antiserum protein/ml of culture medium, compared 
with the highest concentration used in the present study of 333yug/ml 
It is quite likely that the use of such a large concentration of 
antibody would result in a general cytotoxic effect on the yolk sac 
that would inevitably reduce pinoctyosis, rather than a specific 
effect of the antiserum on pinocytosis.
When the effect of antiserum on the utilisation of ^-labelled serum 
proteins by conceptuses was examined, three notable facts emerged.
The first of these was that 8$ fig/ml of antiserum in the culture medium, 
a concentration that reduced the uptake of to of controls
had no effect on the uptake or distribution of radiolabel within the 
tissues of the conceptus. At a higher concentration of antiserum,
333 ^ fi/ml. the uptake of radiolabel was reduced to 62/0 of control 
levels, which is veiy similar to the degree of inhibition of uptake 
by conceptuses of 125I-PVP (5*  of controls). The reason why the lower 
concentration of antiserum should not affect the uptake of %-labelled 
serum proteins but markedly reduce the uptake of 125i_pyp} whUe the 
higher concentration of antiserum affects the uptake of these substrates 
to more or less the same extent, is not clear, particularly when one 
considers that the total protein of conceptuses at harvesting is 
reduced by antiserum (83^/ml). The second point of note is that
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when -uptake of radioactivity by conceptusea was decreased, the 
distribution of the smaller quantity of radiolabel between the yolk 
sac and embryo was unaltered, indicating that degradation of radio- 
labelled proteins was not inhibited by antiserum and that inhibition 
of yolk sac pinocytosis consequentially reduces the uptake of 
radiolabel into the embryo by the same amount, providing further 
evidence of the mediating role of the yolk sac in histiotrophic nutrition. 
Thirdly, the effect of antiserum on pinocytosis of ^H-labelled serum 
proteins by conceptuses was qualitatively and quantitatively the 
same regardless of when the antiserum was present in the culture 
medium. Indeed this has been an impressive feature throughout these 
studies of antiserum and possibly provides a clue to the mode of 
action of antiserum. By the use of immunofluorescent techniques, 
it has clearly been demonstrated (Brent et al., 1971) that anti-yolk 
sac antibody localises within the yolk sac and persists there, for 
periods much longer than do non-specific heterologous gamma globulins 
(Brent, 1971)• This suggests that the anti-visceral yolk sac antibody 
is able to resist degradation by proteolytic enzymes. Since the 
antiserum caused the same degree of inhibition of pinocytosis when 
it was added to the culture medium at the same time as substrate and 
when it was added before the substrate, the teratogenic gamma globulin 
of the antiserum must be rapidly equilibrated with the specific process 
or processes that are being inhibited, and as a consequence decrease 
pinocytosis. Furthermore, inhibition must be maintained at the same 
level over at least a 12 hour period.
The failure of the antiserum at a low concentration to inhibit the 
uptake by conceptuses of ^H-labelled serum proteins, and at both a 
high and a low concentration the uptake of 125i_a3SA j.s difficult to
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explain. However, since the total tissue protein was reduced at 
harvesting1 by antiserum treatment during culture, although the uptake 
of these substrates per unit protein of yolk sac is not affected, the 
absolute uptake by the whole yolk sac will be less.
In none of the experiments described could it be demonstrated that 
yolk sac intralysosomal digestion of protein was being inhibited.
This conclusion is reinforced by the observation that the protein 
contents of both yolk sacs and embryos of conceptuses exposed to 
antiserum in culture were decreased in a similar way. An inhibition 
of yolk sac proteolysis would have led to an accumulation, rather 
that a reduction, of protein in the yolk sac.
There are a number of ways in which the antiserum could be acting to 
inhibit pinocytosis. The pinocytic process requires both energy and 
cytoskeletal involvement (Silverstein et al., 1 9 7 7) and is known to 
be sensitive to inhibitors of energy metabolism and cytoskeleton 
disaggregators. Conceivably, antibodies directed against glycolytic 
or respiratory enzymes or cytoskeletal proteins could affect pino­
cytosis. One problem here however is that it is likely that gamma 
globulin (antibody) is pinocytosed by yolk sac and is subsequently 
incorporated into heterolysosomes. It is therefore difficult to 
envisage how the antibody would gain access to cytosolic or mito­
chondrial enzymes, although Franke et al. (1975) have demonstrated 
by electron microscopy that goat anti-rat placenta antibody both 
labilises lysosomal membrane and causes a reduction in the number of 
microvilli on the apical surface of yolk sac endodermal cells. A 
cytotoxic effect of antiserum and complement has also been described, 
in mouse yolk sac (Billington et al., 19 7 6).
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Alternatively, anti-visceral yolk sac antibody could tie acting, to 
inhibit pinocytosis, at the plasma membrane. The demonstration 
(Schneider et al., 1970b) that membrane recycling between lysosomes 
and plasma membrane can carry with it anti-plasma membrane antibody 
explains how an intralysosomal material can continue to affect an 
event at the plasma membrane. It should be added however that the 
presence in culture of anti-plasma membrane antibody was observed 
not to affect the uptake of other immunoglobulins into fibroblasts 
(Schneider et al, 1970a).
In conclusion, it can be said that the mechanism of teratogenic action 
of anti-yolk sac antiserum involves an interference of the yolk sac- 
mediated histiotrophic nutrition of the embryo, through the inhibition 
of the pinocytic ingestion of macromolecular nutrients by the yolk 
sac. This may constitute the primary defect in antiserum-induced 
teratogenesis, or may be a single manifestation of a more general 
toxic effect of antiserum on the yolk sac.
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CHAPTER NIUE
THE Kt'EECT OF LEOPEPTIN OH YOLK SAC-MET)TATED NUTRITION
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The peptide leupeptin is one of a number of similar substances that 
have been isolated from culture filtrates of Strentomycese (see review by 
Umezawa and Aoyagi, 1977). This group of peptides share the char­
acteristic of being inhibitors of certain groups of proteolytic enzymes, 
though the specificity of each inhibitor is not precisely the same. 
Leupeptin is a tripeptide of the structure acetyl- (or propionyl-) 
L-leucyl-L-leucyl-L-arginal (Figure 9-1), though substitution of 
isoleucine or valine for leucine has been observed (Kondo et al., 1969; 
Kawamura et al., 1969). Among the enzymes that leupeptin is known to 
inhibit are the lysosomal cysteine proteinases cathepsin B (Huisman 
et al., 1974) and cathepsin L (Kirschke et al., 1977). Leupeptin does 
not however inhibit the aspartic proteinase cathepsin D (Kirschke 
et al., 1977).
On the basis of this enzyme-inhibitory action, leupeptin has been demon­
strated to inhibit the degradation of intracellular protein in Reuber H 35 
hepatoma cells (Knowles and Ballard, 1976), isolated rat hepatocytes 
(Hopgood et al., 1977» Seglen, 1978; Solheim and Seglen, 1980;
Ose et al., 1980; Berg et al., 1981; Tolleshaug and Berg, 1981), 
perfused rat liver (Dunn et al., 1979; Ward et al., 1979), perfused 
rat heart (Ward et al., 1979), cultured fetal mouse heart (Libby 
et al., 1979) and cultured 1 7 .5-day rat yolk sac (Knowles et al., 1981).
In the present experiments, the effects of leupeptin upon pinocytosis 
and proteolysis by the yolk sac of the early organogenesis-stage 
conceptus in vitro has besi studied. An effect of leupeptin on the 
yolk sac—mediated pathway of protein utilisation by embryos, due to 
an inhibition of proteolysis in yolk sac lysosomes, would be expected 
to cause a reduction in the flow of nutrient amino acids to the embryo,
9.1 Introduction
CH-CO-NH-■CH-CO-NH-CH-CHO
CH CH <“ 2 ) 3
CH-CH CH-CH 1 * JNHi 0
CH3
i J
CH3 C=NH
Ñh 2
Figure 9.1 Structural formula of 
leupeptin (acetyl-L-leucyl-L-leucyl- 
L-arginal)
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and as a consequence this might result in teratogenesis. A toxic effect 
of leupeptin on cultured 9.5-11.5-day conceptuses has teen demonstrated 
(F. Beck, personal communication), but whether leupeptin is teratogenic 
to rat embryos following maternal injection is hot known. In this 
chapter, a limited study of the teratogenicity in rats of maternally- 
administered leupeptin is described.
q,2 Materials 
Chemicals
Leupeptin
All other
The Peptide Center, Protein Research 
Foundation, Osaka, Japan, 
chemicals used have been listed in previous chapters.
9.5 Methods
9.5.1 Teratogenic Testing of Leupeptin
The procedure was as described for trypan blue (5.3.3). Leupeptin was 
administered at a dosage of 50 mg/kg.
9.3.2 Culture Experime nt s
The procedure was as described for tiypan blue (5 .3.4). In cultures 
that used 1 2 5I-PVP as substrate, leupeptin was added to the culture 
medium to a final concentration of 2 5 , 5 0, 10 0, 200 and 5 0 0 /ig/ml.
For subsequent experiments with 1 2 5I-dBSA and %-labelled serum proteins 
as substrates, leupeptin was added to a final concentration of 25 or
200 /ig/ml.
9.4 Results
9.4.1 Teratogenic Testing of Leupeptin
Injection of leupeptin (5 0 mg/kg) into pregnant rats at either 8 .5  or
9 .5  days of gestation resulted in the production of malformed fetuses
I
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(Table 9*1)• Following injection at 8 .5  days, a resorption rate at 
term of 24% was observed. Of the surviving fetuses, more than 50% 
were visibly externally malformed, and the proportion of fetuses 
that were subsequently sectioned that showed malformations was 73%.
The most common defects observed in this group (Table 9.2) were 
anophthalmia, microphthalmia, hydrocephalus and kidney malformation. 
Maternal injection at 9 .5  days gave rise to a high incidence of 
resorption (48%) but a low malformation rate (Table 9.1). Only 3 of 
the 25 surviving fetuses were externally malformed and inspection of 
these surviving fetuses for visceral and skeletal anomalies showed 
no further malformations. The average weight of fetuses of both 8 .5- 
and 9 .5-day injected groups was significantly ( p < 0 .00l) lower than 
control fetuses from pregnant rats injected with saline at the 
corresponding stages of gestation.
9.4 .2  Culture Experiments
The viability of conceptuses exposed in culture to leupeptin for a 
period of 6 hours, either from 36 to 42 hours or from 42 to 48 hours, 
did not differ from that in cultures in which leupeptin was absent from 
the culture medium, and was at least 95%. Furthermore, no developmental 
deviations were noted among conceptuses exposed to leupeptin during 
culture.
At concentrations of leupeptin of 500 jig/xol or less, present in the 
culture medium for the final 6 hours, the protein contents at harvesting 
of yolk sacs were approximately twice the control value while the protein 
contents of embryos were progressively reduced by an increasing 
concentration of leupeptin, to about 7C% of controls (Figure 9.2).
When leupeptin (2 5 or 200 pg/.ml) was present in culture between 36 and
Nature and J 
time of 
injection
IT°r °F iitreated1 )
No. of I 
implantations 
(% resorptns)
Av. weight 
surviving 
fetuses (g) --
-—
4r+ ernal Abnorrr ^surviving 
fetuses
lalities i No. of
% total \ fetuses 
implntnsi sectioned 
-^------- 1 ' ' - ■■
iio.(-o) sectioned 
fetuses with 
. anomalies
No.of fetuses 
stained with 
alizarin
No.(b^  stained 
fetuses with 
anomalies
Leupeptin 
8.5 days 4 51 (24) 3.45 +1.1* H 
1 
CM 
,
53.85 41.18 | 26 19 (73) 13 0
Leupeptin 
9.5 days 4 48 (48) 3.32 + .42* 3 8.00 4.17 17 2 (1 2 ) 8 0
Saline 
8.5 days 4 45 (4) 4.19 +.42 0 0 0 28 0 15 0
Saline 
9.5 days 4 44 (5) 4.40 +.60 0 0 0 30 0 12 0
* significantly different from saline-injected controls (p< 0.0 0 1)
Table 9.1 Effects on offspring of s.c. injection of leupeptin (50 mg/kg) or saline (0.9%) into pregnant rats. 
Details of method are given in text.
Day of injection 
of leupeptin 8.5 9.5
Abnormality
Anophthalmia 22 (39) 2 (25)
Hydrocephalus 9 (2 1) 0
Kidney (deformed) 9 (2 1) 0
Facial defects 1 (39) 0
Limb defects 0 1 (25)
Tail defects 0 1 (25)
Table 9.2 Abnormalities of fetuses after 
leupeptin treatment of pregnant rats.Figures 
in brackets indicate the size of the population 
examined for the particular defect.
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Figure 9.2 Protein contents of yolk sac (filled symbols) and 
embryo (open symbols) after incubation of conceptuses in the 
presence of leupeptin for either the final 6 hours (squares) 
or the penultimate 6 hours (triangles) of culture, 
means of at least 6 determinations.
Values are
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4 2 hours, the yolk sac protein content was again approximately twice 
the control value, but the embryo protein content fell to about 46%  of the 
control value, at the highest concentration of leupeptin used (Figure 
9.2).
When leupeptin was present with 1 25l-FVP (2.3 /ig/ml), for the final 
6 hours of culture, there was no uptake of radioactivity into embryos 
by harvesting (Figure 9.3)* In the yolk sac, the uptake of radioactivity 
was apparently decreased to between 56%  and 72%  of the control value.
This decrease was independent of leupeptin concentration.
Exposure of conceptuses for the last 6 hours of culture to leupeptin 
(25 or 200 jug/ml) and 1 2 5l-dBSA (11 jag/ml) resulted by harvesting in 
little radioactivity being associated with embryos (Figure 9-4)» All 
of this radioactivity was TCA-soluble. At both leupeptin concentrations 
used the total amount of radioactivity processed by conceptuses was 
decreased to a level approximately one half of the control. B y far 
the greater proportion of this radioactivity was retained within the 
yolk sac; 77% following a leupeptin concentration of 25 yug/ml and 94% 
at a leupeptin concentration of 200 ^ g/ml (Figure 9-4). At either 
leupeptin concentration, yolk sac-associated radioactivity at 
harvesting was more than 95% TCA-insoluble. In controls only 12% 
of the total radioactivity processed by conceptuses was yolk sac- 
associated at harvesting, of which 65%  was TCA-insoluble.
When leupeptin was present in culture between 36 and 42 hours, and 
1 25i_dBSA was present from 42 hours to harvesting, embryos at harvesting 
contained little radioactivity, all TCA-soluble (Figure 9-5). Total 
radioactivity processed by conceptuses exposed to leupeptin was slightly 
leSs than one half the control value. As before, a very high proportion
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Figure 9.3 Radioactivity associated with yolk sac (■) and 
embryo (□) after incubation of conceptuses in the presence of
i  r\ r I-PVP'(2.-3 jig/ml) and leupeptin for the final 6 hours of 
culture. Values are means (+ S.D.) of at least 6 determinations.
60 r
Leupeptin concentration (^ ig/ml)
Figure 9.4 Total radioactivity taken up by yolk sac (each left
hand column) and embryo (each right hand column), and the
radioactivity associated with the yolk sac (total shaded area
of each left hand column) after incubation of conceptuses in the 
125presence of I-dBSA (11 jig/ml) and leupeptin for the final 6 
hours of culture. The proportions of yolk sac-associated and 
embryo-associated radioactivity that were TCA-soluble v'.v, and 
TCA-insoluble are indicated. Values are means (_+ S.D.) of
at least 6 determinations.
i
60
Leupeptin concentration (jig/ml)
Figure 9.5 Total radioactivity taken up by yolk sac (each left hand 
column) and embryo (each right hand column), and the radioactivity 
associated with the yolk sac (total shaded area of each left hand 
column) after incubation of conceptuses in the presence of 125I-dBSA 
(11 jig/ml) for the final 6 hours, and leupeptin for the penultimate 
6 hours of culture. The proportions of yolk sac- and embryo-associated
radioactivity that were TCA-soluble »*«*«
indicated. Values are means (+ S.D.) of
and TCA-insoluble ^  are 
at least 6 determinations.
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of this radioactivity remained associated with the yolk sac at harvesting;
8CP/o following a leupeptin concentration of 25 yug/ml and 91% at a 
leupeptin concentration of 200 ¿ig/ml. More than 90% of the yolk sac- 
associated radioactivity was TCA-insoluble. In controls, only 16% of 
the total radioactivity processed by conceptuses was yolk sac-associated 
at harvesting and of this 47% was TCA-insoluble.
The uptake of radioactivity by conceptuses, cultured for the final 6 hours 
in serum containing %-labelled proteins and leupeptin did not differ 
much from the control value (Figure 9.6). However, the distribution of 
radioactivity between yolk sac and embryo was affected by leupeptin, 
a greater proportion being associated with the yolk sac. At a 
leupeptin concentration of 25 jag/ml, 82% of the total radioactivity 
in the conceptus was yolk sac-associated while at a leupeptin concentration 
of 200 /ig/ml, 9C% of the radioactivity was yolk sac-associated. In both 
cases the proportion of the yolk sac-associated radioactivity that was 
TCA-insoluble was more than 90%. In controls, only 39% of the total 
radioactivity in the conceptus was yolk sac-associated (70% TCA-insoluble). 
Interestingly, the proportion of the decreased levels of radioactivity 
in embryos exposed to leupeptin was more than 90% TCA-insoluble 
(controls less than 80%).
When conceptuses were exposed to leupeptin (2 5 or 200 jag/ml), present 
in culture from 36 to 42 hours, before being transferred to serum 
containing ^H-labelled serum proteins, little effect on the uptake 
of radioactivity by conceptuses at harvesting was observed (Figure 9 .7 ).
At 25 jig/ml, leupeptin increased the proportion of radioactivity that 
was yolk sac-associated to 89%, compared with a control value of 47%.
At 200 ^ ig/ml of leupeptin, the yolk sac-associated radioactivity constituted 
97%  of the total radioactivity of the conceptus. At both concentrations
Leupeptin concentration (jig/ml)
Figure 9.6 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity associated with the yolk sac (total shaded area of 
each left hand column) after incubation of conceptuses in the 
presence of j^njleucine-labelled serum proteins and leupeptin 
for the final 6 hours of culture. The proportions of yolk sac- 
and embryo-associated radioactivity that were TCA-soluble 1 ^  
and TCA-insoluble are indicated. Values are means (+_ S.D.) 
of at least 6 determinations.
15
Leupeptin concentration (jig/ml)
Figure 9.7 Total radioactivity taken up by yolk sac (each left 
hand column) and embryo (each right hand column), and the 
radioactivity that was associated with the yolk sac (total shaded 
area of each left hand column) after incubation of conceptuses 
in the presence of ^ h|leucine-labelled serum proteins for the final 
6 hours, and leupeptin for the penultimate 6 hours of culture. The 
proportions of yolk sac-- and embryo-associated radioactivity that 
were TCA-soluble v.v1 JLt_L and TCA-insoluble are indicated. Values
are means (+ S.D.) of at least 6 determinations.
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of leupeptin employed, more than SSP/o of the yolk sac-associated 
radioactivity was TCA-insoluble (control yolk sac-associated 
radioactivity 3T/o TCA-insoluble) and all the embryo-associated 
radioactivity was TCA-insoluble (control embryo-associated radio­
activity 65% TCA-insoluble).
q .5 Discussion
The teratogenicity of leupeptin in rats has not previously been fully 
reported. Umezawa and Aoyagi (1977), quoting unpublished data of 
Matsuzaki, claimed that following oral administration of 200 mg/kg 
of leupeptin to pregnant rats daily from the seventh to the fourteenth 
days of pregnancy abnormal growth of bones occurred in 4 out of 200 
fetuses, and that subcutaneous injection of 50 mg/kg of leupeptin 
into pregnant rats on the seventh and eighth days, or ninth and tenth 
days of pregnancy, inhibited the growth of bone of fetuses and induced 
abnormalities of the skull and sternum. In the present experiments, 
the results of a limited study of the effects on embryos of leupeptin, 
injected into pregnant rats at 8.5 or 9.5 days of gestation, clearly 
demonstrate that leupeptin is both teratogenic and embryolethal. 
Furthermore, the data indicate that, in common with trypan blue, 
leupeptin is rather more teratogenic when administered to mothers at 
8 5 days of gestation than at 9*5 days. As with other teratogens 
that act during organogenesis, the most common defects elicited by 
leupeptin were anophthalmia, microphthalmia and hydrocephalus. In 
contrast to the report of TJmezawa and Aoyagi (1977), no defects of 
the skeleton were observed.
The presence of leupeptin in culture for 6 hours caused a marked 
alteration in the protein contents of yolk sacs and embryos at 
harvesting. Compared with controls, leupeptin caused a doubling of
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the protein contents of yolk sacs and a decrease in the protein 
contents of embryos. Since leupeptin is known not to affect protein 
synthesis (Seglen, 1978; Libby et al., 1979), the only interpretation 
of these data is that leupeptin induces storage of pinocytosed protein 
in the lysosomes of the yolk sac through an inhibition of proteolysis. 
This in turn would reduce the supply of amino acids available for the 
synthesis of embryonic proteins and cause a decrease in the total 
protein content of embryos. Such an interpretation is confirmed by 
the observations that when conceptuses were cultured for the final 6
presence of leupeptin in culture, either from 36 to 42 hours, or from 
4 2 hours to harvesting, caused a large proportion, always greater than 
8C9á, 0f the total radioactivity in the conceptus to be retained within 
the yolk sac.
The uptake of radioactivity by yolk sacs when conceptuses were exposed 
125f_pvp and leupeptin for the final 6 hours of culture, was 
decreased to levels of between 70% and 55% of the control, though 
there was no relationship between the decrease in uptake of radio­
activity and the concentration of leupeptin in the culture medium.
It is noteworthy that the increase in protein contents of yolk sacs 
at harvesting, following exposure to leupeptin for the final 6 hours 
of culture, was also independent of the leupeptin concentration. In 
the calculation of uptake of radioactivity (see Chapter 2), uptake is 
expressed per mg protein content of tissue. Since an increase in the 
protein content of the yolk sac, not through growth, but through lyso­
somal storage of protein would not cause a corresponding increase in 
the quantity of 12^I-FVP associated with that tissue, the apparent 
decrease in 12^I-PVP uptake by yolk sacs in the presence of leupeptin
hours in a serum whose proteins
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is entirely due to the elevated protein level of the yolk sac caused 
hy the leupeptin, and not to an inhibition of pinosome formation. In 
other words, the quantity of radioactivity per yolk sac was not
7
affected. Of course, with -\H-labelled serum proteins as substrates, 
no decrease in uptake of radioactivity by yolk sac would be observed 
since it is these proteins that are being accumulated in the lysosomes 
of the yolk sac. Consequently, the amount of radioactivity in the 
yolk sac will increase in proportion to the quantity of protein 
accumulated. The uptake of 125l-dBSA, present in culture for the 
final 6 hours, when conceptuses were incubated in the presence of 
leupeptin for 6 hours, either from 36 to 42 hours, or 4 2 to 48 hours 
of culture, was decreased to roughly the same extent as ’'^5x_pvp uptake. 
Similarly, this decreased uptake can be wholly attributed to the rise 
in protein content of the yolk sac as a result of exposure to leupeptin.
Taken together, these data demonstrate that at the concentrations used, 
leupeptin does not affect the rate of pinocytosis in the early organo­
genesis-stage yolk sac. This is consistent with previously reported 
observations (Berg et al., 1981,* Knowles et al., 1981) which showed 
that leupeptin at either 50 /tg/ml or 15 0 pg/ml, did not inhibit the 
uptake of "^I-labelled asialoglycoproteins by isolated rat hepato- 
cytes or 125l-dBSA by the cultured 17.5-day rat yolk sac.
The degradation of pinocytosed 125l-dBSA and ^H-labelled serum proteins 
by yolk sac was strongly inhibited by leupeptin. This is evidence by 
the observations that leupeptin added to the culture medium either 
before or together with the radiolabelled proteins caused a very 
large proportion of the pinocytosed radiolabel to remain associated 
with the yolk sac. Generally, this proportion was slightly more when 
conceptuses were exposed to leupeptin before radiolabel, in contrast
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to the findings of Knowles et al. (1981) who found that yolk sacs,
following their exposure to leupeptin in vitro, quickly recovered
their ability to degrade "^i-cLBSA on re-incubation in leupeptin-free
medium. Furthermore, always more than 9C% of the yolk sac-associated
radioactivity was insoluble in TCA. This large inhibition of the
degradation of pinocytosed protein, as a result of treatment with
leupeptin, is in agreement with previous reports (Dunn et al., 1979;
Ose et al., 1980; Berg et al., 1981; Knowles et al., 1981; Tolleshaug
and Berg, 1981). In view of the findings (Euisman et al., 1974;
fu lKirschke et al., 1977) that leupeptin is a powei^ inhibitor of the 
lysosomal cysteine proteinases cathepsins B and L, but not of the 
lysosomal aspartic proteinase cathepsin D, the most likely explanation 
of these results is that the inhibition of the degradation of 2^^I-dBSA 
and 3H-labelled serum proteins by 9.5-11.5-day yolk sac is effected 
by direct action of leupeptin on degradative enzymes. There are two 
corollaries of such an explanation. Firstly, leupeptin gains access 
to lysosomes, either by pinocytosis or by permeation of the plasma 
and lysosomal membranes. Secondly, the digestion of JI-dBSA and 
¿H-labelled serum proteins in visceral yolk sac is due largely to the 
action of cysteine proteinases. This latter proposal receives strong 
support from the observation (Huisman et al., 1974) that an inhibition 
by leupeptin of more than 95% of cathepsin B activity resulted in a 
strongly decreased rate of degradation of serum albumin by rat liver 
lysosomal extracts. Knowles et al. (1981) observed that leupeptin 
caused more than 75% of 125I-dBSA, taken up by cultured 17.5-day yolk 
sac to remain associated with the tissue after a 5-hour incubation, 
compared with a control value of only 22%. These authors concluded 
that cysteine proteinase(s) must be rate-limiting for the degradation 
of pinocytosed albumin. In neither of these studies did pepstatin,
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a microbial peptide that inhibits cathepsin D (Umezava and Aoyagi, 1 9 7 7), 
influence the rate of degradation of albumin, indicating that in these 
tissues cathepsin D is of little importance in albumin degradation.
In addition to inhibiting the breakdown of 1 l a b e l l e d  asialofetuin 
by isolated rat hepatocytes, leupeptin was also considered (Berg et 
al., 1981? Tolleshaug and Berg, 1981) to inhibit the fusion of 
pinosomes and lysosomes in these cells. Subcellular fractionation 
studies showed that undegraded 1 2 5I_labeUed agialoretuin accufflulated 
both in heterolysosomes and in an organelle of lower density (presumed 
by these authors to be a pinosome). A similar mechanism of action of 
leupeptin could be operating in the early organgenesis-stage yolk sac. 
However, the overall effect of leupeptin, an increase in the yolk sac- 
associated radiolabelled protein and a decrease in the embryo-associated 
radioactivity, would remain the same.
The efficacy of leupeptin in inhibiting the yolk sac-mediated pathway 
of protein utilisation by the early organogenesis-stage conceptus may 
be important in the teratogenic mechanism of leupeptin. However, 
other factors must be considered before any fira conclusions can be 
drawn. For example, some of the proteins present in the plasma 
transudate that bathes the conceptus in utero may not, unlike those 
chosen in the present in vitro studies, be degraded by cysteine 
proteinases to any important degree and hence would not be affected 
by leupeptin. Furthermore, by inhibiting cysteine proteinases, 
leupeptin may secondarily be acting upon other cellular enzymes and 
proteins whose normal turnover is dependent on the action of lysosomal 
proteinases, and whose accumulation in cells may be deleterious. It 
has recently been found (Kominami et al., 1981a, b) that leupeptin, 
administered to rats, labilised membranes of liver lysosomes as
- 144 -
evidenced by the increased activities of a range of lysosomal ensues 
in the cytosol of liver cells, and the greater sensitivity of isolated 
lysosomes to osmotic shock. A similar action of leupeptin on the 
lysosomes of the visceral yolk sac endodermal cells might produce a 
more general toxic effect on these cells, which in turn might adversely 
affect the embryo. Alternatively, leupeptin may be able to penetrate 
directly to the embryo and produce a toxic effect there, the action 
of the peptide on yolk sac lysosomal proteolysis being of only secondary 
importance. Finally, an effect of leupeptin on the mother, which 
secondarily affects the embryo, cannot be ruled out, althouJiEeck 
(personal communication) has noted an embryotoxic effect of leupeptin 
invitro, indicating that it is able to act on the developing conoeptus 
independently of the maternal organism.
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.CHAPTER TEN 
GENERAL DISCUSSION
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10,1 Histiotrophic Nutrition
Beck et al. (1967a) proposed that the visceral yolk sac fulfilled an 
important nutritional function during the early organogenesis period of 
rat embryogenesis. the evidence for this proposal is, as emphasised 
in the General Introduction to this Thesis, of a rather circumstantial 
and limited nature. In Chapters 2, J and 4 of the present study, 
experiments designed to test critically the hypothesis of Beck et al. 
have been described. The data from these experiments provide, in my 
mind, conclusive evidence that the yolk sac performs a critical 
nutritional function during early organogenesis by a mechanism entirely 
concordant with that proposed. Although these data have already been 
discussed in preceding Chapters, it is appropriate here to consider 
them in a broader context and to indicate specific areas of the 
nutritional scheme in which our knowledge is still incomplete.
Figure 10.1 represents diagrammatically the data of Chapters 2, 3 and
4. The visceral yolk sac endoderm pinocytoses macromolecules from the 
extracellular fluid and incorporates them into heterolysosomes in the 
apical regions of the cell. The observations that non-digestible 
macromolecules, 125I-PVP and [^ h] dextran, are accumulated in the 
yolk sac and do not gain access to the embjyo, suggest that the yolk 
sac is the only tissue of the early organogenesis-stage conceptus which 
macromolecules can enter. This suggestion is strengthened by the 
finding that 125I-iBSA, a more physiological substrate, does not 
penetrate intact to the embryo, but is taken into the yolk sac by 
pinocytosis. The further observation that 125I-d3SA is degraded in the 
yolk sac lysosomes demonstrates this tissue’s ability to hydrolyse 
proteins, an essential pre-requisite according to the model (Figure 10.1 )
hw,t*'>enfc jjrol-e-i*
moleculti
Figure 10.1 Proposed pathway of yolk sac-mediated protein
nutrition of early organogenesis-stage rat embryo.
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However, it was suggested (Section 5.5 ) that yolk sac intralysosomal 
hydrolysis of ^^j-dBSA, a heterologous protein, might simply he a 
mechanism to de-toxify a potentially harmful foreign substance and that 
homologous proteins, abundantly present in the culture serum in vitro, 
and in the fluid surrounding the conceptus in útero (vide infra), 
traversed the yolk sac in vesicles that did not fuse with lysosomes 
and hence were not degraded but were delivered intact to the embryo. 
There are reports in the literature which demonstrate that passage 
of intact homologous proteins across the rat yolk sac does occur. 
Mayersbach (1958) showed that fluorescent-labelled homologous serum 
proteins, injected into the maternal blood during the last third of 
gestation, could be traced through the visceral yolk sac endodermal 
cells and into the fetus. Brambell and Halliday (19 5 6) and Anderson 
(1 9 5 9 ) observed a transfer of gamma-globulins across the visceral 
yolk sac from the mother to the fetus. Masters et al. (19 6 9) confirmed 
this finding and also observed that radiolabelled albumin and transferrin 
were transmitted to the fetus in small quantities during the last 5 days 
of gestation. It is interesting to note too the observations of Schultz 
(1 9 6 6 ) who found that a small but significant amount of yeast invertase 
a foreign protein, was transferred from mother to fetus as early as day 
1 2  of gestation. It was unclear however whether this protein was 
transmitted through the yolk sac or the chorioallantois. In other rodent 
species, the transfer of maternal proteins to the fetus by a route 
through the yolk sac has also been reported. During the second half of 
g-estation, the guinea pig fetus received intact homologous (Anderson and 
heissring, 19 6 1; Leissring and Anderson, 196l) and heterologous (King 
gxid Bnders, 1 9 7 0) proteins that had been injected into the mother.
Shortly after implantation of the mouse embryo, maternal immunoglobulins
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were detected in the cells and fluida of the embryo (Eernaxd et ^  
1977). This latter study is of particular significance since, in 
contrast to the others cited, it demonstrates that intact maternal 
protein crosses the yolk sac during early organogenesis, a time 
during which yolk sac-mediated histiotrophic nutrition is presumed 
to be of greatest importance. It should be added though that only a 
very small fraction of the considerable quantity of maternal protein 
taken into the yolk sao cells actually found its way into the embryo, 
and besides, the transfer of gamma globulins into the embryo or fetus 
at any stage of gestation is unlikely to be of nutritional importance, 
but rather would serve to endow the fetus with some immunity in 
preparation for the immediate post-natal period when the newborn's own 
immune system is yet poorly developed.
In the present study, radiolabel, derived from homologous serum proteins 
or haemoglobin present in the culture medium, was detected in large 
amounts and associated with many different proteins in the tissues of 
the embryo and the yolk sac. Prom the kinetics of uptake of radiolabel 
into the conceptus and the time-dependent ratio of TCA-soluble to 
-insoluble radioactivity in the tissues, it was argued (Section 4 .5 ) 
that very little, if any, of the radioactivity in the embryo was due 
to uptake of intact radiolabelled proteins present in the culture 
medium, but that it was derived from digestion of pinocytosed radio- 
labelled proteins in the yolk sac lysosomes. Hence the hypothesis that 
the uptake and digestion of 1 2 5I-cLBSA by the yolk sac is an 
action specifically directed against foreign proteins cannot be 
sustained; it is clearly an example of a general response by yolk sac 
to most, probably all, proteins to which this tissue is exposed, and 
which forms the basis of the yolk sac's nutritional role during early 
organogenesis. Furthermore, if the passage of intact homologous protein
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to the embryo were the essence of histiotrophic nutrition, it would be 
expected that an absence of such homologous protein from the environment 
of the conceptus would prevent normal growth and development of the 
embryo. The findings that early organogenesis-stage conoeptuses can 
be cultured in human (Chatot et al., 1980) and fetal calf (Fisher, 1981) 
serum, clearly indicates the non-toxic nature of heterologous proteins.
One final piece of evidence that demonstrates unequivocally that rat 
serum proteins do not enter the embryo intact comes from the observations 
(reported in Chapter 9) that the lysosomal proteinase inhibitor 
leupeptin, added to cultures with radiolabelled serum proteins, effectively 
blocked the uptake of radioactivity into the embryo and caused a 
concomitant accumulation of undigested radiolabelled protein within the
yolk sac.
The mechanism of utilisation of protein by the early rat conceptus 
outlined here, contains striking parallels to that proposed for the 
chick embryo (Hassell and Klein, 1971; Klein, 1975). The chick yolk sac 
is divided into two zones, the area pellucida, proximal to the developing 
embryo, and the area opaca, distal to the embryo. It is the area opaca 
that has been observed to ingest and degrade the radiolabelled egg white 
protein [14cJ ovalbumin, present in the medium in which chick embryo 
explants were cultured. The digestion products, amino acids, were 
utilised in the synthesis of embryonic proteins. The uptake of 
[1 4 c] ovalbumin by the area pellucida ox the embryo itself, was not
observed.
A feature of this mechanism, and equally of that proposed in the present 
study for the rat conceptus, is that the site of synthesis of embryonic 
protein is unknown. There are two possibilities. The amino acids 
produced by proteolysis in the yolk sac either diffuse, or are transported
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into the embryo and are there incorporated into newly synthesised 
proteins, or they are utilised for synthesis of embryonic protein 
in the yolk sac, and then transported into the embryo. The latter 
possibility is perhaps more likely once the vitelline circulation 
has been established (around gestational-day 10,5). The 15-day rat 
yolk sac is able to synthesise alphafetoprotein (Gitlin and Boesman, 
1 9 6 7 ), as is the 1 2 -day mouse yolk sac (Dziadek and Adamson, 1978; 
Dziadek, 1978), the 15-day rabbit yolk sac (Branch and Wild, 1972) 
and the chick yolk sac (Gitlin and Kitzes, 19 6 7). Furthermore, the 
visceral yolk sac endoderm of the chick embryo has been identified 
as the exclusive site of serum protein synthesis (Young et al., 1980). 
Whether mammalian, in particular the rat, yolk sac is able to syn­
thesise proteins during early organogenesis is unknown, except in 
the mouse yolk sac in which alphafetoprotein synthesis does not 
occur before the 1 2 th day of gestation (Dziadek and Adamson, 1978), 
well after the formation of a functional chorioallantoic placenta.
Further work is required before this aspect of yolk sac-mediated 
protein nutrition is more fully understood.
That the yolk sac can serve an important and elaborate function in 
the protein nutrition of the early rat conceptus, and presumably in 
nutritional mechanisms involving other classes of biological macro- 
molecules, is not in reasonable doubt, and the finding of Cockroft (1 9 7 9), 
confirmed in the present study, that early organogenesis-stage 
conceptuses grow and develop normally in vitamin- and glucose-supplemented 
dialysed serum clearly demonstrates that exogenous proteins alone are 
perfectly adequate in supplying the embryo with amino acids. What is 
less certain however is whether such a process is of quantitative 
significance to the developing conceptus in útero. It was demonstrated
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in Chapter 4 that L-leucine successfully competed with j>£j leucine, 
derived from digestion in the yolk sac of |Vj leucine-labelled serum 
proteins, for incorporation into embryonic proteins. It is clear 
therefore that the ratio of protein to free amino acid in the 
environment of the conceptus will be of critical importance in 
determining the extent to which proteolytically-derived amino acids 
are utilised in embryonic protein synthesis. In an electron micro­
scopical study, Merker and Villegas (19 7 0) examined the nature of the 
fluid bathing the rat conceptus during early organogenesis. These 
workers described a periembryonal sinus which surrounds the conceptus 
and which contains sluggishly-moving maternal blood, delivered to 
this region by the decidual blood vessels. In such a relatively static 
medium, free amino acids would quickly be used up and not replaced 
by fresh blood, and in any case, the concentration of free amino acid 
in rat plasma is more than 10 0 times less than protein-bound amino 
acid (Long, 1 9 6 1). In view of this, proteins present in the peri­
embryonal sinus are likely to be of maximum importance in the provision 
of amino acid precursors for the synthesis of embryonic proteins, and 
it is concluded that the visceral yolk sac, by the mechanism demon­
strated in.vitro, is of paramount significance in furnishing the 
early organogenesis-stage rat conceptus with such amino acids in útero
10.2 Histiotrophic Nutrition as a Target for Tera.try^o
The early organogenesis period of rat embryonic development is the time 
both when yolk sac-mediated histiotrophic nutrition is at its height 
and the embryo is maximally sensitive to teratogenic insult (Wilson, 
-1 9 7 3 ). The nutritional mechanism would appear therefore to be a likely 
and vulnerable target for the actions of some teratogens (Lloyd et 
al., 1974), and there are many reports in the literature (reviewed
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by Giroud, 1968, and Hurley, 1977) of embryotoxieity and teratogenesis 
resulting from nutritional deficiency.
Brent and Franklin (i960) showed that clamping the uterine blood vessels 
of 9 .5-day pregnant rats effectively blocked the uptake of maternally- 
injected macromolecules by the visceral yolk sac. Clamping for periods 
of between only 50 minutes and 5 hours induced embryo resorption and 
malformation, thus demonstrating a correlation between reduced 
histiotrophic nutrition and teratogenesis. Conceivably, any substance 
capable of inhibiting pinocytosis and/or proteolysis, processes here 
shown to be essential for the utilisation of exogenous protein by the 
conceptas during early organogenesis, is also a potential teratogen.
To exert a direct action on yolk sac-mediated protein nutrition, the 
teratogen must be present, in an active form, in high enough concentration 
in the maternal plasma that bathes the conceptus during the susceptible 
period.
Three teratogens employed in the present study, trypan blue, suramin 
and sodium aurothiomalate, have all been proposed to exert their 
teratogenic action by disturbing yolk sac nutritional function. All 
three substances localise in the yolk sac lysosomes following their 
pinocytic uptake by yolk sac cells, and also bind avidly to plasma 
proteins (see Chapters 5 , 6 and 7 for references). In the case of 
trypan blue, it is the free dye molecule, and not the protein-bound 
form, that is considered to be active in inhibiting pinocytosis 
(Willia® 3 et al., 1976), and hence teratogenesis. The failure of 
trypan blue in the present study to inhibit the rate of pinosome 
formation suggests that insufficient free dye was present in the 
culture medium, most of it being bound to serum proteins. It is
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predicted that elevation of the total trypan blue concentration in 
the culture medium would eventually result in a high enough concentration 
of free trypan blue to inhibit pinocytosis. Similarly, a very high 
concentration of trypan blue in the plasma surrounding the conceptus 
in utero would be necessary to saturate the binding capacity of plasma 
proteins and enable sufficient free trypan blue to inhibit pinocytosis 
by the yolk sac.
Suramin appeared to affect protein utilisation by cultured conceptuses 
in two ways, by inhibiting pinocytosis of protein by the yolk sac, and 
also by inhibiting the fusion of pinosomes with lysosomes, thus 
preventing proteins from being digested by lysosomal enzymes. It is 
perhaps significant, in view of the foregoing discussion of trypan 
blue, that high concentrations of suramin were necessary to produce 
this effect.
Sodium aurothiomalate affected the protein nutrition of cultured 
conceptuses by inhibiting the yolk sac intralysosomal degradation of 
pinocytosed serum proteins. The consequence of this action was to 
reduce the amount of amino acids available for protein synthesis in 
the embryo and, as discussed in Chapter 7, this probably constitutes 
the mechanism of teratogenic action of aurothiomalate.
iphe effects of anti-visceral yolk sac antiserum in inhibiting pinocytosis 
by the yolk sac (Chapter 8) and leupeptin, a potent inhibitor of 
lysosomal proteolysis (Chapter 9), were clear cut. The powerful action 
exerted by these teratogens on protein utilisation by conceptuses most 
^^j^gly represents their mode of teratogenesis.
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Substances that produce their teratogenic effect by inhibiting 
pinocytosis by the visceral yolk sac would cause a deficiency in 
the amount of pinocytosed substrate reaching the conceptúa tissues. 
Proteins would be the host important, if not the only, maeromolecules 
in short supply. It is known that in vitro, glucose can satisfy 
the energy requirements of the conceptúa (Shepard et al., 13?0. 
Taniumra and Shepard, 15 7 0, Cockroft, 1979, Sanyal, 19 00). Given 
that rat plasma contains little polysaccharide but a relative abundance 
of free glucose, and that glucose is able to permeate cell membranes 
and does not rely on pinocytosis for its entry into cells, inhibition 
of pinocytosis by the yelk sac is unlikely to affect the energy meta- 
holism of conceptuses. The observation (Cockroft, 1979) ttot folio 
acid, an important coenzyme in nucleic acid biosynthesis, is 
essential for normal development of conceptuses in vitro, together with 
the facts that folic acid deficiency in_vivo is teratogenic (reviewed 
h y  Hurley, 1977) and insignificant counts of nucleic acid are present 
in plasma, demonstrates that conceptuses are able to synthesise their 
own nucleic acids and are not dependent on an exogenous source.
Nucleic acid metabolism too therefore will not be directly affected 
hy inhibitors of pinocytosis by yolk sac. Inhibition of yolk sac 
intralysosomal proteolysis would of course result in embryonic protein 
malnutrition. A second important effect of proteolysis inhibition 
m i g h t  he that deficiencies of certain essential amino acids occur.
It is interesting to note that trypan blue-treated pregnant mice, 
given a diet supplemented with the essential amino acid L-threonine, 
produced significantly fewer offspring with exencephaly than controls 
receiving no L-threonine supplement in their diets (Zawoiski, 1980). 
Supplementation of the diet with other, non-essential, amino acids 
failed to produce this effect.
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From the results of the experiments described in Chapters 5 to 9 
of this Thesis, it can be concluded that yolk sac mediated histiotrophic 
n u t r i t io n  is, in all probability, a target for certain teratogens.
Whole-Embryo Culture
Throughout this study extensive use has been made of the „hole-embryo 
culture technique developed by New and associates (New et al., 1 9 7 3, 
1 9 7 6 a). This technique, along with its variations (reviewed by New, 
1 9 7 8 ), has provided mammalian embryologists with an invaluable tool 
for the investigation of various aspects of embryonic development. 
Through the use of such culture methods important advances have been 
made in the study of teratogenic mechanisms (New and Brent, 1 9 7 2 . 
Horriss and Steele, 1974! Steeie et al., -,9 7 4. Cockroft and New, 1 9 7 5 . 
Kochhar, 1 9 7 5 1 Hew, 1976, 1978; Cockroft and Coppola, 1 9 7 7, Bauchar, 
1979; mrkes et al., 1981; Sanyal et al., 1 9 8 1), morphological and 
functional development of the embryo (Deuchar, ,9 7,. payne and Deuchar, 
1 9 7 2 ; Steele and New, 1974; Eobkin et al., 19 7 6; Morriss and New, 19 7 9) 
and aspects of embryonic metabolism and biochemistry (Cockroft, 19 7 9. 
Sanyal, 1980; Shepard et al., 1970; Tanimura and Shepard, 19 7 0). It 
is hoped that the present study has made a significant and worthwhile 
contribution to the rapidly expanding corpus of knowledge of early 
mammalian embryology that has been due largely to the advent of 
simple and reliable culture techniques.
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